Merck's Keytruda Receives First-Line Nod From FDA In Lung Cancer: What Does It Mean? https://t.co/OYkEXSVFr8  Markets  Finance  TCOT
Merck beats by  0.09, beats on revenue https://t.co/4jW8aIlNAU  Merck
 BMY  Merck:

Merck‚Äôs Keytruda Receives First-Line Nod From FDA In Lung ‚Ä¶:

https://t.co/Oet0jT8SF5
Can Merck's top performers keep new generics, biosims at bay? https://t.co/QMbTtwJGt4
Merck's Keytruda wins coveted first-line lung cancer nod, cementing rise 'from laggard to leader' https://t.co/duhhzLvKjc
Better Buy: Merck & Co. Inc. vs.  AbbVie Inc. Read more: https://t.co/IT3t58EU8O  ABBV
Better Buy:  Merck & Co. Inc. vs. AbbVie Inc. Read more: https://t.co/7VYRBtJyAs  Merck
Merck wins early U.S. approval for Keytruda in untreated lung¬†cancer https://t.co/xfThBNt0A2
ü§óü§óü§óü§óü§ó Merck drug gets FDA approval as a first-line lung cancer treatment https://t.co/s5F0rLLWih via  WSJ
Better Buy: Merck & Co. Inc. vs. AbbVie Inc. - Fox Business https://t.co/W79XbSjX0k
Better Buy: Merck & Co. Inc. vs. AbbVie Inc. https://t.co/B6FYPazXq2
 Merck wins early U.S. approval for  Keytruda in untreated  lungcancer https://t.co/l7AxieI3Qg
Merck talks I/O combo strategy as Keytruda nabs first-line NSCLC approval: Merck talk... https://t.co/cLXc7m3HC3 https://t.co/Jk0El8Y8L5
 Merck  Accelerator for  Entrepreneurs to  Innovate  STEM  merckgroup https://t.co/bfDXGXTBcQ
FreedomWonInc. Better Buy: Merck & Co. Inc. vs. AbbVie Inc.: How do Merck and AbbVie‚Ä¶ https://t.co/d6Ve2Z3diE
So excited to carve a pumpkin tomorrow with my pre-K babies tomorrow üòãüéÉ
Merck's Keytruda wins approval in first-line  lungcancer.  Merck  FDA https://t.co/BtGEv015nq https://t.co/mFVV5dwBqa
Better Buy: Merck & Co. Inc. vs. AbbVie Inc. - FOXBusiness https://t.co/lBOa6IqKoD
Can  Merck's top performers keep new generics, biosims at bay? https://t.co/dI1RfOwYq1
. Merck announces the launch of a new online educational resource about  Biosimilars. https://t.co/XgCPDFOraV
Pembrolizumab Approved in US for First Line in NSCLC
 keytruda  Merck  https://t.co/OSaB2mPmmp
 news  Better Buy: Merck & Co. Inc. vs. AbbVie Inc.  business  fdlx
 U.S.FoodandDrugAdministration After FDA Approval, Merck Posts Better-Than-Expected Earnings. Read more: https://t.co/QBIfmRap9k
After FDA Approval,  Merck Posts Better-Than-Expected Earnings. Read more: https://t.co/6iX0U8F80s  Merck
 Kodacon Better Buy: Merck & Co. Inc. vs. AbbVie Inc. Read Blog: https://t.co/Z2nczCOMDJ
Better Buy: Merck & Co. Inc. vs. AbbVie Inc.: How do Merck and AbbVie compare on product lineups, pipelines, ... https://t.co/Z0ILUhvBmK
Better Buy: Merck & Co. Inc. vs. AbbVie Inc.: Merck (NYSE:Merck) and AbbVie (NYSE:ABBV) compete head-to... https://t.co/EBvnf6hP8n  pharma
 Merck & Co.'s Keytruda Is "Off to The Races". Read more: https://t.co/ROTL8QlYdG  Merck
Congrats Scott von Lutcken  Merck for winning marketing researcher of the year  PMRGroup for his work in‚Ä¶ https://t.co/TX6u2qMt0p
Top virologists working for Merck have blown the whistle with shocking revelations that the company routinely fabricated lab results.
Dividend Stock Merck Crushes Q3 Expectations Following Lung Cancer Drug Win ; https://t.co/JyxlPiX1jw
 TacoTuesday awaits. Get out of your weekday rut with  PerdueChicken  promotion  PerdueCrew -‚Ä¶ https://t.co/REyBjAuxAo
Better Buy: Merck & Co. Inc. vs. AbbVie Inc.: How do Merck and AbbVie compare on product‚Ä¶ https://t.co/HSI47ubCaE
 Merck talks I/O combo strategy as Keytruda nabs first-line NSCLC approval. Read more: https://t.co/UIrrSO4SFe  Merck
Merck beats Street 3Q forecasts, hikes 2016 profit forecast https://t.co/FsPXBrUj9k
 Merck Consumer Health CMO on who makes healthcare decisions. Read more: https://t.co/S9DfTzs3Vl  Merck
Merck talks I/O combo strategy as Keytruda nabs first-line NSCLC approval https://t.co/A3rgqoosaG
Patients win! Merck drug gets FDA approval as a first-line lung cancer treatment https://t.co/j8sljK0fni via  WSJ
The FDA has just approved the Merck's mAb bezlotoxumab (Zinplava) to reduce the recurrence of Clostridium difficile‚Ä¶ https://t.co/34LMJcFVt3
Lung cancer drug fuels Merck sales growth in third quarter, as it tops earnings estimates  acerimrat https://t.co/LGdWsdfLr1 via  NJBIZ
Merck drug gets  FDA approval as a first-line lung cancer treatment https://t.co/3Sl1Nnpztw via  WSJ  BritneySpears! https://t.co/xnVxzfI0x3
 Merck&Co World-Wide Sales for  KEYTRUDA was 356m USD in Q3 2016 (Up 124%)  Merck https://t.co/nV4d63AuvE
 Merck&Co World-Wide Sales for  TEMODAR was 78m USD in Q3 2016 (Down 6%)  Merck https://t.co/nV4d63AuvE
 Merck&Co World-Wide Sales for  EMEND was 137m USD in Q3 2016 (Down 3%)  Merck https://t.co/nV4d63AuvE
Merck Revenue and Profit Rise on Cancer Drugs, Vaccines - Wall Street Journal https://t.co/8jMKLlddH4
Gardasil propelled  Merck to a strong third quarter - but don't expect that to last. Read more: https://t.co/NmjPmEuPhj  Merck
 Merck&Co World-Wide Sales for  GARDASIL/ GARDASIL9 was 860m USD in Q3 2016 (Up 38%)  Merck https://t.co/nV4d63AuvE
Merck & Co.'s Keytruda Is "Off to The Races" https://t.co/tPaDMa8dNl
Since launching in late 2014 sales of Merck amp Co s NYSE Merck Keytruda a cancer fighting drug are already gro... https://t.co/tRDCit5xbS
Merck Consumer Health CMO on who makes healthcare decisions https://t.co/U4sSxxrPSX
 mhealth solutions should support the physician-patient relationship, not seek to replace it. https://t.co/MbEL9fPUNm  FierceHealth  JMottl
Merck: "We drove growth across many of our core areas, including  oncology, vaccines, and hospital &‚Ä¶‚Ä¶ https://t.co/wKP00lM8NS
Better Buy: Merck &amp; Co. Inc. vs. AbbVie Inc. https://t.co/FsWp1VfYJo
Merck Consumer Health CMO on who makes healthcare decisions: Atilla Cansun, chief marketing officer at M... https://t.co/qhI8DpMti2  CMO
 Merck  ABBV:

Better Buy: Merck & Co. Inc. vs. AbbVie Inc.:

https://t.co/BmgXEOgWtI
 Merck metastatic non-small cell lung cancer drug gets  FDA go, providing alternative to chemo reports  BeckermanJosh https://t.co/jIYGRzW6aH
FDA Approves  Merck & Co.'s KEYTRUDA (Pembrolizumab) In Metastatic NSCLC For First-Line Trea... Read more: https://t.co/fj7b2F4k5k  Merck
Vaccine and cancer drug sales give pharma firm  Merck a boost. Read more: https://t.co/7jUaKQv1su  Merck
. Merck announces that  Zinplava has been approved by  US_FDA 
https://t.co/kwVymcpjRQ https://t.co/6KVzslwByE
Merck KGaA backs equipment-sharing platform
https://t.co/fxmL5T9n2m
Merck & Co.'s Keytruda Is "Off to The Races" - Motley Fool https://t.co/KRmOdyTrIN
FDA grants early approval for  Merck's Keytruda for untreated lung cancer. Read more: https://t.co/UNMADk3hA2  Merck
 Merck & Co 3rd-qtr revenues and earnings beat expectations. Read more: https://t.co/D0o6II0ltI  Merck
FDA approves Merck's Zinplava to reduce recurrence of Clostridium difficile infection https://t.co/QSYW4mtyhE
 Merck & Co 3rdqtr revenues and earnings beat expectations. Read more: https://t.co/8EdjgCvWZb  Merck
 Finance &  Money Merck & Co.'s Keytruda Is "Off to The Races": Keytruda sales a.. https://t.co/Vw26RLZ95b https://t.co/odIIkxJQ9u
 Merck strengthens its position in oncology space with Keytruda's newest FDA approval https://t.co/MrHBzSK5jh
FDA Approve Merck's Zinplava To Reduce Clostridium Difficile Infection-https://t.co/LLkyqA7N0w https://t.co/mWQExtveHz
Merck Admits Shingles Vaccine Can Cause Eye Damage‚Ä¶and Shingles https://t.co/6nEawOxfWn
 DoctorChristian  Charbrevolution AIDS virus from African green monkeys imported by merck by Maurice Hilleman top vaccine scientist .
How's my wallet growing or shrinking?? Market Misses Upside on Merck https://t.co/JpQlmBsQRF
Market Misses Upside on Merck - Strong third-quarter results and better sales for cancer and hepatitis C drugs ... https://t.co/PQUJ6swSrT
Hiking the beautiful Vermont mountains  yesterday üå≥üçÇ   Merck Forest‚Ä¶ https://t.co/OUPmZfeuDL
Apple Inc. (NASDAQ:Apple), Merck & Company, Inc. (NYSE:Merck) - A Peek Into The Markets: U.S. - https://t.co/xW9bxKePfn
 Merck Announces 'rd-Quarter Results. Read more: https://t.co/9VGnZji9qG  Merck
Merck beats Street 3Q forecasts, 3Q net income of  2.18 billion https://t.co/kGdSjDMSXA via  wcdailylocal
 Mobile tech a ‚Äòmust have‚Äô for docs  businessofhealthcare https://t.co/MpO8tISSDo
Merck & Co.'s Keytruda Is "Off to The Races" https://t.co/UZJpKUZHzZ  nasdaq  bolsa
Merck & Co.'s Keytruda Is "Off to The Races"   daytrading
 HATD Since launching in late 2014 sales of Merck amp Co s NYSE Merck Keytruda a cancer fighting drug are already growing quickly Howev...
 Stocks  Actions Merck & Co.'s Keytruda Is "Off to The Races": Since launching in la... https://t.co/fvC2UJH8vX  Algeria  ÿßŸÑÿ¨ÿ≤ÿßÿ¶ÿ±
Merck & Co.'s Keytruda Is "Off to The Races": Since launching in late 2014 sales of Merck amp Co s NYSE Merck K... https://t.co/fPuObyWiCA
WikiLeaksstockInfo Merck & Co.'s Keytruda Is "Off to The Races": Since launching in late 2014 sales of Merck ... https://t.co/msN6xPVNTd
Merck & Co.'s Keytruda Is "Off to The Races": Since launching in late 2014, sales of Merck & Co. ... ... https://t.co/zzW7UuWg5T  pharma
Merck & Co. (Merck) Q3 2016 Results - Earnings Call Transcript https://t.co/j6dW1Po0wf  goodmorning https://t.co/HXFDfOzIGf
Merck breezes past Q3 profit expectations, raises forecast https://t.co/AaqlBuowdx
Merck shares climb 3% after third-quarter earnings¬†beat https://t.co/SNhcqMJTOf
Merck & Co.'s  Keytruda Is Off To The Races  mrk  nsclc  cancer  stocks  investing https://t.co/D6ZzlzvWuE
Merck beats quarterly revenue expectations https://t.co/NBFO5KeoGG  beats
Keytruda wins approval as first-line metastatic NSCLC  immunotherapy treatment for  lungcancer patients https://t.co/jE4bRWrAxt via  Reuters
Story of a Steak is back! Check out https://t.co/qpSpTaWE25 for stories, video and photos. 
 Merck 
 AngusAssoc https://t.co/JIDhnLygu7
i literally have the best fianc√© everüíú
 chuckxcampbell  frozenbinarydev I know pumpkin, my problem is the amount of money Merck and Elly Lily put into the DSM-V
Merck breezes past Q3 profit expectations, raises forecast - Higher sales of vaccines and prescription medicine... https://t.co/6OfJ0w7fd8
ICYMI, Merck's Keytruda OKd for 1st Line NSCLC; PhRMA Banks  100m Ahead of Pricing Fight, more in  Regulatory Recon: https://t.co/ksaizyigNg
 BMY "Well Dr. Prins indicated both BMY and Merck" on ADFN InvestorsHub message boards: https://t.co/PnURBar7PO
 Lung  cancer  drug fuels  Merck sales growth in third quarter, as it tops earnings estimates https://t.co/SVHqb0vWx1
Jim Cramer --  Merck, Lilly Pressured by Political Uncertainty. Read more: https://t.co/k5okGtbDUs  Merck
Merck talks I/O combo strategy as Keytruda nabs first-line NSCLC approval: Merck talks I/O combo strategy as ... https://t.co/O2IEw1O98T
FierceBiotech: Merck talks I/O combo strategy as Keytruda nabs first-line NSCLC approval: Merck talks I/O com... https://t.co/Tu72oErwTP
Jim Cramer -- Merck,  Lilly Pressured by Political Uncertainty. Read more: https://t.co/aueTVwHdrZ  LLY
U.S. FDA approves Merck's lung cancer drug as firstline treatment: Merck &amp; Co Inc on Monday said the U.S. Food‚Ä¶‚Ä¶ https://t.co/7y7OAfuXc6
Your campaign reports say different. Does Merck Employees PAC ring a bell? How about the Marathon Employee PAC? Nee‚Ä¶ https://t.co/kBuLNJdHq9
Merck talks I/O combo strategy as Keytruda nabs first-line NSCLC approval https://t.co/FyvXK1eP7g  pharma
 Merck breezes past 3Q profit expectations, raises forecast. Read more: https://t.co/74g85uXhqL  Merck
FDA approves Merck's lung cancer drug as first-line treatment https://t.co/MwZfVY8srC https://t.co/ImUSxJ7EeC
Merck breezes past 3Q profit expectations, raises forecast https://t.co/r6DGUfilyP
Upcoming info session with Christopher Winrow from  Merck. Register now on OSCARplus and learn everything about car‚Ä¶ https://t.co/fixEmN1a0B
Keytruda wins approval as first-line  immunotherapy treatment for  lungcancer patients. https://t.co/oGOeNtD2sV via  Reuters  LUNGFORCE
Merck & Co.'s Keytruda Is "Off to The Races": Keytruda sales are already growing rapidly‚Ä¶ https://t.co/ZKpaYiYO4A
Merck breezes past 3Q profit expectations, raises forecast Read https://t.co/j7WloTWMdG
Briefing Room: Kelly Coulson joins Merck Animal Health‚Äôs Food Animal Marketing team 
https://t.co/5AQLhg3T36
Gardasil propelled Merck to a strong third quarter ‚Äî but don‚Äôt expect that to last: Marketwatch https://t.co/SiFY1439Mz
 Merck & Co., Inc. Surges After  Earnings,  EliLilly and Co. Slips  LLY  Merck https://t.co/DYYJ2lB32c
Merck drug gets FDA approval as a first-line lung cancer treatment https://t.co/AqXN4aZWHv via  WSJ
Gardasil propelled Merck to a strong third quarter ‚Äî but don‚Äôt expect that to last via ... https://t.co/tBC9QTywti
 Merck scores second approval in two days with Keytruda's NSCLC indication https://t.co/MrHBzSsurJ
Coulson joins Merck Animal Health's Food Animal Marketing team: Coulson joins Merck Animal Health's Food Anim... https://t.co/XfqUhErcmj
Donnell Lawson Jimmy Ortiz Sean Benson You going to hell if you laugh. Corey Frank Merck Merchant Charles E.... https://t.co/X8W2FqKz4n
 FDA approves Merck drug as a first-line treatment for certain  lungcancer patients https://t.co/U8QGqUhs98
 Job  Stellenangebot https://t.co/s92U5qaxgg - Merck Group: Account Manager - Industrial Food & Bev. (m/f)
Merck wins early U.S. approval for Keytruda in untreated  lungcancer https://t.co/BMqk4Y2syr via  Reuters
Merck talks I/O combo strategy as Keytruda nabs first-line NSCLC approval: Merck talks I/O com... https://t.co/IgOh0ub3T0  MedicalDevice
 biotech  science  news  biotech Merck talks I/O combo strategy as Keytruda nabs first-line NSCLC approval: /... https://t.co/W6alcmgsR8
 news  biotech Merck talks I/O combo strategy as Keytruda nabs first-line NSCLC approval: // Merck... https://t.co/NQciOa1wmM  biofinder
Merck &amp; Co.& 39;s Keytruda Is &quot;Off to The Races&quot; https://t.co/iDYCiYlxs2
 Merck:

Merck & Co.‚Äôs Keytruda Is ‚ÄúOff to The Races‚Äù:

https://t.co/rcqcbuhS6w
 Merck  Hillary true relationship with  Russia Watch in full https://t.co/94wQ92Hg7Y https://t.co/RQ6oXAwfgq
 Merck MLK saw Gandi as inspiration.  Hillary sees him as a joke https://t.co/JyjBZLSrf7
 Merck  Keytruda wins approval in first-line  lungcancer  pharma  pharmamktg https://t.co/3BzNJPtb0z
Market Misses Upside on Merck - https://t.co/beDhIWAZBL third-quarter results and better sales for cancer and hep‚Ä¶ https://t.co/itc2H7vF4L
Keytruda drove  Merck's sales increase in Q3; now the drug is slated for more combo therapies https://t.co/h5RVUn4cPX
 LSF16  Merck Reverse Pitches - Driving engagement with local academia, biotech and venture capitalists in key regional scientific comm's
RESULTS: Merck promoted school-entry mandate legislation by serving as an information resource, lobbying... https://t.co/mb9Hhnj50d
Merck Breezes Past 3Q Profit Expectations, Raises Forecast  expectations https://t.co/XNxjTD1j2w
 Merck Investigate reporting at the Mexican border.  BuildTheWall https://t.co/zKzXUdBB2l
 Merck Take home the top documentary of 2016: available Oct.11
Pre-order: https://t.co/dACXVor1zw https://t.co/uh1ZurYoog
Merck Consumer Health CMO on who makes healthcare decisions: https://t.co/xDAOpDriis
 LSF16  Merck Reverse Pitches - Interestedin any and all opportunities that have a strong scientific rationale. No limits around TAs
Several Big Pharmas posted Q3 results today incl.  Merck &  LillyPad -  gsk results tomorrow all covered in  CoxonStocks.  PanmureGordon
Important talk  GMercyU: "Image Bite Politics: News & the Visual Framing of Elections" by M Grabe of  IUMediaSchool Wed 10/26 7 pm in Merck.
The Journal Record - Merck breezes past 3Q profit expectations, raises forecast https://t.co/V8rWtm0sDa
MadePressMP: Market Misses Upside on Merck - https://t.co/lPOrusdmEF third-quarter results and better sales for c‚Ä¶ https://t.co/R7fytwKaXH
 CEOVazquez  Walmart  SodexoGroup  EYnews  Merck  WEConnection  MEmpresarias excellent Corporations committed to women!
Market Misses Upside on Merck - https://t.co/9pYqCNxmAf third-quarter results and better sales for cancer and hep... https://t.co/fIkt95dxWF
FDA approves Merck's lung  Cancer  Drug as first-line  Treatment: Merck & Co Inc on Monday said the U.S. Food... https://t.co/LIXz62bXa3
Merck talks I/O combo strategy as Keytruda nabs first-line NSCLC approval - https://t.co/FDD0rDuKfG
 sarahkrug1  Merck You've been quoted in my  Storify "Shared Decision Making Summit 2016: An Unofficial Transcript" https://t.co/L1t54CDnyJ
FDA Gives Early OK to Merck‚Äôs Keytruda for Frontline Lung Cancer https://t.co/NnXRzMvw2L https://t.co/Wa1WYS0P4L
I liked a  YouTube video https://t.co/0HDCMjzyKr Taurus November 2016 Terra Merck
U.S. FDA approves Merck's lung cancer drug as first-line treatment https://t.co/BhfG0Pb7wY
Merck profit and revenue boosted by cancer drugs: Merck & Co. posted increases in third-quarter reven... https://t.co/jq2SfhWnCF  pharma
 news  biotech Merck talks I/O combo strategy as Keytruda nabs first-line NSCLC approval https://t.co/SX3pzLODLV
Vemma Drink Coulson joins Merck Animal Health's Food Animal Marketing team - National Hog Farmer: Coulson joi... https://t.co/9MEcKOs3CP
Merck Consumer Health  CMO on who makes  healthcare decisions.  hcmktg  Merck https://t.co/S8R4fbLnfN https://t.co/naxmiX4YI0
Technical Alert: Merck Higher After Q3 Report: 
 62.30 - October 19 high

 62.26 - October 20 high

 61... https://t.co/UCNdaknjDL
 ZIOP Too bad ZIOP's partner EMD Serono (a.k.a Merck KGaA) is no relation to Merck U.S.A, the discoverer of Keytruda.
Merck Breezes Past 3Q Profit Expectations, Raises Forecast https://t.co/klVnnXvFvv
Vaccine and cancer drug sales give pharma firm Merck a boost https://t.co/zpYyoDczZ0
Market Misses Upside on Merck: Strong third-quarter results and better sales for cancer and... https://t.co/AKY2rcntDF  PSID  ABBV  CBPO
Market Misses Upside on Merck: Strong third-quarter results and better sales for cancer and hepatitis C drugs... https://t.co/Zb1tCYVxNF
WSJ Market Misses Upside on Merck: Strong third-quarter results and better sales for cancer and hepatitis C d... https://t.co/8qZzuXnOGH
How The Biopharmaceutical Industry Provides A Sparkle Of Hope https://t.co/eudaHNfckB  Merck  FredHassan  PhRMA  IamBiotech
For Merck, it was a lot of forces, heard microbiome described as a ‚Äúnew system‚Äù, had to get in.  JLABSBos  Microbiome
 ovarian Merck Announces ThirdQuarter 2016 Financial Results: Dateline City KENILWORTH N.J. ThirdQuarter‚Ä¶ https://t.co/pVXZGijmPE  cancer
 ovarian U.S. FDA approves Merck's lung cancer drug as firstline treatment: Merck &amp; Co Inc on Monday‚Ä¶ https://t.co/o8EzA4kkbp  cancer
Gardasil propelled Merck to a strong third quarter ‚Äî but don‚Äôt expect that to last https://t.co/Jetob0aqEN
Merck profit and revenue boosted by cancer drugs - MarketWatch: Wall Street JournalMerck profit and revenue b... https://t.co/zJHZDrhkAj
Merck Created Hit List to Destroy, Neutralize,Discredit Dissenting Doctors https://t.co/NK3tszoD7r ‚Ä¶<above the law.Ghostwriting, journals
Can Merck's top performers keep new generics, biosims at bay? - FiercePharma https://t.co/9v7AvIhU36
MarketWatch: "Gardasil propelled Merck to a strong third quarter ‚Äî but don‚Äôt expect that to last" https://t.co/HNtll3WP7P  finance  topsto‚Ä¶
Happy to join some very impressive tech leaders in Prague for the  Merck 2016  innovation summit https://t.co/OzSy2rim7T
Study Stopped Early as Merck & Co. (Merck)'s Immunotherapy Drug Wows in Bladder Cancer Trial  https://t.co/k1X5I4NRA3
Gardasil propelled Merck to a strong third quarter & x2014; but don& x2019;t expect that to last https://t.co/TKG3ItnEAb
Gardasil propelled Merck to a strong third quarter ‚Äî but don‚Äôt expect that to last https://t.co/8tJvju5EAq  econ  mises  keynes
Gardasil propelled Merck to a strong third quarter ‚Äî but don‚Äôt expect that to last https://t.co/3i2IuUTaBw  Stocks
 MARKETNEWS Gardasil propelled Merck to a strong third quarter ‚Äî but don‚Äôt expect that to last https://t.co/sIQW0xo3Nj
Gardasil propelled Merck to a strong third quarter ‚Äî but don‚Äôt expect that to last: New CDC guidelines‚Ä¶ https://t.co/LkOs075xXM MARKETWATCH
Gardasil propelled Merck to a strong third quarter ‚Äî but don‚Äôt expect that to last https://t.co/5z1w9leJ91  Busine‚Ä¶ https://t.co/3XRiLhjvYT
FDA approves Merck's lung cancer drug as first-line treatment - Fox News https://t.co/a2BOQHuhvi via Black Swan Intelligent Insight‚Ñ¢
Merck profit and revenue boosted by cancer drugs - MarketWatch https://t.co/Qc2SrGnFqA
Gardasil propelled Merck to a strong third quarter ‚Äî but don‚Äôt expect that to last https://t.co/PMpT7d3G3C New CDC guidelines should have ‚Ä¶
Gardasil propelled Merck to a strong third quarter ‚Äî but don‚Äôt expect that to last: New CDC guidelines should... https://t.co/1liSKxR5St
 Innovation is happening right now!  latinamerica  brazil  msd  Merck https://t.co/BFOkqEmt3f
Merck Breezes Past 3Q Profit Expectations, Raises Forecast https://t.co/IUtT8gy8cx  EMM
 valleyfeverkc can also  affect our pets! https://t.co/mez72DJkbT via  Merck Manuals https://t.co/damzqayRZ8
 TriangleTuesdays  JOB ALERT!  Merck seeks a Senior Sourcing Specialist: https://t.co/YNht03hmfC
FDA Approves Merck‚Äôs KEYTRUDA¬Æ (pembrolizumab) in Metastatic NSCLC for First-Line therapy lung cancer |  scoopit https://t.co/YDNH5e4ynx
 Merck & Co. Cements Lead Over Rivals After the FDA Grants Early Approval of Keytruda  . Read more: https://t.co/uYIbNcut4z  Merck
Technical Alert: Merck Higher After Q3 Report
WSJ: Market Misses Upside on Merck https://t.co/rw1vHoJMKZ  PAID
Hillary bout to merck you https://t.co/A4dPOOyzRQ
Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/ELHy16fNLb
 XON chatter about Ziopharm Cancelling on Mizuho Conference. Maybe name tags will say Merck KGaA ?
Merck drug gets FDA approval as a first-line lung cancer treatment https://t.co/DRJ5Qyeuf9 v√≠a  WSJ
Visions for the Future of Biopharma Manufacturing |  scoopit https://t.co/hjqNaXC5zZ
Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/n7yCKeNq2T  lungcancer  immunotherapy  keytruda  health
 Merck FDA Approves Keytruda as First-Line Treatment of Metastatic NSCLC. Read more: https://t.co/EzSE3Divhx  Merck
Market Misses Upside on Merck: The Food and Drug Administration on Monday gave Merck the green light to marke... https://t.co/iKtQmBlDBoeing
 Merck Wins Early U.S. Approval for Keytruda in Untreated Lung Cancer https://t.co/ZBLGBX4iHx  Merck  lungcancer  cancer  oncology  nsclc
Merck Announces 'rd-Quarter Results: The company announced the U.S. Department of Agriculture approved a lice... https://t.co/Mxw1wOUt2N
 CityAM Vaccine and cancer drug sales give pharma firm Merck a boost https://t.co/3Lblh5kF3c
 Merck Crushes Q3 Expectations Following Lung Cancer Drug Win. Read more: https://t.co/vxcYH3fIYi  Merck
 Google  Merck Breezes Past 3Q Profit Expectations, Raises Forecast - New York Times https://t.co/I02JFT0XLa
Pharmalot Pharmalittle  Merck drug wins FDA nod as firstline lung cancer treatment. Read more: https://t.co/doukNLvtra  Merck
Merck profit and revenue boosted by cancer drugs - MarketWatch https://t.co/Mp1M8BqIqT  cancer
Merck (Merck) Beats on Q3 Earnings amp; Revenues, Lifts View - https://t.co/y6Xke9DaOB https://t.co/WUUuLwxuBr https://t.co/arRIAp0eqy
Merck Announces 3rd-Quarter Results https://t.co/iPLFzf9HSf
Merck predicts lung cancer dominance for Keytruda immunotherapy https://t.co/z87Kfjdv9s
Shared via https://t.co/nVqspaz3tz: FDA approves Merck's lung cancer drug as first-line treatment
University of Edinburgh strikes license deal with life sciences giant  Merck_lifesci https://t.co/Q3kPH6kkGt‚Ä¶ https://t.co/s9g7aRmZl9
Merck & Co. (Merck) Stock Price Up 1.6% After Strong Earnings https://t.co/6tW6L4SVfC
Managing Director of Merck's Global Health Innovation Fund:how pharma can leverage  DigitalHealth. Could've been‚Ä¶ https://t.co/kv402ZQ7c7
Merck R&D chief, on 3Q earnings call, says 'Keytruda is changing the cancer treatment landscape' - agree? https://t.co/TUWnbds6Nl via  WSJ
 Merck gets leg up on  BMY after FDA approval of Keytruda for NSCLC https://t.co/MrHBzSK5jh
The 4 top sectors Merck is investing on digital health:patient recruitment, patient engagement,data analytics & rea‚Ä¶ https://t.co/VleW0yhhuv
https://t.co/ISVYyO8fuX and cancer drug sales give pharma firm Merck a boost
Merck Wins Early U.S. Approval For Keytruda In Untreated Lung Cancer (Reuters) https://t.co/qMvBLKIDDV
Merck profit, revenue boosted by cancer drugs - MarketWatch https://t.co/hamfKSkPp6  cancer
Merck talks I/O combo therapies https://t.co/mqxWhM2P3J
Merck profit and revenue boosted by cancer drugs - MarketWatch https://t.co/ASAvhboTZX  health
Preventing Curiosity = Preventing Innovation https://t.co/q8zUDVqgSx  merck_de  merckgroup
Merck & Co.  Merck Stock Price Up 1.6% After Strong Earnings https://t.co/sNsbahvUPA
Merck & Co. (Merck) Q3 2016 Results - Earnings Call Transcript https://t.co/43PL1vaqw3
Merck Breezes Past 3Q Profit Expectations, Raises Forecast - New York Times https://t.co/0SgJB4eyVM
Dr. Ryan Vargo, Purdue Alum from Merck, leads roundtable discussion with IPPH students  Merck https://t.co/Uunbrfx8sF
Options Traders Blitz Merck & Co., Inc. (Merck) After Earnings, Keytruda Win https://t.co/AxCQSkg6DO
In a snap, FDA OKs Merck's Keytruda for frontline lung cancer https://t.co/tr4ZUyxEsy [h/t  JohnCendpts]
Merck Announces ThirdQuarter 2016 Financial Results https://t.co/25R3JAPOnR https://t.co/Q7epILZ1fh
U.S. FDA approves Merck's lung cancer drug as firstline treatment https://t.co/QiAiGWKC8D https://t.co/s6B724rXZC
finzine:  Merck Merck Announces 3rd-Quarter Results https://t.co/KqEBrXYxh8
Why wait? FDA gives early OK to Merck‚Äôs Keytruda for frontline lung cancer ‚Äì ENDPOINTS https://t.co/BMJY6g7PPq
Merck's Keytruda achieves 24 percent response in bladder cancer study

(Reuters) - Merck & Co's immunotherapy Ke https://t.co/0PZQUHtPZ5
 Merck Merck Announces 3rd-Quarter Results https://t.co/jTkXmMphaD
The Seattle Times Merck (Merck) Beats on Q3 Earnings amp; Revenues, Lifts View https://t.co/4qeLm0Ldvy Merck & Co.,‚Ä¶ https://t.co/CqkamMJOsd
Next stop, Merck station
Merck & Co Inc. (Merck) Q3
Earnings: U D 2.99B.
EPS:  1.07.
Revenue: U D 10.54B.
SAlphaTrending: Merck & Co. (Merck) Q3 2016 Results - Earnings Call Transcript https://t.co/yD6IVVyDfa  Merck
 Reuters  FDA approves Merck's lung cancer drug as first-line treatment https://t.co/Uj3S65TiQf
 Merck stock edged higher after the company recorded healthy third-quarter results.  Merck https://t.co/wy5i6vvMKJ
Merck & Co. (Merck) Q3 2016 Results - Earnings Call Transcript https://t.co/dKubXjOzzP  Merck
Merck  Drug Gets FDA Approval as a First-Line Lung  Cancer  Treatment: Merck Merck 1.48 % & Co.‚Äôs immunotherapy... https://t.co/AcFdYqBvsG
'New day' in lung cancer as Merck drug shines, works with chemo

COPENHAGEN (Reuters) - Merck & Co scored a doub https://t.co/7PRNOPnazZ
 FDA approves Keytruda ( Merck) for first-line treatment of PD-L1-expressing metastatic  NSCLC https://t.co/UjqUfnTnDu  lungcancer  lcsm
Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment https://t.co/ZBpOGE455U https://t.co/HtJzaqZwgf
 cancer Merck Announces ThirdQuarter 2016 Financial Results https://t.co/AFyLL7JRWW https://t.co/84aIIlRRaq
Debiopharm Announces Clinical Collaboration w/ the Merck-Pfizer Alliance in Cancer  Immunotherapy https://t.co/eAUXyoGpbk
https://t.co/3z9uSVqwt3 FDA Approves Merck's Lung Cancer Drug as First-Line Treatment
How a Merck cancer breakthrough caused Bristol-Myers‚Äô stock to plunge https://t.co/USIt37xb46
Two approvals in two days for Merck |  scoopit https://t.co/tZ6lfq1Gc5
Merck & Co., Inc. Surges After Earnings, Eli Lilly and Co Slips https://t.co/VRvjdx5v70 via  NewsRepublic
Merck Q3 call results.  Get your feed.   money  pharma  earningsseason https://t.co/6vEKecxzhy
 Merck sees two drug approvals this week: one for Zinplava and another for Keytruda indication https://t.co/6eQ08o68Kd
Pharmalot, Pharmalittle: Merck drug wins FDA nod as first-line lung cancer treatment - STAT https://t.co/iI3nsOUfdG
Merck Crushes Q3 Expectations Following Lung Cancer Drug Win https://t.co/piHVu80o5D via  NewsRepublic
News: Merck Beats Street 3Q Forecasts Hikes 2016 Profit Forecast https://t.co/NaDp2T7JUB
Merck Survey: 4 out of 5 doctors say  mobile  technology is changing the office visit https://t.co/SfK7wmfeQ8 via‚Ä¶ https://t.co/vN84lJeX7S
UPDATE 3-Merck predicts lung cancer dominance for Keytruda immunotherapy https://t.co/X5c7oql2vW
Merck's Keytruda wins coveted first-line lung cancer nod https://t.co/hl8INAhGBa
 NowReading:  FDA approval of  Keytruda gives Merck only first-line treatment for  lungcancer, via  Reuters_Health https://t.co/vQIldfBZki
 Merck's continuing  Keytruda successes are good for the stock and good for many stage IV cancer suffers!
Merck breezes past 3Q profit expectations, raises forecast https://t.co/mvweo9lj0w  EMM
Merck & Co. (Merck) Q3 2016 Results - Earnings Call Transcript https://t.co/ip2JfmISu7  StockMarketInsights
Good news in Ab therapeutics: FDA approves Merck‚Äôs Zinplava to reduce recurrence of C. difficile infection https://t.co/81mOh6ycxl
Merck's Keytruda wins coveted first-line lung cancer nod, cementing rise 'from laggard to leader'.
https://t.co/5jFJc3Ieh7
Merck & Co. (Merck) Q3 2016 Results - Earnings Call Transcript https://t.co/iZUeYYP&GEy  Markets  Finance  TCOT
UPDATE 3-Merck predicts lung cancer d... https://t.co/nXQw8eMPiz
FDA approves Merck\'s lung cancer drug as first-line treatment https://t.co/2AoBv6VCWj
FDA approves Merck's lung cancer drug as first-line treatment - Reuters https://t.co/NzGz2vhPU9 via Black Swan Intelligent Insight‚Ñ¢
UPDATE 3-Merck predicts lung cancer dominance for Keytruda immunotherapy
FY2016 Earnings Estimate for Merck & Co. Issued By SunTrust Banks  Merck https://t.co/uAS4FVexWq
Shared via Reuters: Merck wins early U.S. approval for Keytruda in untreated lung cancer
Two approvals in two days for  Merck  |  BioPharmaDive  https://t.co/jOQjpm2Wzi
MSD's  Keytruda given first  US_FDA approval for first line treatment: https://t.co/FJxd2qMuZG  Merck  pharma
Vote  Yeson61 California Drug Price Relief Act
Let Big Pharma  FeelTheBern
Don't fall for the propaganda Merck and‚Ä¶ https://t.co/fla9M9YG1S
Merck Announces 3rd-Quarter Results  Merck - https://t.co/ue9hoZF7pW https://t.co/npxyJEcfAU
Merck Breezes Past 3Q Profit Expectations, Raises Forecast - New York Times: Miami HeraldMerck Breezes Past 3... https://t.co/nYaiXeTRCu
With great power..... Comes the test of integrity... FAIL! https://t.co/tivE1eoDhy
I'm at Merck & Co, Inc in Madison, NJ https://t.co/qKL4BHj5e3
FDA Approves Merck‚Äôs KEYTRUDA¬Æ (pembrolizumab) in Metastatic NSCLC for First-Line Treatment Read more:... https://t.co/QLBue4INAD
UPDATE 3-Merck predicts lung cancer dominance for Keytruda¬†immunotherapy https://t.co/Ecayp8xuy5
 news  Merck breezes past 3Q profit expectations, raises forecast  business  fdlx
Merck Breezes Past 3Q Profit Expectations, Raises Forecast - New York Times https://t.co/cPsSFYoIrG  health
 Merck_Engage how about a virtual dietician that guides people as they chose what they eat?
Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment: Merck Merck 1.48 % & Co.‚Äôs immunotherapy ca... https://t.co/nItYz9fmV0
Merck & Co.'s  keytruda shows survival benefit versus chemotherapy in advanced urothelial  cancer - https://t.co/aK9q9StarR -  oncology
https://t.co/L7KuTJWNT2 Solo ad packages here range from  5.95- 199.95, with databases from 13,200 - 8 https://t.co/Nhk1PuaQgQ
 Reuters UPDATE 3-Merck predicts lung cancer dominance for Keytruda immunotherapy https://t.co/mVvoHbNJrv
Merck Breezes Past 3Q Profit Expectations, Raises Forecast - New York Times https://t.co/Ywgsts2Kc1  google  health
Merck beats Street 3Q forecasts, hikes 2016 profit¬†forecast https://t.co/wsJoIo6PQ8
UPDATE 3-Merck predicts lung cancer dominance for Keytruda immunotherapy: NEW YORK, Oct 25 - Merck & Co on Tuesday‚Ä¶ https://t.co/RHTFd1E13u
Merck Breezes Past 3Q Profit Expectations, Raises¬†Forecast https://t.co/UnIBdzwRsA
UPDATE 3-Merck predicts lung cancer dominance for Keytruda immunotherapy: NEW YORK, Oct 25 - Merck & Co on Tu... https://t.co/RK2gSmsgpU
Merck beats Street 3Q forecasts, hikes 2016 profit forecast  KansasCity  bhive https://t.co/VpD4jFsLDp
The latest The Mobile Technology Daily! https://t.co/vTBI2aA2c3 Thanks to  etrackit  PyramidCiGlobal  Mersive  technology  merck
Companies such as Merck, Pfizer would send reps to your Docs ofc offering them mass rebates and other prizes to prescribe their drugs
Merck beats Street 3Q forecasts, hikes 2016 profit forecast https://t.co/FvhhA3Cib1  EMM
Merck's Keytruda succeeds in key bladder  cancer trial: https://t.co/yMVYl0vVed ... via  Reuters_Health
Merck's Keytruda wins coveted first-line lung cancer nod, cementing rise 'from laggard to leader': https://t.co/sVEtYQTCRj  Merck  pharma
UPDATE 3-Merck predicts lung cancer dominance for Keytruda immunotherapy: NEW YORK, Oct 25 - Merck ... https://t.co/np66pkK7Ro  iGazette
UPDATE 3-Merck predicts lung cancer dominance for Keytruda immunotherapy: NEW YORK, Oct 25 - Me... https://t.co/tuWA7bKA3T (By  Reuters)
 Merck Beats Street 3Q Forecasts, Hikes 2016 Profit Forecast . Read more: https://t.co/0HPZgdK2V7  Merck
FiercePharmaMerck Breezes Past 3Q Profit Expectations, Raises ForecastNew York TimesHigher sales of vaccines ... https://t.co/zbv3O0huO7
 Gamedesign

 Merck  Accelerator for  Entrepreneurs to  Innovate  STEM merckgroup https://t.co/9ArHanERaB https://t.co/30qZrPetuA

‚Äî Mich‚Ä¶
Merck wins FDA approval for its immuno-oncology flagship Keytruda in first-line NSCLC, getting leg up on rival BMS. https://t.co/cwq1EhPv7I
 Merck  Accelerator for  Entrepreneurs to  Innovate  STEM  merckgroup  https://t.co/NoGqtuidx4 https://t.co/7lsMsUzQXy
 cancer Merck talks IO combo therapies https://t.co/h9JVdpdo0J https://t.co/hZbmZbFqae
 LatestNews Higher sales of vaccines and prescription medicines, coupled with restrained spending, helped Merck & Co. post a 20 perce...
Is Merck getting out of flat? Learn more: https://t.co/dRDGXVpIUv  Merck
 Merck:

Options Traders Blitz Merck & Co., Inc. (Merck) After Earnings ‚Ä¶:

https://t.co/xYERidOWEj
Merck breezes past 3Q profit expectations raises forecast https://t.co/ePKQTPmqp8 https://t.co/RJBJZJK4NN
Merck 3Q results crush expectations; it hikes 2016 forecast but sees headwinds. https://t.co/XEU09zFWgg https://t.co/C0yZOgp1qe
With first Shingrix application, GSK advances toward  1B market duel with Merck https://t.co/jOtRrDfmhx
Market Misses Upside on Merck - Wall Street Journal https://t.co/sSb4Cv9Dwd  market  news https://t.co/drGOXq3dnE
 Market ‚Ä¢ Market Misses Upside on Merck: Strong third-quarter results and better sales for cancer and hepatit... https://t.co/gHxSrnAXuH
Market Misses Upside on Merck: Strong third-quarter results and better sales for cancer a... https://t.co/TGEXtu77BO  Financenews  Money
Merck Breezes Past 3Q Profit Expectations, Raises Forecast - New York Times: https://t.co/MODhPc2vYS‚Ä¶ https://t.co/9aQZabJm7W
I liked a  YouTube video https://t.co/DQXbbz8WX6 Sagittarius November 2016 Terra Merck
. Merck collaborated with health literacy experts to design a simple online guide to buying and using health care i‚Ä¶ https://t.co/0KWv0qbUK9
 CELG If this continues to drop, could they be a target for Merck to buy?
 Health Merck (Merck) Beats on Q3 Earnings amp; Revenues, Lifts View - https://t.co/sCWJ1AjReV https://t.co/SUte2JqIeK  Southeast Asia
Merck Gets FDA OK For Keytruda in Metastatic Non-Small Cell Lung Cancer - Shares Up 2%
Merck Manuals‚Äô Robert Porter: Mobile tech a ‚Äòmust have‚Äô for docs  mHealth https://t.co/bcNSTa6Jqx https://t.co/fs1vT6ivj6
 modesto Merck beats Street 3Q forecasts, hikes 2016 profit forecast https://t.co/5sCrCmJXVS
FDA Approves Merck‚Äôs Keytruda (pembrolizumab) for First-Line Treatment of Certain Patients with ... https://t.co/rcypqVhlPj
Merck Manuals‚Äô Robert Porter:  Mobile tech a ‚Äòmust have‚Äô for docs - https://t.co/7e5lyI3Qji
Merck breezes past 3Q profit expectations, raises forecast https://t.co/ch2BevzkHU via  YahooNews *More   to lobby for more opium deaths*
FDA Approves  Merck‚Äôs  Zinplava (bezlotoxumab) to Reduce Recurrence of Clostridium difficile Infection https://t.co/kyMvXiyC2d  CDif  CDI
Merck lifts full-year guidance after quarterly forecast beat https://t.co/x9JUj90eco
 FDA OKs  Merck‚Äôs  Keytruda ( pembrolizumab) for 1st Line Treatment of Metastatic Non-Small Cell Lung Cancer https://t.co/dAueGCVDqw  NSCLC
 Merck:

Market Misses Upside on Merck:

https://t.co/nWhDhFvxAp
 Merck talks M&A, combination therapies for Keytruda in Q3 earnings call https://t.co/h5RVUn4cPX
 MedicalStudy Pharmalot, Pharmalittle: Merck drug wins FDA nod as first-line lung cancer treatment... https://t.co/TJk8GzSwkv  AfyaKenya
Market Misses Upside on Merck: Strong third-quarter results and better sales for cancer and hepatiti...... https://t.co/hUEInFKDz0
Two approvals in two days for  Merck https://t.co/gRvnLxuQJy via  biopharmadive
IBDinvestors: Merck Crushes Q3 Expectations Following Lung Cancer Drug Win https://t.co/gqswm5LBTt
Merck (Merck) Tops Q3 EPS by 8c; Narrows FY16 Outlook - https://t.co/WOFp6Eoiwc https://t.co/5GhPyfEvVm
 Merck cements advantage in  I/O with first-line approval https://t.co/YDwAgTqlIe via  biopharmadive
Merck Beats Street 3Q Forecasts, Hikes 2016 Profit Forecast https://t.co/9FKLRTYSiO
Merck Crushes Q3 Expectations Following Lung Cancer Drug Win https://t.co/7XU0PJ3swa
 Merck Keytruda Gets FDA Approval for First-Line Lung Cancer. Read more: https://t.co/U4xYOxZpzK  Merck
 Merck's Keytruda wins approval in first-line lung cancer. Read more: https://t.co/Pdq9WUQddd  Merck
 Merck talks  I/O combo therapies https://t.co/T7nxHpvxUB via  biopharmadive
Can Merck's top performers keep new generics, biosims at bay? - FiercePharma https://t.co/FAAOUHrDg4  health
Market Misses Upside on Merck: Strong third-quarter results and better sales for cancer and hepatiti... https://t.co/aMHwIIfg5J  Morelos
 OBSERVATORIO Market Misses Upside on Merck: Strong third-quarter results and better sales for... https://t.co/SUHc60woLE  _RAFAELNIEVES
 Markets  News Market Misses Upside on Merck: Strong third-quarter results and better sales... https://t.co/LDp3W2kAGv  Economy  Finance
Merck & Co. (Merck) Gains with Earnings Due https://t.co/PvTLi60HR7
[WSJ Markets] Market Misses Upside on Merck https://t.co/IIyoGODG45
Market Misses Upside on Merck: Strong third-quarter results and better sales for cancer and hepat... https://t.co/EdTF7VJlkS  investment
Market Misses Upside on Merck: Strong third-quarter results and better sales for canc... https://t.co/AvWP56fLC8 https://t.co/fv7jPydbnr
WSJ - Market Misses Upside on Merck https://t.co/LhrZ4tuB2C  finance
 Merck talks I/O combo therapies |  BioPharmaDive  https://t.co/zZ6ncJMokd
Lung Cancer News!!! BRIEF-Merck says aims to be leader in second-line lung cancer - Reuters https://t.co/Mz6rMtJPyg
 ovarian Pharmalot Pharmalittle Merck drug wins FDA nod as firstline lung cancer treatment: Merck won‚Ä¶ https://t.co/uw4RZNFvFi  cancer
WSJbusiness: "Market Misses Upside on Merck" https://t.co/BFqYBetKpW  financemarket  business
 charlotte Merck beats Street 3Q forecasts, hikes 2016 profit forecast https://t.co/9EUV8gmV1X
Can Merck's top performers keep new generics, biosims at bay? - FiercePharma: FiercePharmaCan Merck's top per... https://t.co/EL5FFoyoUn
 Merck beats Street 3Q forecasts, hikes 2016 profit forecast. Read more: https://t.co/7HYBmSFefU  Merck
At the speakers' dinner 4 the 7th Annual  HCSummit. (L-R) Cynthia, Christie Travis/MBGH, Murray Harber/MSBGH, Scott‚Ä¶ https://t.co/FdUwmUXQfo
Can Merck's top performers keep new generics, biosims at bay? - FiercePharma https://t.co/xSOqml7kgY  google  health
Merck breezes past 3Q profit expectations, raises¬†forecast https://t.co/HhAzeyFfli
 Merck Tops Q3 Earnings, Revenue Estimates. Read more: https://t.co/o3vvGOZGk3  Merck
 Merck Beats on Q3 Earnings & Revenues, Lifts View. Read more: https://t.co/Qcb489zexb  Merck
FDA Approves Merck‚Äôs KEYTRUDA¬Æ (pembrolizumab) in Metastatic NSCLC for First-Line Treatment of... | Business Wire https://t.co/Ss5w7HI8Ws
UPDATE 2- Merck quarterly revenue beats, raises full-year forecast. Read more: https://t.co/xRlDPamHCR  Merck
US OKs first-line use of Merck‚Äôs Keytruda in lung cancer https://t.co/TDyWgVniqO
 Merck beats quarterly revenue expectations. Read more: https://t.co/kFNDHlFWXm  Merck
 Merck Lifts Full-Year Guidance After Quarterly Forecast Beat. Read more: https://t.co/9bep8veA8s  Merck
Merck Popularized Cocaine: German Pharma Corporation Worked With Sigmund Freud https://t.co/vnq7B5NWZX
Word on the Street about Merck‚Äôs Animal Health Segment: Market Realist https://t.co/ELYXbBYNiH
The Merck Manual of Diagnosis and Therapy (13th Edition) by Editors Robert Be... https://t.co/kbJqUEwb8r via  amazon
 Drugscom  FDA Approves Mercks Keytruda (pembrolizumab) for First-Line Treatment of https://t.co/V72RL7CaxP
Merck wins early U.S. approval for Keytruda in first-line NSCLC https://t.co/8BOZwDQkqw via  Reuters https://t.co/eNTlKBk6P5
theedgemarkets: Merck quarterly revenue beats, raises full-year forecast https://t.co/lGMNppCj5U
 kpsmartypants  NoProp61  Merck  pfizer It a big scam.
Merck quarterly revenue beats, raises full-year forecast https://t.co/fS0F8KCRc3
Merck Q3 2016 earnings https://t.co/dpgLlQXsg8 via  BusinessInsider
 Biotech  STEM Jim Cramer -- Merck, Lilly Pressured by Political Uncertainty https://t.co/y4axDJ4MRq
Merck shares climb 3% after third-quarter earnings beat https://t.co/Wz4MwYBVpd via  MarketWatch
Merck Crushes Expectations Following Lung Cancer Drug Win ‚Ä¶ : https://t.co/aeUKwn4TXN ,, https://t.co/NVE1y8nOsS
Apitope Regains Full Rights to Potential MS Therapy, ATX-MS-1467. Read more >> https://t.co/Hn1eN059Vo
 Merck Beats Street 3Q Forecasts, Hikes 2016 Profit Forecast
https://t.co/cTVg5GuCNT
These 2 stocks battle it out! https://t.co/vfNfQ47phi (your capital is at risk)  Bayer  Merck https://t.co/QzwaPUs0Uk
Is chemo dead for some pts w/  lungcancer? FDA quickly approves  Keytruda for 1L tx!  Immunotherapy  lci  carolinas https://t.co/PcO0zZGBln
Merck gets early OK for Keytruda in first-line lung cancer https://t.co/Fwxh5h5q54
 Merck gets early OK for Keytruda in first-line lung cancer. Read more: https://t.co/uYkMl1Bhyh  Merck
 Merck reports 19.6 percent jump in quarterly profit. Read more: https://t.co/hFbRGakLQq  Merck
Credit Management Executive - Merck Ltd. - https://t.co/2sTwLtokV7
 Merck Q3 Profit Rises; Lifts 2016 Outlook . Read more: https://t.co/Zc20h5nS3Z  Merck
Merck‚Äôs Keytruda wins coveted first-line lung cancer nod  biopharma daily https://t.co/02u10fYLIR https://t.co/dY4XCjKYCQ
 Merck Shares Climb 3% After Third-quarter Earnings Beat. Read more: https://t.co/sKlUfUIyBu  Merck
 Merck : Revenue and Profit Rise on Cancer Drugs, Vaccines. Read more: https://t.co/6zDPqd5FYA  Merck
 Merck reports 19.6 pct jump in quarterly profit. Read more: https://t.co/tZmvSXjsyq  Merck
Paolo Carli, MD of Merck Middle East and Egypt, contributed on the 18th WIL forum , strong and positive messages on‚Ä¶ https://t.co/99laCbTjJC
 Merck Q3 Profit Rises; Lifts 2016 Outlook. Read more: https://t.co/zXf04bZucR  Merck
 neurology news: Pharmalot Pharmalittle Merck drug wins FDA nod as firstline lung cancer treatment https://t.co/wOlcLwHn5w
 Merck's Q3 Results, Guidance Look Strong. Read more: https://t.co/GsGI6mNKsl  Merck
Merck Beats Street 3Q Forecasts, Hikes 2016 Profit Forecast - U.S. News & World Report https://t.co/5LEQAmRbze
. Merck drug gets  FDA approval as a first-line lung  cancer treatment https://t.co/DHLijeOpoq via  WSJ  health  healthcare  pharmaceuticals
 Merck raises its full-year forecast because one drug has been crushing it (). Read more: https://t.co/Bt7bglpUUu  Merck
 Merck Beats Estimates as Sales of Gardasil Vaccine Surge https://t.co/f5d09l0ux5 via
 Merck gets early OK for Keytruda in firstline lung cancer. Read more: https://t.co/XjsTPwOyAr  Merck
Balancing your dreams with the tangible needs of others is a c... More for Aquarius https://t.co/ZZfjyDsKrR
US OKs firstline use of  Mercks Keytruda in lung cancer. Read more: https://t.co/xT0IH35AWV  Merck
 Merck Beats Street 3Q Forecasts, Hikes 2016 Profit Forecast. Read more: https://t.co/gpRW9htLIY  Merck
 Merck : beats Street 3Q forecasts. Read more: https://t.co/7Nykjq7ewZ  Merck
PhII study shows positive benefits of  Keytruda-chemo combination. Merck aims for NCCN backing. https://t.co/eSMbBOCu0G
Shared via Reuters: FDA approves Merck's lung cancer drug as first-line treatment
 Merck beats Street 3Q forecasts. Read more: https://t.co/1ln9vvEY39  Merck
IBDinvestors: Merck rebounding after earnings beat & new  FDA approvals, but stock still on trial. https://t.co/BjtsEFlVDj
Merck rebounding after earnings beat & new  FDA approvals, but stock still on trial. https://t.co/zAbio1LIRY
 KEYTRUDA Now Approved in Metastatic NSCLC for 1st-Line Treatment of Patients Whose Tumors Have High PDL1 Expression https://t.co/GK8k9BoODT
 Merck I think you have a case for Libel against Gabor Mate  justis4U here https://t.co/RJhDq5QHn0
Venture Lounge Life Sciences & Medtech   Merck Innovation Center  aescuvest  medtech goes  Fintech  medvesting
Investor Group Calls for Drugmakers to Be Transparent on Pricing https://t.co/crZWCTkKmk  Healthcare  Pharma  Mylan‚Ä¶ https://t.co/bkoOWA5Q7m
Merck's Keytruda Approved for 1st Line NSCLC;  PhRMA Banks  100m Ahead of Pricing Fight, more in  Regulatory Recon: https://t.co/ksaizyigNg
After FDA approval, Merck posts better-than-expected earnings  Merck https://t.co/6k9noekkmT via  TheStreet
 Merck Reports Better Than Expected 3Q Earnings. Read more: https://t.co/9ERrwwcra3  Merck
 Merck Beats Street 3Q Forecasts. Read more: https://t.co/Z6P&GtGPSDQ  Merck
Volume Alert - Merck 61.83 Merck & Company  Merck Hit a high today of 61.93 Closing the day 10:30 at 61.83 +1.08 + https://t.co/89Ha4H59yZ
 seattle Merck beats Street 3Q forecasts, hikes 2016 profit forecast https://t.co/fHjDzsqz38
Pharmalot, Pharmalittle: Merck drug wins FDA nod as first-line lung cancer¬†treatment https://t.co/pTMpgOIdzY https://t.co/eGG0MNMBea
Can Merck's top performers keep new generics, biosims at bay? - https://t.co/xZjhFqevkU
Merck Solidifies Lung Cancer Immunotherapy Lead Over Bristol-Myers Squibb https://t.co/pn06ODo5BK
„ÄêONCOLOGY Pick Up News„Äë„Äë

FDA approves Merck's lung cancer drug as first-line treatment from REUTERS Health NEWS... https://t.co/YjJkjFXuGh
 Merck Profit Rises on Cancer Drugs, Vaccines. Read more: https://t.co/WaGo0YICFk  Merck
FDA Approves  Merck's Keytruda in Metastatic NSCLC as FirstLine Treatment. Read more: https://t.co/dsKRdzju87  Merck
FDA Approves  Merck's Keytruda in Metastatic NSCLC as First-Line Treatment. Read more: https://t.co/6OyohITqDC  Merck
 U.S.FoodandDrugAdministration FDA Approves Merck's Keytruda in Metastatic NSCLC as First-Line ... Read more: https://t.co/j1F8mbrAXs
 U.S.FoodandDrugAdministration FDA Approves Merck's Keytruda in Metastatic NSCLC as FirstLine T... Read more: https://t.co/GYLdkYlkhQ
FDA OKs Merck's Keytruda as first-line treatment for lung cancer https://t.co/rNH0DBTpes
Global Creatine Phosphate Sodium Market 2016: Sigma-Aldrich, Merck Millipore, TCI America, MP Biomedical, Aff https://t.co/XqxWbMaxkb  pr
Merck lifts full-year guidance after 3Q¬†beat https://t.co/w0cskfcmXO
 news  Merck Profit Rises on Cancer Drugs, Vaccines  business  fdlx
FDA approves Merck's lung cancer drug as first-line treatment  https://t.co/w6c5x5nOKS
Green News:  Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/hRb45K0vgu
Merck & Co.  Merck Posts Earnings Results, Beats Estimates By  0.08 EPS https://t.co/hOCDBvEdVF
UPDATE 1- Merck wins early U.S. approval for Keytruda in untreated lung cancer. Read more: https://t.co/WTGwHD7zat  Merck
 FinancialBuzz: 
Merck Announces Third-Quarter 2016 Financial Results 
https://t.co/bmou8PfgF4  Stocks  market  TCOT
 Merck  so excited and inspired listening this morning!
After FDA Approval, Merck Posts Better-Than-Expected Earnings - https://t.co/FhqNK4S6Ed https://t.co/bvaxIIs01x  health
US OKs first-line use of  Merck's Keytruda in lung cancer. Read more: https://t.co/IeqApKktsg  Merck
 Merck and  Omnicom partnership allows clients to tap into all the expertise of Omnicom agencies - a great model  PMRGroup  SKIMgroup  PMRG
Merck   Merck 
Warning in Pre-market 09:10 am  triggered 13 minutes before the security price rose   trading  markets‚Ä¶ https://t.co/gFE5G8zwj3
FDA Approves Merck‚Äôs KEYTRUDA¬Æ (pembrolizumab) in Metastatic NSCLC for First-Line Treatment of Pa... https://t.co/hNVgnCokU7  YahooFinance„Çà„Çä
Word on the Street about Merck‚Äôs Animal Health Segment via Cafepharma Detail Piece Daily Pharma ... https://t.co/prWq7PEO9r
Merck quarterly revenue beats, raises full-year forecast via Cafepharma Detail Piece Daily Pharma ... https://t.co/JZcXoEqxD9
 CEOVazquez  Walmart  SodexoGroup  EYnews  Merck  WEConnection  MEmpresarias great event!
Merck Beats Street 3Q Forecasts, Hikes 2016 Profit¬†Forecast https://t.co/ye64HHfzSs
finzine:  Merck Merck Crushes Q3 Expectations Following Lung Cancer Drug Win https://t.co/t66oyOkgnD
FDA approves Merck‚Äôs Zinplava to reduce recurrence of Clostridium difficile¬†infection https://t.co/qPURhHx2TW
After FDA Approval, Merck Posts Better-Than-Expected Earnings - https://t.co/iafBy5Hn2r https://t.co/VmpSCaVR0c
After FDA Approval, Merck Posts Better-Than-Expected Earnings - https://t.co/1tmdXgTXbg https://t.co/nqFlE0PTSj  google
FDA approves first-line use of Merck & Co.'s Keytruda in non-small-cell lung cancer - FirstWord Pharma https://t.co/OVzbXkyyYV via  fwpharma
FDA approves first-line use of Merck & Co.'s Keytruda in non-small-cell lung cancer https://t.co/Z3rPxBkhaG
FDA approves  Merck's lung cancer drug as first-line treatment. Read more: https://t.co/zRPPZEyfAx  Merck
Best Selling Blockbuster Monoclonal Antibodies 2015
https://t.co/K71yMg1YvU
 antibodies  biologic  biosimilar  insulin  vaccines  dyadic  C1
Merck Profit Rises on Cancer Drugs, Vaccines - Merck posted increases in revenue and profit as a closely watche... https://t.co/t8v0ACQcaY
Jim Cramer -- Merck, Lilly Pressured by Political Uncertainty  Merck https://t.co/hCBviSn4TR https://t.co/g6cp1KBrEO
After FDA Approval, Merck Posts Better-Than-Expected Earnings  Merck https://t.co/U7Mq7MMiyB https://t.co/Ke2OGmSXaY
Merck beats Street 3Q forecasts, hikes 2016 profit forecast https://t.co/mMtrPUUj4c  MontCo
[DelcoTimes Biz] Merck beats Street 3Q forecasts, hikes 2016 profit forecast https://t.co/rteeDdNudF
Merck beats Street 3Q forecasts, hikes 2016 profit forecast https://t.co/9gGxw2d8TN  BucksCounty
Merck beats Street 3Q forecasts, hikes 2016 profit forecast https://t.co/xtCy0V6zwj -- by  NextDoorNerd
. Merck announces that  US_FDA has approved  Zinplava, to reduce  Cdifficile recurrence in  patients‚Ä¶ https://t.co/cEGhVOmHyN
 Merck Merck Crushes Q3 Expectations Following Lung Cancer Drug Win https://t.co/rlj2Px3drm
Merck quarterly revenue beats, raises full-year forecast: Yahoo/Reuters https://t.co/X2GqI3WZet
Merck Lifts Full-Year Guidance After Quarterly Forecast Beat
Wellness > Merck raises its full-year forecast because one drug has been.. https://t.co/txTFBUsaKF https://t.co/w7WELReeor
Licensing deal to give  Merck access to Scots innovation. Read more: https://t.co/QeeE5nsaJ5  Merck
Januvia revenues down 1% this quarter. https://t.co/LUAGdChQLY
Is Merck getting out of flat?  Merck https://t.co/CcKSqQIRcy
FDA Approves  Merck's KEYTRUDA¬Æ (pembrolizumab) in Metastatic NSCLC for First-Line Treatment... Read more: https://t.co/FbT4uHGseJ  Merck
FDA Approves  Mercks KEYTRUDA√Ç pembrolizumab in Metastatic NSCLC for FirstLine Treatment of ... Read more: https://t.co/PvWIr0EZyR  Merck
Merck: The Ugly Side of Gardasil - Sign the Petition! https://t.co/qJa9Y8HhSO
Merck KGaA‚Äôs (Merck) ‚ÄúBuy‚Äù Rating Reaffirmed at DZ Bank AG https://t.co/5KS6QaI5mn
Merck Beats Street 3Q Forecasts, Hikes 2016 Profit Forecast - https://t.co/hU4xyDibjp  Newsonline
BRIEF- Merck & Co says FDA also approves a labeling update for Keytruda for treatment of pat... Read more: https://t.co/wVO5iUPFt8  Merck
foxnewshealth : FDA approves Merck's lung cancer drug as first-line treatment ‚Ä¶ https://t.co/aE0xPLuE1R) https://t.co/CxaMUuCuRx
Merck & Co. Cements Lead Over Rivals After the FDA Grants Early Approval of Keytruda https://t.co/y4PLuTDl38
Merck beats quarterly revenue expectations  merck https://t.co/MR2lSuRSa6
 Merck & Co Inc. Reports 10% Increase In Q3 Profit. Read more: https://t.co/URJG10draF  Merck
Merck beats Street 3Q forecasts, hikes 2016 profit forecast: Higher sales of vaccines and prescription medicines‚Ä¶‚Ä¶ https://t.co/ALeIBdc2mK
4 Small Biotechs That Could Give Gilead, Merck & Co. Pfizer Some Competition With NASH https://t.co/0DLMdqpcY5
US STOCKS-Wall St set to open flat as investors assess earnings: * Merck, Procter & Gamble‚Ä¶ https://t.co/vaRfSg6uGX
Merck Beats Street 3Q Forecasts, Hikes 2016 Profit Forecast https://t.co/8XrssxWMPh  USA  US  USBiz
 Merck & Co. Shares Bought by Alps Advisors Inc. Read more: https://t.co/8whJ5CxZGV  Merck
Merck quarterly revenue beats, raises full-year forecast https://t.co/XHtoqmOM5o

REV  10.54B vs  10.24B
EPS  1.07‚Ä¶ https://t.co/OuupRAUWPl
 Merck FDA Keytruda Now OK For Some Patients With Untreated Lung Cancer. Read more: https://t.co/HdeZcuxHeq  Merck
 Merck thank u for ur commitment to patients around the globe  BringYourselfToWork
enBusiness_news: Merck beats Street 3Q forecasts, hikes 2016 profit forecast: FILE - In this Thursday, Dec. 18, 20‚Ä¶ https://t.co/YRAGbNPkrs
 Merck FDA: Keytruda Now OK For Some Patients With Untreated Lung Cancer. Read more: https://t.co/nDdhHlgLB6  Merck
Merck beats Street 3Q forecasts, hikes 2016 profit forecast: FILE - In this Thursday, Dec. 18, 2014, file pho... https://t.co/UAXhz8MmWM
 Merck:US Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment  MERCK & CO  https://t.co/ItPmpcSzsm  SP500
Merck gets early OK for Keytruda in first-line lung cancer: FDA fast-tracks
approval of PD-1/PD-L1 ... https://t.co/dIaD0VUtwq by PMLive
Merck beats Street 3Q forecasts, hikes 2016 profit forecast (from  AP) https://t.co/Ci1zMwgTSm
 Merck Merck Lifts Full-Year Guidance After Quarterly Forecast Beat - TheStreet https://t.co/ujiHd1gU15
Merck Beats Street 3Q Forecasts, Hikes 2016 Profit Forecast - U.S. News & World Report: The‚Ä¶ https://t.co/8RkOfGC4qF
 clinicalapprovals : Pharmalot Pharmalittle Merck drug wins FDA nod as firstline lung cancer treatment https://t.co/pC0eqsnsqF
 prostatecancer news Pharmalot Pharmalittle Merck drug wins FDA nod as firstline lung cancer treatment https://t.co/5qrQd6oRw5
BRIEF-Merck says aims to be leader in second-line lung cancer https://t.co/vknflHXwoe
News:  health Pharmalot Pharmalittle Merck drug wins FDA nod as firstline lung cancer treatment https://t.co/JMfXaI1sxy
Two approvals in 2 days for Merck: Zinplava  (C. diff), Keytruda (non-small cell lung cancer)  https://t.co/eA8u4qFtgY via  biopharmadive
Merck beats Street 3Q forecasts, hikes 2016 profit forecast: Restrained spending and higher sales of vaccines... https://t.co/FzILyMKpgZ
Merck Beats 3Q Expectations: Restrained spending and higher sales of vaccines and prescription medicines for ... https://t.co/9s8m9dx3hi
Why wait? FDA gives early OK to Merck‚Äôs Keytruda for frontline lung cancer - https://t.co/xJzCZEqBLy
Merck & Co.  Merck Updates FY16 Earnings Guidance https://t.co/M5NcukfgcQ
 U.S.FoodandDrugAdministration BRIEF-Merck & Co says FDA also approves a labeling update for Ke... Read more: https://t.co/FelpPfLO6D
DTN Stock Market: Merck beats Street 3Q forecasts, hikes 2016 profit forecast: Restrained spending and higher... https://t.co/xK2hEzlgUo
Merck Beats Street 3Q Forecasts, Hikes 2016 Profit Forecast - U.S. News & World Report: The Seattle TimesMerc... https://t.co/IUnuL4X6iz
Merck beats Street 3Q forecasts, hikes 2016 profit forecast: Higher sales of vaccines and‚Ä¶ https://t.co/Px7Octi1dz
 venturelounge getting started with keynote speaker Dr. Lanthaler  MerckAccelerator  Merck  munyachivs‚Ä¶ https://t.co/Xa3na3hf8d
This drug is a game changer! . Merck drug gets FDA approval as a first-line lung cancer treatment https://t.co/7AVoYakHmV via  WSJ
FDA OKs Merck's bezlotoxumab to reduce recurrence of C. diff infection in certain patients https://t.co/fmH9mBdtZr  Merck
FDA Approves Merck‚Äôs ZINPLAVA‚Ñ¢ (bezlotoxumab) to Reduce Recurrence of Clostridium difficile Infection (CDI)  https://t.co/6duGTFRJs6
 U.S.FoodandDrugAdministration FDA Approves Merck's KEYTRUDA¬Æ (pembrolizumab) in Metastatic NSC... Read more: https://t.co/zhIWnP6lnh
 kansas Merck beats Street 3Q forecasts, hikes 2016 profit forecast https://t.co/GzQgZ9tLJW
 Melanoma News: Pharmalot Pharmalittle Merck drug wins FDA nod as firstline lung cancer treatment https://t.co/WEr2Fc5lQo
 NutritionistGal FDA approves Merck's lung cancer drug as first-line treatment - Merck & Co Inc on Monday ... - https://t.co/681XWLA7Iw
Anti-PD-1 pembrolizumab (Keytruda,  Merck) approved as 1st-line option for advanced lung cancer pts.  immunotherapy https://t.co/q7ZJxTPwkA
Merck KGaA‚Äôs  Merck ‚ÄúBuy‚Äù Rating Reaffirmed at DZ Bank AG https://t.co/ZDLEFUfbd9
Winslow Asset Management Inc. Sells 2,206 Shares of Merck & Co.  Merck https://t.co/8530IJX4J8
Merck & Co.  Merck Shares Bought by Pathstone Family Office LLC https://t.co/gNmn8w27FL
 Merck  Podesta Lobbying Firm supporting  Hillary and defender of  ACORN pedo scandal https://t.co/7P78aYu3lh
ED  Merck feels that embracing  change benefits not only the org but also one‚Äôs own career! Read on  StraightTalk  https://t.co/AsLJSJ2X1r
Merck shares flat; co. beat estimates as sales of Gardasil vaccine surged https://t.co/LbfnTXeAHV via  business  Merck
More Tuesday reading:  DTC Animation Study Moving Forward After FDA Rejects Merck Critique https://t.co/86gDOO6Ln6
Merck & Co.  Merck Posts  Earnings Results, Beats Estimates By  0.08 EPS https://t.co/mrKkrPXk1k
What To Expect From Merck's Q3 Earnings? -  https://t.co/Jxv0zGOxNx
 cancer Pharmalot Pharmalittle Merck drug wins FDA nod as firstline lung cancer treatment https://t.co/SwL6KNY3pP https://t.co/rl5Mir0BrL
 green Merck wins early U.S. approval for Keytruda in untreated lung cancer: Merck & Co has won U.S. approval... https://t.co/WxO5VSgLbB
Merck Beats Street 3Q Forecasts, Hikes 2016 Profit Forecast: Restrained spending and ... https://t.co/WIBLAnJ38q https://t.co/KFfzvVNoXy
Merck Beats Street 3Q Forecasts, Hikes 2016 Profit Forecast: Restrained spending and higher sales of va... https://t.co/zxTbXdu2ED (NYT)
 LatestNews Restrained spending and higher sales of vaccines and prescription medicines for cancer and other diseases helped Merck & ...
Merck   Merck 
Warning in Pre-market 06:46 am  triggered 17 minutes before the security price fell   trading  markets‚Ä¶ https://t.co/2lvWlbAL0s
Smart cars free form displays seamlessly integrate into car interior  merck_de  mobilit√§t  zukunft  querdenken16 https://t.co/rKVkGyFAz2
Merck's 3Q Keytruda sales of  356M fell short of Street views, but sales seen surging on FDA green light of use in lung cancer  Merck
Private Advisor Group LLC Increases Position in Merck & Co.  Merck https://t.co/LRlK5MmlbV
Pharmalot Pharmalittle Merck drug wins FDA nod as firstline lung cancer treatment https://t.co/ZoTHF94Dvs https://t.co/YFJpoddFSu
On Merck Q3 earnings call... https://t.co/kD9cOVdDgq
FDA approves Merck's lung cancer drug as first-line treatment - Fox News https://t.co/ABH0KrKQUp
Merck beats Street 3Q forecasts, hikes 2016 profit forecast - U.S. News & World Report https://t.co/RiYAEoJw6M
 truthhertz Here's your site if you like going natural. Merck Popularized Cocaine: German Pharma Corporation Wo... https://t.co/4wSByraOU0
We're proud to have  merck,  MelanomaReAlli,  ParentProjectMD & more join our Patients Count Leadership Council. https://t.co/Mtvsdd6HtC
. US_FDA Approves  Merck‚Äôs  KEYTRUDA in  NonSmallCellLungCancer  for 1st-Line Treatment of Patients. https://t.co/oKjcpSFYGZ  RareDiseases
 madison Merck beats Street 3Q forecasts, hikes 2016 profit forecast https://t.co/fYAwXgmY3i
 Cancer News: Pharmalot Pharmalittle Merck drug wins FDA nod as firstline lung cancer treatment: Merck won ea... https://t.co/OsOruE5dJG
FDA Approves Merck's  Keytruda in Metastatic NSCLC as First-Line Treatment: https://t.co/68zAmU0Ct1
 GM  Merck  CaterpillarInc and  ChipotleTweets are all set to release quarterly earnings by the end of the day today https://t.co/NJz5rUsjkl
. Merck recognizes that  pharma companies have important responsibilities in addressing  AMR.  DavosDeclaration‚Ä¶ https://t.co/jIVTbRH5S5
Merck wins early U.S. approval for Keytruda in untreated  lung  cancer:   https://t.co/9qfh3cp6yI via  Reuters
Great job  BelisaDlasCasas moderating  Walmart  SodexoGroup  EYnews  Merck panel  WEConnection &  MEmpresaria Forum! https://t.co/RtxHsS5v0X
Keytruda wasn't the only  Merck drug getting an okay from FDA this week https://t.co/JhpD2ddvMb
Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment https://t.co/0pLgqeUyvS? via  Nasdaq
Merck & Co.  Merck Shares Bought by Ajo LP https://t.co/GF4ZHSdMAB
US_Business. Merck Beats Street 3Q Forecasts, Hikes 2016 Profit Forecast - NYTimes https://t.co/1SA1nhfSLq
Pharmalot.. Pharmalittle.. Good Morning.. lots of headlines today.. https://t.co/wI5juqgAy6  pharma  Merck  SRPT  PFE  marijuana  FDA  BMY
‚ÄúVaccines are Not for Public Health, It‚Äôs Really About Profit‚Äù ‚Äî Former Merck Sales Rep Reveal https://t.co/86pdE3K08p
FDA approves Merck‚Äôs Keytruda to treat metastatic NSCLC in people with high PD-L1 expression, expands 2nd line use https://t.co/KMOKZz1NmY
 drugdiscovery news: Pharmalot Pharmalittle Merck drug wins FDA nod as firstline lung cancer treatment https://t.co/RN3Y5hQn8R
 PFE Merck Keytruda Gets FDA Approval for First-Line Lung Cancer https://t.co/ySlB2aZ5Gb
New drugs to fight the antibiotic-resistant gut infection C diff are coming to market:  antibioticresistance  https://t.co/U9t1yny5fa
Merck's Keytruda wins coveted first-line lung cancer nod, cementing rise 'from laggard to leader' https://t.co/IlHOQeesnS  pharma  lcsm
MT  rm_arredondo: Showing off GHall to  Drexelalumni & planning collab w/  Merck & our new Supply Chain MS program! https://t.co/0aFNjDR83V
New: Merck Beats Street 3Q Forecasts, Hikes 2016 Profit Forecast https://t.co/yDzx6UtJz4
FDA Approves Merck‚Äôs KEYTRUDA¬Æ (pembrolizumab) NSCLC for First-Line Treatment of Patients Who Have High PD-L1 https://t.co/El579R0CmQ
Merck beats Street 3Q forecasts, hikes 2016 profit forecast https://t.co/61XQIDG3m2  Chicago
FDA approves Merck's lung cancer drug as first-line treatment https://t.co/4VpmahSn09

 lcsm  pharma  bigpharma  hcsm
Merck Beats Street 3Q Forecasts, Hikes 2016 Profit Forecast https://t.co/LwOBRHL6rv  ApsnyNews
Merck beats Street 3Q forecasts, hikes 2016 profit forecast - U.S. News & World Report: Fairfield CitizenMerc... https://t.co/1exyF3j4Ps
BRIEF-Merck says aims to be leader in second-line lung cancer  stocks  fx https://t.co/HILtCg6oqC
Merck beats Street 3Q forecasts, hikes 2016 profit forecast - U.S. News &amp; World Report https://t.co/OSFKsnQVVw https://t.co/ce3LNYa6X8
FDA approves Merck's lung cancer drug as first-line treatment  science https://t.co/CB9mKGbfgo https://t.co/0AzX6BS2XG
US STOCKS-Wall St set to open flat as investors assess earnings: * Merck, Procter & Gamble rise after profit ... https://t.co/xt5MarP36N
Here‚Äôs what to expect for  Merck next quarter. https://t.co/mkRkwm9vLD
Merck beats Street 3Q forecasts, hikes 2016 profit forecast https://t.co/HDejzNgxBe  CancerAwareness
Cancer Update: Merck beats Street 3Q forecasts, hikes 2016 profit forecast: Restrained spending and higher sa... https://t.co/NccJGE3Woo
. Merck showing declining innovation rates for antibiotics. Need new Push & Pull incentives.  AMRSymposium https://t.co/dasLVPzQ6Y
US STOCKS-Wall St set to open flat as investors assess earnings: * Merck, Procter & Gamble rise aft... https://t.co/afo36aRbsY  iGazette
Merck reports better than expected 3Q  Earnings  Merck https://t.co/TcNyOHET6C  business
US STOCKS-Wall St set to open flat as investors assess earnings: * Merck, Procter & Gamble rise... https://t.co/ooAFhebCjg (By  Reuters)
Merck & Co., Inc. Surges After Earnings, Eli Lilly and Co Slips https://t.co/ffaP3rNLGD  valuewalk
Birth of a new lung cancer med. Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/09Def40MVD via  Reuters
Merck Beats Street 3Q Forecasts, Hikes 2016 Profit Forecast https://t.co/Yd89jvdL4n  newyorktimes
Business LOTP update: FoxBusiness: Merck reports better than expected 3Q  Earnings  Merck https://t.co/NiRQfhZbpR  busniess  news
Merck reports better than expected 3Q  Earnings  Merck https://t.co/1TJG6fDVs5
Merck Beats Street 3Q Forecasts, Hikes 2016 Profit Forecast https://t.co/E5rmGBDMjB  ShoutNews
A closing word from Ken Frazier on our 3Q financial results.  Merck https://t.co/JqjOTfDpdH
Merck beats Street 3Q forecasts, hikes 2016 profit forecast: Restrained spending and higher sales of vaccines and‚Ä¶‚Ä¶ https://t.co/CbJgqvLS6C
Merck Beats Street 3Q Forecasts, Hikes 2016 Profit Forecast: Restrained spending and higher sales o... https://t.co/e0btNfpknu  business
Merck Beats Street 3Q Forecasts, Hikes 2016 Profit Forecast: Restrained spending and higher sales of vaccines... https://t.co/IpjpGqW1jM
Market: Merck Boosts Outlook as Key Cancer Treatment Gets New Ap...https://t.co/MWomkN2vhP  markets https://t.co/qKoetulgLX
Merck Africa Luminary 2016 Cote D'Ivoire Central African Republic First Lady to champion Merck More than a Mother i‚Ä¶ https://t.co/080FIitzmk
Merck Beats Street 3Q Forecasts, Hikes 2016 Profit Forecast - Restrained spending and higher sales of vaccines ... https://t.co/hUGnwY9YpP
Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/J7ZtBMCC05 via  ReutersIndia
UPDATE 2-Merck quarterly revenue beats, raises full-year forecast: * Q3 revenue rises 5 pct to  10.54 bln vs.... https://t.co/A7rwGE9wz2
Merck beats Street 3Q forecasts, hikes 2016 profit forecast - Daily Mail https://t.co/Q7aSQwBopo
 Merck Stock Futures Edge Up; New Oriental Rises, Sonic Dives https://t.co/yoapMvwWak
Merck beats Street 3Q forecasts, hikes 2016 profit forecast https://t.co/tsUcvw8tDz  DSNTech  business
Merck beats Street 3Q forecasts, hikes 2016 profit forecast https://t.co/LOxjl8f0Hw  Delco
GSK files the first licensing application for shingles vaccine:

https://t.co/I6RSUddZIC https://t.co/yyxyZTP3sp
UPDATE 2-Merck quarterly revenue beats, raises full-year forecast https://t.co/SVqnYyfJLx  Company  MnA
Merck & Co.  Merck Releases Earnings Results, Beats Estimates By  0.08 EPS https://t.co/5vEnIxxtSU
UPDATE 2-Merck quarterly revenue beats, raises full-year forecast https://t.co/kJVVcyDbu5  companynews
 Merck: Merck beats by  0.08, beats on revs; raises FY16 EPS in-line, raises rev above consensus https://t.co/oEbGh0j6vR
UPDATE 2-Merck quarterly revenue beats, raises full-year forecast https://t.co/X5CCiyRWdv  reuters https://t.co/Czi5xjxLJp
Merck Drug Keytruda Gets FDA Approval as a First-Line Lung Cancer Treatment - WSJ https://t.co/vUDLO4HTHH
Wow! Our members active in Chile  Walmart  SodexoGroup  EYnews  Merck speaking at  WEConnection &  MEmpresaria Forum https://t.co/V6u7pHHwkN
FDA approves Merck's Zinplava to reduce recurrence of Clostridium difficile‚Ä¶ https://t.co/2k2a4dqp22  DSNHealth
UPDATE 2-Merck quarterly revenue beats, raises full-year forecast https://t.co/KeyL44r0b4
Merck Beats Street 3Q Forecasts, Hikes 2016 Profit Forecast. https://t.co/QVOgPWuQ5D
Business : Merck Beats Street 3Q Forecasts, Hikes 2016 Profit Forecast https://t.co/TxAMfZwKvE
Merck Beats Street 3Q Forecasts, Hikes 2016 Profit Forecast
UPDATE 2-Merck quarterly revenue beats, raises full-year forecast https://t.co/DEBJWV9pnA  business  bloomberg
Tuesdays at Pony Club mean Tutoring Tuesdays! Merck Animal Health graciously sponsors the USPC webinar series.... https://t.co/5U7xq6Qeys
Merck  & Co. updates FY16 guidance to  3.71-3.78 EPS  & revenue guidance to  39.7-40.2 billion.  https://t.co/FFZJzV6b0e  Merck  Merck
UPDATE 2-Merck quarterly revenue beats, raises full-year forecast https://t.co/vPsxePxNgU  company  news https://t.co/ia7KpUFX8i
Merck Beats Street 3Q Forecasts, Hikes 2016 Profit Forecast https://t.co/rek0eSOkZc  Nytimes
 Marijuana  WEED UPDATE 2-Merck quarterly revenue beats, raises full-year forec... https://t.co/7VcUPBBiE5 https://t.co/ZbsM48QHdL  MLCG
ICYMI:  Merck get first-line lung approval for Keytruda - beating out I/O competitors https://t.co/qTK6igYJ63
Merck earnings, revenue top expectations ‚Äì CNBC - Merck earnings, revenue top expectations CNBC Merck reported ... https://t.co/tsLOnvzaYu
Merck‚Äôs lung cancer drug earns FDA‚Äôs approval ‚Äì French Tribune https://t.co/6DSgjH4ktz
Merck  Merck Reports Q3 EPS  1.07 vs  0.99 est, Revenue  10.54B vs  10.18B est  stocks  trading  earnings  SPY  QQQ  DIA
DTN Canada: Merck beats Street 3Q forecasts: KENILWORTH, N.J. - Merck & Co. (Merck) on Tuesday reported third-q... https://t.co/kd6A1KeZBD
Merck Revenue and Profit Rise on Cancer Drugs, Vaccines https://t.co/isXD6H6RIg? via  Nasdaq
Merck beats Street 3Q forecasts, hikes 2016 profit forecast: KENILWORTH, N.J. (AP) ‚Äî Higher sales‚Ä¶ https://t.co/t17GzaEmWL  Tips2Trade  T2T
 Fda Approves  Merck'sLungCancerDrug As First-Line Treatment... https://t.co/CqZTePkVbW https://t.co/k4FXT2Sdwh
Merck beats Street 3Q forecasts: KENILWORTH, N.J. - Merck & Co. (Merck) on Tuesday reported third-quarter net i... https://t.co/PsA5GJWyjA
Merck quarterly revenue beats, raises full-year forecast  stocks  fx https://t.co/lCgvMnmX7f
FDA approves Merck's lung cancer drug as first-line¬†treatment https://t.co/e6l8Vp84PD
Keytruda approved to treat  lungcancer in 1st line!  https://t.co/RRvONgMvsP  ShareHope  LCSM
EuroBiotech Report: Novartis-TxCell, AbbVie rejects Ablynx, Merck KGaA, Medicxi‚Äôs Parkinson‚Äôs startup and Ascendis https://t.co/SwPtVHlBwj
Merck beats Street 3Q forecasts, hikes 2016 profit forecast - U.S. News & World Report: Wall Street JournalMe... https://t.co/SZDUsz0rgE
colondroneme: Merck wins early U.S. approval for Keytruda in untreated lung cancer
Merck beats Street 3Q forecasts, hikes 2016 profit forecast: Restrained spending and higher ... https://t.co/Upnul3cDGX  TheArkOfTwitter
Merck beats Street 3Q forecasts, hikes 2016 profit forecast - U.S. News & World Report - DizzBee
https://t.co/bshdDc19Au
 fb
 Merck beats Street 3Q forecasts, hikes 2016 profit forecast  diseases  cancer  Merck&Co. https://t.co/ts568ysrKl https://t.co/NsJW3W30gW
(Canadian Business): Merck beats  Street 3Q forecasts, hikes 2016 profit forecast : Restrained spending and.. https://t.co/w7XrQnEcob
Merck beats Street 3Q forecasts, hikes 2016 profit forecast https://t.co/UNEwkVYb8v  beats
Merck beats Street 3Q forecasts https://t.co/EaBQJCY0kw  beats
 MedicalXpress :-) FDA approves Merck's Zinplava to reduce recurrence of Clostridium diff... https://t.co/AqIbZg4ris  Health  HealthNews
FDA approves Merck's Zinplava to reduce recurrence of Clostridium difficile infection https://t.co/sPrvG8Z6Tp  biotech
Merck beats Street 3Q forecasts hikes 2016 profit forecast https://t.co/hvQbtzOhPD
Merck Revenue and Profit Rise on Cancer Drugs, Vaccines - Wall Street Journal https://t.co/XANCiCf70H  health
FDA approves Merck's lung cancer drug as first-line treatment - Fox News https://t.co/BnYxmmj9uV  cancer
Merck beats Street 3Q forecasts, hikes 2016 profit forecast - KENILWORTH, N.J. (AP) ‚Äî Higher sales of vaccines ... https://t.co/wIFgHdDy7M
Article: FDA approves Merck's lung cancer drug as first-line treatment  - FDA approves Merck's lung (cont) https://t.co/d38Ut7BKSq
FDA approves Merck's Zinplava to reduce recurrence of  Clostridiumdifficileinfection https://t.co/jgtBYXxVFA
Company News: Merck (Merck) Q3 results beat analysts‚Äô forecasts

Merck reported Q3 FY 2016 earnings of  1.07 per sha‚Ä¶ https://t.co/b2at9We2dM
Full-year guidance all over the map:

Disappoint:
* Visa
* 3M
* Cat
* Whirlpool

Better:
* GM
* DuPont
* UTX
* Merck

 CNBC
Merck  Merck is "actively engaged" in looking for partnerships & collaborations & bolt-ons, and is not limited by size
Noice!! https://t.co/hLZSQjKvVh
2017 GCTO-Medical Writing Intern Job - Merck - Gwynedd, PA https://t.co/yCLMxCQHwI  internshipsinPA
Merck Revenue and Profit Rise on Cancer Drugs, Vaccines - Wall Street Journal https://t.co/4ZMU0TAGTe  google
"We're committed to reducing the impact of  InfectiousDiseases, which affects millions of patients around the world." -Roger Perlmutter  Merck
Merck Set For Big Move After 3-Month Slumber  Merck https://t.co/xtZMEUwuAd via  investopedia
 Merck  CTMGInc  clinicaltrials Folks should research the benefits of this group !!
 GILD - Merck Profit Rises on Cancer Drugs, Vaccines https://t.co/XJq6ovj8Gl
"In the third quarter Merck Research Laboratories made substantial progress on multiple fronts." -Roger Perlmutter  Merck
 Merck, take a look at  OWCP (https://t.co/ucepSloaL7). Great acquisition candidate. ;)
Merck beats Street 3Q forecasts, hikes 2016 profit forecast: KENILWORTH, N.J. (AP) ‚Äî Higher sales of vaccines and‚Ä¶ https://t.co/TeTEA95HOf
Merck Reports Better Than Expected 3Q Earnings https://t.co/Dcu1q6ciox
 MickeyDelDembow07 Merck Beats Street 3Q Forecasts, Hikes 2016 Profit Forecast: Higher sales of vaccines and prescription medicines f...
 news  money Merck Beats Street 3Q Forecasts, Hikes 2016 Profit Forecast: Higher sales of vaccines ... https://t.co/3Vbt3SImFv  business
Merck wins early U.S. approval for Keytruda in untreated lung cancer: (Reuters) - Merck & Co has ...... https://t.co/XpfeMOx5up
Merck wins early U.S. approval for Keytruda in untreated lung cancer: (Reuters) - Merck & Co has ... https://t.co/kjD1W1Kn5k  HealthNews
Merck Boosts Outlook as Key Cancer Treatment Gets New Approvals https://t.co/yzmU3hauwA
Merck beats Street 3Q forecasts, hikes 2016 profit forecast https://t.co/Ezjgc4YnkT  education
 Merck Q3 top line up +5%; net income up +20%; shares up +2%  premarket. I'm LONG  Merck long-term.
 businessinsider Why a Merck Kgaa logo on an article about Merck & Co? Confusing!
 graphicdesign  graphic  design

 Graphicdesign  webdesign Merck Lifts Full-Year Guidance After Quarterly Forecast Beat - ‚Ä¶
Merck beats Street 3Q forecasts, hikes 2016 profit forecast -- https://t.co/zcJYo9PTvA: https://t.co/Lye4Qkg6m8
Merck beats Street 3Q forecasts, hikes 2016 profit forecast: https://t.co/QFW714GFrE
 news  latest Merck beats Street 3Q forecasts: KENILWORTH, N.J. (AP) ‚Äî Merck & Co. (Merck) on Tuesday reported third-quarter ... ‚Ä¶
Merck Announces Third-Quarter 2016 Financial Results - Business Wire (press release) https://t.co/codAj720xS
"We remain confident in our  diabetes franchise and we are pleased with our continued strength globally." - AdamHSchechter  Merck
Merck beats Street 3Q forecasts, hikes 2016 profit forecast https://t.co/6JlmiTLTQf  tech  science
 latest  news Merck beats Street 3Q forecasts: KENILWORTH, N.J. (AP) ‚Äî Merck & Co. (Merck) on Tuesday reported third-quarter ... ‚Ä¶
. Merck Beats Estimates as Sales of Gardasil  Vaccine Surge https://t.co/9kdThDFRab  health  healthcare  doctors  ibd  gi  wellness  immune
porterhayley: Merck wins early U.S. approval for Keytruda in untreated lung cancer
 Merck beats Street 3Q forecasts, hikes 2016 profit forecast https://t.co/JD97pL1RI5
 Typography  GraphicDesign Merck Lifts Full-Year Guidance After Quarterly Forecast Beat - https://t.co/TPuYgzUuZ0:‚Ä¶ https://t.co/uTFDv2iNYd
Merck beats Street 3Q forecasts, hikes 2016 profit forecast  PhysOrg Higher sales of vaccines and prescription med‚Ä¶ https://t.co/Zb5tQOYmUU
"We drove growth across many of our core areas, including  oncology, vaccines, and hospital & specialty care." - AdamHSchechter  Merck
"Our top- & bottom-line growth in the quarter driven by solid operational performance sets us up for a strong 2016 overall" -Rob Davis  Merck
Merck beats Street 3Q forecasts https://t.co/nzzjIyV4vd  DuPage  news
 Graphicdesign  webdesign Merck Lifts Full-Year Guidance After Quarterly Forecast Beat - https://t.co/4IbjyQ8cxb: ‚Ä¶ https://t.co/wYcFEwMRvp
UPDATE 1-Merck quarterly revenue beats, raises full-year forecast https://t.co/hUNJlik2Ht
Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/LNGKgGIr1z  health  Reuters
Merck lifts full-year guidance after quarterly forecast beat https://t.co/pavTO0Oboj via  TheStreet
Merck wins early U.S. approval for Keytruda in untreated lung cancer   health
Merck raises its full-year forecast because one drug has been crushing it https://t.co/PXQt4RSxCf via  bi_contributors
David Varisano Merck wins early U.S. approval for Keytruda in untreated lung cancer: (Reuters) - Merck & Co h... https://t.co/4R20hBPUGn
Merck wins early U.S. approval for Keytruda in untreated lung cancer: (Reuters) - Merck & Co has won U.S. app... https://t.co/0TamzRmVqb
Merck beats Street 3Q forecasts: KENILWORTH, N.J. (AP) ‚Äî Merck & Co. (Merck) on Tuesday reported third-quarter ... https://t.co/GXb3IPPtvR
 healthNews Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/pWZbFKH2wQ
Live Long Merck wins early U.S. approval for Keytruda in untreated lung cancer: (Reuters) - Merc... https://t.co/HGN9Inrq9e Think Health
Merck wins early U.S. approval for Keytruda in untreated lung cancer: (Reuters) - Merck & Co has... https://t.co/SbrCOhlxX4  health_news
 Merck Listen to Merck & Co. earnings call and get LIVE transcript/updates here: 
https://t.co/TGm6ClJq2H  earnings  stocks  healthcare
RN NURSE: Merck wins early U.S. approval for Keytruda in untreated lung cancer: (Reut... https://t.co/1Q02wyrmkv https://t.co/c5AS8hv8NV
INSULIN Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/bWwlGYnQ21 https://t.co/cetEisx45n
DEPRESSION Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/v3FkL6Luwa https://t.co/oQUEMdIN7X
OVERWEIGHT   Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/FrncoK4qTL https://t.co/7PtOdF6Ab9
MarketCurrents: Merck Q3 top line up 5%; net income up 20%; shares up 2% premarket https://t.co/UsyIjQOY2F  premarket  Merck
DIABETES     Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/iAy1UQkfE0 https://t.co/n6Sd12OQkt
PARKINSON'S Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/9hA5qDWVro https://t.co/EAXtHQG2V2
ALZHEIMER'S Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/PwqGM7tfGV https://t.co/SjJjd2zkqa
HEALTHCARE Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/gtW106H0It https://t.co/XMVNZYttTe
NORCROSS   Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/eObeQAOy03 https://t.co/tM4Czbhjif
HI   Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/z0NfwSbIss https://t.co/tqb7eB88Rr
CALIFORNIA WINE Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/DIx7vR0Y9J https://t.co/3NF9573bxe
"3Q positions us well to deliver a balanced portfolio that'll generate long-term growth & value for shareholders & society" -K. Frazier  Merck
OHIO Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/Kx7VP6dUnL https://t.co/Hj0tzLcdRY
EMERGENCY Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/h9SI7blrbi https://t.co/9EBOAWzGdq
BUFFALO DIET Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/WF9vyJtuO1 https://t.co/AiPIgFdnPz
 Maine Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/ARzwGB647f https://t.co/3Ryep6gfts
NYC HEALTH Merck wins early U.S. approval for Keytruda in untreated lung cancer  https://t.co/CUJnFF7b4M
Tennessee   Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/YjSEjv1jRq https://t.co/xtCfRXQB3h
CA HEALTH Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/wihs3LgBZW https://t.co/5QQVMulrif
NYC HEALTH Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/jGsmIsa5Du https://t.co/aLmGJVaIfy
CUSTOMER   Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/0wsxv2blm0 https://t.co/RbAYOGI6bh
"Our appetite for BD has not changed. We continue to seek the best opportunities to augment our pipeline & portfolio." -Ken Frazier  Merck
WEB    Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/bCiwL9br0D https://t.co/C2kEuQEwsK
GOVERNMENT   Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/MGfD9fmRJJ https://t.co/pTwf4yNLSS
OFFICE Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/WxuD1tbJ6U https://t.co/v2Ukc322Df
MEDIA Merck wins early U.S. approval for Keytruda in untreated lung cancer: (Reuters)... https://t.co/fjpiRBa5PU https://t.co/8mVubr7ydL
PENN HEALTH Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/eHbIOVCmgS https://t.co/ZDBCOZpW2e
Merck KGaA: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Ac... https://t.co/BlrOFvLrG7
 Penn  Hospital Merck wins early U.S. approval for Keytruda in untreated lung cancer  https://t.co/khuLMNmWUO
 Denver  CO Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/VhJgqTRopc https://t.co/vIDtwQHSYV
DRIVER Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/CtwUxAg80e https://t.co/0Fic1rMJnk
NYC   Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/11deioF1uB https://t.co/ILLRw0GCdP
VIDEO Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/wFykbGtwCV https://t.co/j1TFjkSfgm
THERAPIST Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/FPDMWDGkPs https://t.co/KpwW7Vc43x
HEALTH Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/GG08hU1Vct https://t.co/Yad8HgWO27
RN Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/NjpxwYmnb8 https://t.co/OElzJR40dV
 jpwtweets Merck wins early U.S. approval for Keytruda in untreated lung cancer: (Reuters) - Merck... https://t.co/u1GFupRR00  jpwtweets
 Hollywood  Film Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/UIvlic25EI https://t.co/KhW178cm6G
TV Merck wins early U.S. approval for Keytruda in untreated lung cancer: (Reuters) - ... https://t.co/XMpo5bMiNi https://t.co/PLLUVpF1Rh
Stock Futures Edge Up; Merck, Keybanc, Baker Hughes Climb https://t.co/PiRhybxAV0
 Merck Merck Q3 top line up 5%; net income up 20%; shares up 2% premarket https://t.co/0evHn3FqkB
Merck Lifts Full-Year Guidance After Quarterly Forecast Beat - https://t.co/x44QzhWEnt https://t.co/k43jlDfAWU
Merck gets early OK for Keytruda in first-line lung cancer https://t.co/IuxESlAGLl  pharma
finzine:  Merck Merck beats Street 3Q forecasts, hikes 2016 profit forecast https://t.co/vD93wQLwmf
FDA approves Merck's lung cancer drug as first-line treatment | https://t.co/dTHarMDneb
On Merck  Merck earnings this morning. Discussing the FDA approval of Keytruda by the FDA, which came yesterday.
US FDA approves Merck's lung cancer drug as first-line treatment - Reuters UK https://t.co/MKFEld41X8 via Black Swan Intelligent Insight‚Ñ¢
 Merck Merck beats Street 3Q forecasts, hikes 2016 profit forecast https://t.co/kcdUPrZXtg
"This is what Merck is all about, and we are honored to be making a real difference in the fight against  cancer." -Ken Frazier  Merck
Merck‚Äôs Q3 Results, Guidance Look¬†Strong https://t.co/zZiVLg8lTH
 Breaking Merck beats Street 3Q forecasts, hikes 2016 profit forecast Read More : https://t.co/fGevJPbvQM
Merck Q3 top line up 5%; net income up 20%; shares up 2% premarket https://t.co/NNz7fFgpXR  premarket  Merck
Merck Lifts Full-Year Guidance After Quarterly Forecast Beat - https://t.co/2SyXLnnLqO: seattlepi.comMerck Lif... https://t.co/U3iTPBxYEe
 US  OKs first-line use Merck‚Äôs Keytruda lung cancer https://t.co/l7X8TSXRkN
Merck raises its full-year forecast because one drug has been crushing it (Merck) https://t.co/nj150ioqHf
News:  health Merck gets early OK for Keytruda in firstline lung cancer https://t.co/FYtXCMI1Oe
 News  Business Merck raises its full-year forecast because one drug has been crushing it (Merck) https://t.co/0kplTIkzxZ
Merck beats Street 3Q forecasts, hikes 2016 profit forecast -  https://t.co/CJul3nUrc9
 nasdaq What To Expect From Merck's Q3 Earnings? - Merck Merck 160 is set to report its Q3 16 earnings on October... https://t.co/4Sl1L2qtgK
Now trending: https://t.co/kXEeknlpYq
Merck beats Street 3Q forecasts, hikes 2016 profit forecast: Higher sales of vaccines and prescription medicines‚Ä¶ https://t.co/r7JxDrcdUW
Investors are invited to join our sales and earnings conference call starting now. Follow the conversation at  Merck. https://t.co/YBJijkIEYi
Merck reports 19.6 pct jump in quarterly profit https://t.co/jypESTmPCN
Shared via Reuters: Merck's Keytruda succeeds in key bladder cancer trial
FDA approves Merck& 039;s lung cancer drug as first-line treatment https://t.co/xf55RsY6OD
Merck raises its full-year forecast because one drug has been crushing it (Merck) (Business Insider) https://t.co/JuTo1QzjS9
FDA approves Merck's lung cancer drug as first-line treatment - Fox News https://t.co/9SuEh6yV9s ‚Ä¢ https://t.co/MmJAa7KXeT
USFDA approves keytruda: U.S. FDA approves Merck's lung cancer drug as first-line treatment - ET HealthWorld https://t.co/Mm0c7jrhDM
Package insert warns pregnant women: avoid chickenpox vaccine recipients for 6 weeks https://t.co/dd0ttnd768 (5.4) -  HopkinsMedicine agree?
 NicholasCarr, a writer and technology critic, warns of the danger of constantly being online.‚Ä¶ https://t.co/Abs9ZDSXH5
Brakes truly off for checkpoint inhibitors in NSCLC! Pembrolizumab now FDA approved firstline standard of care. https://t.co/8W8JRUQZ8Y
Merck Announces Third-Quarter 2016 Financial Results https://t.co/29IYKKNk2Z
Merck‚Äôs  Keytruda  received FDA approval as a first-line treatment for certain  lungcancer  cancer patients - wjs 
https://t.co/yY22Q1wTjl
Merck raises its full-year forecast because one drug has been crushing it (Merck) https://t.co/mCL4lChdCy  ROIMentor
 BREAKING Merck beats Street 3Q forecasts, hikes 2016 profit forecast   news
Merck Revenue and Profit Rise on Cancer Drugs, Vaccines - Wall Street Journal: PMLiVE Merck‚Ä¶ https://t.co/MtVOPBfcA9
Merck wins early U.S. approval for Keytruda in untreated lung cancer
Educating Patients on Effective Poison Treatments‚ÄîCommentary by Merck Manual author, Dr. Gerald F. O‚ÄôMalley: https://t.co/WxvlkfpFPF  MedEd
Merck beats Street 3Q forecasts https://t.co/J9ToRmvGPd
finzine:  Merck Merck Lifts Full-Year Guidance After Quarterly Forecast Beat https://t.co/SQhAzsYpDY
Coverage of CIR researcher Marc Vendrell's agreement with Merck to make new fluorescent disease reporter molecules.
https://t.co/dKWwIku6Af
Agree. KN021-G was fascinating. Bizarre to potentially use PDL1 status as a chemo selection tool  DrRiyazShah  GuneetWalia  Merck
Merck drug gets FDA approval as a first-line lung cancer treatment https://t.co/oOyWiDKzBR üîì by  ppppos via  c0nvey
Merck profit, revenue boosted by cancer drugs - MarketWatch https://t.co/1owkkPYeM0
FDA approves Merck's lung cancer drug as first-line treatment - Merck & Co Inc on Monday said the U.S. Food and Dru‚Ä¶ https://t.co/1ry84R0vyv
Merck Announces Third-Quarter 2016 Financial Results: Merck , known as MSD outside the United States and Cana... https://t.co/VtZEpJveKS
Merck Announces Third-Quarter 2016 Financial Results: Merck , known as MSD outside the Uni... https://t.co/ePE8mxc8JB staryourweightloss
FDA approves Merck's lung cancer drug as first-line treatment
 Merck  Merck.XE:

Merck Revenue and Profit Rise on Cancer Drugs, Vaccines:

https://t.co/OqowidhjQf
 Merck Merck Lifts Full-Year Guidance After Quarterly Forecast Beat https://t.co/YCbSfKMiH0
https://t.co/n94yDlOYME UPDATE 1-Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/Nv58H996gL
 Reuters UPDATE 1-Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/Zv5wI1RGl6
Merck Lifts Full-Year Guidance After Quarterly Forecast Beat  Merck https://t.co/17nqf3Tlbp https://t.co/WrpcwEgPHE
Merck beats estimates following better-than-expected sales of HPV vaccine ht... https://t.co/B60f7tDYSW via‚Ä¶ https://t.co/dJzq0i9NuC
Merck gets early OK for Keytruda in first-line lung cancer - PMLiVE https://t.co/LF7cxRwjIJ
FDA approves Merck's lung cancer immunotherapy drug  Keytruda as first-line... https://t.co/stMRezZ0mt by  CMichaelGibson via  c0nvey
Merck Q3 Profit Rises; Lifts 2016 Outlook https://t.co/FdWJaFTEqa
Merck & Co Inc. Reports 10% Increase In Q3 Profit https://t.co/VF4lJ2f6mG
Merck Shares Climb 3% After Third-quarter Earnings Beat - FOXBusiness https://t.co/AgwPCzj7GT
Merck beats Street 3Q¬†forecasts https://t.co/6mATxsLlUK
Merck beats Street 3Q forecasts - FOXBusiness https://t.co/mDkNuom5TF
‚óà FDA approves Merck's lung cancer drug as first-line treatment: Merck & Co Inc on Monday said the U.S. F... https://t.co/XcA8k3CvFK ‚óà
 teamfollowback UPDATE 1-Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/O41eSayCUv  sougofollow
FDA approves Merck's lung cancer drug as first-line treatment: Merck & Co Inc on Monday said the U.S. Food an... https://t.co/rLam0pFCDZ
Fr  MyKembangSepatu FDA approves Merck's lung cancer drug as first-line treatment: Merck & Co Inc on Monday s... https://t.co/f1PCUN8M7o
Health : FDA approves Merck's lung cancer drug as first-line treatment: Merck & Co Inc on Monday said... https://t.co/ziXzeltCBm  health
 Merck beats Street 3Q forecasts https://t.co/2xdrcETs2J https://t.co/nTR5nvXl78
 Merck:

Merck‚Äôs Q3 Results, Guidance Look Strong:

https://t.co/z6uC4WAWQL
 Merck:

Merck Lifts Full-Year Guidance After Quarterly Forecast Beat:

https://t.co/ToNJfRSOis
New post: "Merck raises its full-year forecast because one drug has been crushing it (Merck)" https://t.co/7IDufTLRtO
Merck raises its full-year forecast because one drug has bee... https://t.co/Hq8lJHcBJf via  BusinessInsider  look https://t.co/rZqEwrcQAH
 news  Merck beats Street 3Q forecasts  business  fdlx
Merck raises its full-year forecast because one drug has been crushing it https://t.co/MudSNZJTqs https://t.co/JduAgTQPwf
Merck  & Co. announces earnings.  1.07 EPS. Beats estimates.  10.50b revenue. https://t.co/3vUGM7FWlj  Merck  Merck
 businessinsider A mistake often made: your story about Merck & Co Inc has the wrong logo picture (ie  the German M‚Ä¶ https://t.co/6YwjMwsGOM
Merck Beats Street 3Q Forecasts - https://t.co/SAVROehWCz
Business LOTP update: businessinsider: Merck raises its full-year forecast because one drug has been crushing it https://t.co/4mE4vcfr5T ‚Ä¶
UPDATE 1-Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/2YHG8Vyd0z  trading  market
Benzinga: Merck's Q3 Results, Guidance Look Strong https://t.co/0y4AUlKa8B  Merck
News: Merck gets early OK for Keytruda in firstline lung cancer https://t.co/2vutc3sh0j
Merck Beats Street 3Q Forecasts - New York Times https://t.co/m27juOXJoD
business: Merck beats estimates following better-than-expected sales of HPV vaccine https://t.co/odY1F2UraR https://t.co/50UF4IS7qU
HoerterFX Notes: Merck beats Street 3Q forecasts: Merck & Co. (Merck) on Tuesday reported third-quarter net inc... https://t.co/cfrsqLsiqc
Trading Street: Merck beats Street 3Q forecasts: Merck & Co. (Merck) on Tuesday reported third-quarter net inco... https://t.co/o5f0t4b1Mj
 fezziwig2008 "look for partnering".... did Merck / CNBC said this or you?
BRIEF-Merck & Co Q3 non-gaap EPS  1.07: Oct 25 (Reuters) - Merck & Co Inc : 
  Q3 non-gaap earnings per share... https://t.co/0iakpDMoSA
Merck beats Street 3Q forecasts: KENILWORTH, N.J. (AP) ‚Äî Merck & Co. (Merck) on Tuesday reported third-quarter net‚Ä¶ https://t.co/WXy1sabJDU
Merck's Q3 Results, Guidance Look Strong https://t.co/IER2s7X5hr  Merck
UPDATE 1-Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/VFTipwkaJK  company  ne‚Ä¶ https://t.co/D3UGwTzNkU
FreedomWonInc. Merck Shares Climb 3% After Third-quarter Earnings Beat: Shares of Merck‚Ä¶ https://t.co/6mv83YdLKp
Merck reports 19.6 pct jump in quarterly profit https://t.co/UCqdYEqHis  company  news https://t.co/03kfyZmIbh
businessinsider: Merck raises its full-year forecast because one drug has been crushing it https://t.co/T3J7YVqYuy https://t.co/6LQLcaYcR0
Merck raises its full-year forecast because one drug has been crushing it (Merck) https://t.co/lCeOGKn0i8  business  news
Merck Beats Street 3Q Forecasts - New York Times
Merck raises its full-year forecast because one drug has been crushing it (Merck)  news https://t.co/1a3OASdJcM https://t.co/hZiV6vwGro
clusterstock: Merck raises its full-year forecast because one drug has been crushing it https://t.co/ssj5bXLDk5 https://t.co/dLoBKnvUa8
Merck raises its full-year forecast because one drug has been crushing it (Merck): Thomson ReutersMerck & Co In... https://t.co/U4LlwE26wz
Merck raises its full-year forecast because one drug has been crushing it (Merck) https://t.co/bs9jRsPMWy  MGWV  TFB  F4F
Merck beats estimates following better-than-expected sales of HPV vaccine https://t.co/il8eGqdPl6 https://t.co/eUH7twPFTj  business
Business Merck raises its full-year forecast because one drug has been crushing it (Merck) https://t.co/c2pNVtHAXr
Merck raises its full-year forecast because one drug has been crushing it (Merck) https://t.co/cQP1fB2Q47  businessinsider
Merck raises its full-year forecast because one drug has been crushing it (Merck): Thomson Reuters... https://t.co/aA1ZtUqzTJ  TaNeaOnline
businessinsider: Merck raises its full-year forecast because one drug has been crushing it https://t.co/tVhDSEsFSS ‚Ä¶
UPDATE 1-Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/7DqjNizA2R  companynews
UPDATE 1-Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/enLWrXqyVB  business  bloomberg
Merck reports 19.6 pct jump in quarterly profit https://t.co/V7BO2wV5wA  business  bloomberg
Merck reports 19.6 pct jump in quarterly profit https://t.co/EIjpBIPxNW  companynews
Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment - WSJ https://t.co/lWZuTj3CAX
Merck raises its full-year forecast because one drug has been crushing it (Merck): Thomson Reute... https://t.co/XDpmQyC6GI  AceNewsReport
 business Merck raises its full-year forecast because one drug has been crushing it (Merck): Thomson ReutersMer... https://t.co/DQuIt1R9Cf
Merck raises its full-year forecast because one drug has been crushing it (Merck): Thomson Reut... https://t.co/1MwsstrFVv  business  news
UPDATE 1-Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/LP6pGQOo8H  reuters https://t.co/eIeHc8nj2e
 Breaking Merck beats Street 3Q forecasts Read More : https://t.co/fGevJPbvQM
Merck reports 19.6 pct jump in quarterly profit https://t.co/QDBhMCv9YG  reuters https://t.co/02HJf4xV27
Merck beats Street 3Q forecasts: Merck & Co. (Merck) on Tuesday reported third-quarter net income of  2.18 billion.‚Ä¶‚Ä¶ https://t.co/qPRxVOcPbS
UPDATE 1-Merck wins early U.S. approval for Keytruda in untreated lung cancer https://t.co/gSnetS57IQ  Company  MnA
Merck reports 19.6 pct jump in quarterly profit https://t.co/wtwCBx7o3F  Company  MnA
 news Merck beats Street 3Q forecasts: KENILWORTH, N.J. (AP) ‚Äî Merck & Co. (Merck) on Tuesday reported third-qu... https://t.co/1FSyaWS0Om
Merck beats estimates following better-than-expected sales of HPV vaccine https://t.co/Ng3FOo6jKg https://t.co/AGsLR0i8ko
 Merck: Merck Announces Third-Quarter 2016 Financial Results | Merck Newsroom Home https://t.co/y8xVbQaf3u
UPDATE 1-Merck wins early U.S. approval for Keytruda in untreated lung cancer: * FDA moves cement M... https://t.co/h8B6KoTDKz  iGazette
 Merck Q3: It's all about  Keytruda 
https://t.co/bubgqsOTzZ 
 pharma  biotech  FDA
US OKs first-line use of Merck‚Äôs Keytruda in lung cancer - https://t.co/Hsh0lQGb7C
 Marijuana  WEED UPDATE 1-Merck wins early U.S. approval for Keytruda in untrea... https://t.co/gIGTGYamZ3 https://t.co/ZbsM48QHdL  MLCG
UPDATE 1-Merck wins early U.S. approval for Keytruda in untreated lung cancer: * FDA moves cement Merck's lea... https://t.co/rYrKWpw9f1
UPDATE 1-Merck wins early U.S. approval for Keytruda in untreated lung cancer: * FDA moves ceme... https://t.co/NOZfteoda8 (By  Reuters)
(Canadian Business): Merck beats  Street 3Q forecasts : KENILWORTH, N.J. (AP) _ Merck & Co. (Merck) on Tuesday.. https://t.co/VsBDryWgef
New post: "Merck beats Street 3Q forecasts" https://t.co/qv1KFAZ3je
Merck beats estimates following better-than-expected sales of HPV vaccine https://t.co/J7ftm10Rvm https://t.co/QSUlDUqkPY  BSAFunds  Merc‚Ä¶
7+ TOP YouTube  VideoMarketing Stats https://t.co/lvPuEFrvUc Merck beats estimates following better-than-expected‚Ä¶ https://t.co/HRuo6QVtuv
MSD‚Äôs Keytruda given first FDA approval for first line treatment: MSD, known as Merck in the US, has scored a... https://t.co/woonIvuPQS
 news  Merck Shares Climb 3% After Third-quarter Earnings Beat  business  fdlx
Merck & Co posts 10% increase in Q3 profit https://t.co/nAnLNa7xAr https://t.co/csV5iYjZbk
Merck  Merck Tops Q3 EPS by 8c; Narrows FY16 Outlook https://t.co/HnIyWXyPOf
 ZacksInvestmentResearch was for earnings of 98 cents per share. The results surpassed Wall Street expectations. https://t.co/Ui6WOloXtA
 biotech  science Merck Announces Third-Quarter 2016 Financial Results: Third-Quarter 2016 Worldwide Sales We... https://t.co/YM0i84a6p6
Merck Announces Third-Quarter 2016 Financial Results: Third-Quarter 2016 Worldwide Sales Were  10.... https://t.co/01jni3f8Ak  biofinder
Merck partner NewLink grabs up to  76M in Ebola vax funding from feds https://t.co/9rJ0qZUaqL
Merck beats Street 3Q forecasts https://t.co/G9ImZNcNkF  Seattle
Check out the highlights from this morning‚Äôs financial results.  Merck https://t.co/rIbAv4oXsL
Merck reports 19.6 pct jump in quarterly profit
New  EdinburghUni licence agreement with  Merck set to enhance our 
understanding of disease https://t.co/S1s0weVD2c https://t.co/8DBexlhu3W
Merck reports 19.6 pct jump in quarterly profit: Oct 25 - Merck & Co Inc reported a 19.6 percent rise
in quar... https://t.co/v4IJpRwwkB
CNBC: Merck earnings, revenue top expectations https://t.co/heWmkThiwT
Merck shares climb 3% after 3rd-quarter earnings beat - MarketWatch https://t.co/RkI0JhsdbL
UPDATE 1-Merck wins early U.S. approval for Keytruda in untreated lung cancer  stocks  fx https://t.co/mx23cFblvP
Merck shares climb 3% after third-quarter earnings beat https://t.co/pnBYnIoliY
Merck & Co. raises annual guidance as third-quarter profit, sales rise https://t.co/YTTEFjm31D  Merck
New: Merck reports 19.6 percent jump in quarterly profit https://t.co/06cXSX0DTW
Merck earnings:  1.07 a share, vs 99 cents estimate  Merck  Merckearnings https://t.co/9lsrvx1v7X https://t.co/a6SwuMSSll
FDA approves Merck's lung cancer drug as first-line treatment  merck  keytruda  johngbaresky https://t.co/HydQJsa12p
What to Expect From Merck Earnings - Yahoo Sports https://t.co/ICwBoPchsE
 FDA approves  Merck's cancer drug as first-line treatment > Solid win for Merck and lung cancer patients https://t.co/VDs676Ak8P
Retweeted Fox Business Alert ( FoxBizAlert):

BREAKING NEWS: Merck Reports Better Than Expected 3Q Earnings... https://t.co/HSDWfOm4FT
 Merck & Co. Stake Increased by VNBTrust National Association. Read more: https://t.co/PbASSYwGv4  Merck
Merck earnings, revenue top expectations https://t.co/CzyjBHzlt7  BSAFunds  MerchantCashAdvance  BlueStreakAdvances
Job Offers: Medical Representative - Consumer Health - Merck Ltd. https://t.co/X00uTSM9rm  asiajobs  ThailandJobs  PhuketJobs
FoxBusiness - Dow component Merck reported an adjusted 3Q profit of  1.07 per share, topping the estimate for  0.... https://t.co/b9gEHlcBJO
 Merck:

Merck earnings, revenue top expectations:

https://t.co/Asavx18Z8o
Merck earnings, revenue top expectations https://t.co/KJGp6XMwID
Merck  Merck with an earnings beat in Q3. Up 3% in premarket
https://t.co/o9YmQ5BoeingFM
Stop stigmatizing women with infertility problem ‚Äì Aisha Buhari: https://t.co/UUXhoPUPRg https://t.co/tj65gJVK3c
 Merck 3Q Keytruda sales were  356M. That's about right in line with estimates. https://t.co/bj80ANQP1M https://t.co/XYJ8OdnNBY
 news  Merck Reports Better Than Expected 3Q Earnings  business  fdlx
 MARKETWATCH Merck shares climb 3% after third-quarter earnings beat https://t.co/UXB1lvKXWH
Merck shares climb 3% after third-quarter earnings beat https://t.co/HOoj4t7yrN  Stocks
Merck shares climb 3% after third-quarter earnings beat https://t.co/0CCHWlIVqo MARKETWATCH
Merck shares climb 3% after third-quarter earnings beat https://t.co/CtR8XKlOFt  Tips2Trade  T2T
Merck's stock surges 2.8% premarket after Q3 results https://t.co/N80hRbsqdA
Merck shares climb 3% after third-quarter earnings beat https://t.co/R1LWCAoZhY ‚Üí via  AlertTrade
Merck beats by  0.09, beats on revenue  Merck https://t.co/CpLgUsvIMx
 HATD Shares of Merck & Co. Inc.  were up 3% in premarket trade Tuesday after the company beat third-quarter expectations. The compan...
 Mercados  Finanzas Merck shares climb 3% after third-quarter earnings beat: Shares of Merck & Co. Inc.  were... https://t.co/ALklIDnILY
Merck shares climb 3% after third-quarter earnings beat: Shares of Merck & Co. Inc.  were up 3% in premarket ... https://t.co/Ytc3OEx5yY
Merck shares climb 3% after third-quarter earnings beat: Shares of Merck & Co. Inc.  were up... https://t.co/pP1uDBEcmY  Stocks  Trading
Shares of Merck & Co. Inc.  were up 3% in premarket trade Tuesday after the company beat third-quarter expectations. The company repo...
Merck shares climb 3% after third-quarter earnings beat: Shares of Merck & Co. Inc.  ... https://t.co/CBTsAzdsL9 https://t.co/493ZhFPXF7
 Earnings Merck Announces Third-Quarter 2016 Financial Results: KENILWORTH, N.J.--(BUSINESS WIRE... https://t.co/BYT6Ixf1FJ Earning News
Merck Announces Third-Quarter 2016 Financial Results https://t.co/cTT2MhAjGd  pharma  pharma
Merck Reports Better Than Expected 3Q Earnings - FOXBusiness https://t.co/zFyde4q3AB
Merck now sees 2016 adj. EPS  3.71- 3.78; FactSet consensus  3.75 https://t.co/N80hRbsqdA
Merck Q3 adj. EPS  1.07; FactSet consensus 99 cents https://t.co/N80hRbsqdA
Merck Q3 EPS 78 cents vs. 64 cents a year ago https://t.co/N80hRbsqdA
PharmaMKTnet: Merck Announces Third-Quarter 2016 Financial Results https://t.co/0LVUBgWNzn via BusinessWire
HoerterFX Notes: Merck Reports Better Than Expected 3Q Earnings: Dow component Merck reported an adjusted 3Q ... https://t.co/cWwFXX9eRU
Trading Street: Merck Reports Better Than Expected 3Q Earnings: Dow component Merck reported an adjusted 3Q p... https://t.co/9HR7z9xr0Q
Merck Announces Third-Quarter 2016 Financial Results -  https://t.co/zwkuoqAvXM
MarketCurrents: Merck beats by  0.09, beats on revenue https://t.co/bDhlxBjhyc  premarket  Merck
 Merck Merck Announces Third-Quarter 2016 Financial Results https://t.co/h3BQQ4bTsQ
 Merck:

Merck (Merck) Tops Q3 EPS by 8c; Narrows FY16 Outlook:

https://t.co/VreSWvnzA5
EARNINGS ALERT: Merck EPS beats  1.07 (adj.) vs.  0.99 (est.)  ‚Ä¢  revs. beat  10.536B vs.  10.177B (est.)

 Merck
Merck beats by  0.09, beats on revenue
Follow  Merck for this morning's live 3Q Sales and Earnings Coverage starting at 8AM ET https://t.co/vTCsHDLt7Y
 Merck:

Merck Announces Third-Quarter 2016 Financial Results:

https://t.co/crKTQ9CyOD
BREAKING NEWS: Merck Reports Better Than Expected 3Q Earnings https://t.co/qjqQd9WZ8f
 Merck Merck Announces Third-Quarter 2016 Financial Results... - https://t.co/cdT7bKtwKc
Livesquawk:  Merck Merck & Co Q3 16 Earnings Results:
-Adj EPS:  1.07 (Estimate  0.99)
-Revenue:  10.5B (Estimate  10.2B)
Merck beats by  0.09, beats on revenue https://t.co/KAh9UYs15X  premarket  Merck
Click here to see our 3Q financial results: https://t.co/iIQaDOssIx  Merck
US OKs first-line use of Merck‚Äôs Keytruda in lung cancer - US regulators have issued a green light for first-li... https://t.co/F3GxSxP5Ic
Merck : Announces Third-Quarter 2016 Financial Results  https://t.co/jMCoShvmFK
 Merck Merck & Co Q3 16 Earnings Results:
-Adj EPS:  1.07 (Estimate  0.99)
-Revenue:  10.5B (Estimate  10.2B)
"FDA approves Merck's lung cancer drug as first-line treatment" https://t.co/N00NDrt0C0  Reuters_Health
Licensing deal to give Merck access to  Edinburgh healthcare innovation
https://t.co/KoIAUkGAJA https://t.co/Yqkudfeuuy
Merck gets early OK for Keytruda in first-line lung cancer - https://t.co/PCPqhh6Xy3
MSD's  Keytruda given first  US_FDA approval for first line treatment https://t.co/FJxd2qMuZG  Merck  pharma
Scientist, Molecular Discovery - Antibody Job - Merck - Palo Alto, CA https://t.co/mOiiBsIXcG
Bioinformatics Lead Job - Merck - Cambridge, MA https://t.co/HWf6kk1xtm
FDA approval for Keytruda in metastatic non-small cell lung cancer for first line treatment where tumour has high P‚Ä¶ https://t.co/VLjgmo1tzk
FDA approves Merck's lung cancer immunotherapy drug  Keytruda as first-line treatment | Reuters https://t.co/4UOAkpJCrk
Merck‚Äôs CMO is preparing everyone to live to 100 https://t.co/sh4qdM5ShK
"US OKs first-line use of Merck‚Äôs Keytruda in lung cancer" https://t.co/1q1rZLYFZO  pharma  biotech  bigpharma  medtech
MERCK ACCELERATOR KENYA SPRING 2017 APPLICATION IS NOW OPEN! - FUNDS UP TO  30k - https://t.co/HHCGQbU8wZ https://t.co/P4vMKS7rdd
US OKs first-line use of Merck‚Äôs Keytruda in lung cancer https://t.co/Ibyx5lHOTs  pharma  health
Associate  director, Safety and Environment- Boston, MA  job:  Merck, Boston, MA. https://t.co/tvubs6geFu  MBoeing  jobs  USA
Merck Sharp and Dohme calls early end to successful Keytruda bladder cancer trial https://t.co/LKT0uCRs1N
Final workshop for the  Health Unit team of the  MSAS Community. Pictured: MSD  Merck Fellows, Tambacounda &  Dakar‚Ä¶ https://t.co/sKeIYLgpGk
 keytruda gets FDA approval as a first-line lung  cancer treatment 
https://t.co/GzzBNqbTt0 via  WSJ
Scrip: It‚Äôs Here: Merck‚Äôs  Keytruda Cleared For First-Line Lung Cancer https://t.co/OXoUrc7aLj¬† via‚Ä¶‚Ä¶ https://t.co/tEhE02jnvT
 MobileTechnology enhances patient experience.  HealthCare  MobileTech 
https://t.co/k7tJw06niQ https://t.co/hUK6ceYqYj
 news  latest Merck's Keytruda wins coveted first-line lung cancer nod: Just a couple weeks after presenting full results o... ‚Ä¶
 latest  news Merck's Keytruda wins coveted first-line lung cancer nod: Just a couple weeks after presenting full results o... ‚Ä¶
 SpiritSamba  Charbrevolution  tracifrost1976  DoctorChristian  RichieAllenShow Yep, Merck have told him under no circumstance can he do it.
What to Expect From Merck Earnings - Yahoo Sports  Health  News https://t.co/BHbwNMB2VH
Merck's Keytruda wins coveted first-line lung cancer nod: Just a couple weeks after presenting full results o... https://t.co/OIfmFlw2QZ
Fundamental analysis show Merck & Co  Merck is almost 10%  Undervalued before  Earnings https://t.co/OkbvKoqGMK https://t.co/KBB1rbawyU
FDA approves Merck's lung  cancer drug as first-line treatment: https://t.co/9t0jQ56G8k  ChannelNewsAsia  lifesciences
 What to Expect From Merck Earnings - Yahoo Sports https://t.co/zSrkUSFbtb
It‚Äôs Here: Merck‚Äôs  Keytruda Cleared For First-Line Lung Cancer https://t.co/o4igQhjVa7 via  PinkSheetMaryJo  oncology
INDUSTRY NEWS: Merck drug gets  FDA approval as a first-line  lung  cancer treatment via  WSJ  pharma  biotech https://t.co/C81ltCUbvY
ICYMI: Why wait? FDA gives early OK to Merck‚Äôs Keytruda for frontline lung cancer
 Merck  BMY
https://t.co/EgtMMz3KAb
"What to Expect From Merck Earnings - Yahoo Sports" https://t.co/qLi0kVd574  HealthNews
The Merck Veterinary Manual   https://t.co/hSi8BmTSH1 https://t.co/rmBgxf2Z0H
Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment - https://t.co/0TlFWx0t3Y  GoogleAlerts
ETHealthworld | U.S. FDA approves Merck's lung cancer drug as first-line treatment https://t.co/EC2wh80u2N
Pharmaceutical companies in ny  cafe  pharma  merck https://t.co/sgGIq1Fe30  Camping
FDA approves Merck's lung cancer drug as first-line treatment | Reuters https://t.co/yuE1zaiyJj
‚ÄúVaccines are Not for Public Health https://t.co/BF3qRsHhhH
Merck drug gets FDA approval as a first-line  lung cancer treatment https://t.co/ClCKE1jbtH via  WSJ
Merck's Keytruda wins coveted first-line lung cancer nod - FiercePharma https://t.co/jqum9R7nx8  health
Good spread of coverage today for our story on University of Edinburgh's deal with pharma giant Merck  innovation https://t.co/asnUbxD1Ah
A look at our solution allowing  merck4bio to print batch numbers & dates on medical pouches more efficiently‚Ä¶ https://t.co/I8VjFP7J6s
Global Dendritic Cell Cancer Vaccine Market 2016 ‚Äì Merck, Northwest Biotherapeutics, Glaxo Smith Kline‚Ä¶ https://t.co/DYgXo087xC
 FDA waves through  Merck's  Keytruda in 1L NSCLC in wake of impressive  ESMO16 data https://t.co/jLaIP1ICpU  cancer
FDA approves first-line use of Merck & Co.'s Keytruda in non-small-cell lung cancer https://t.co/ce6kgWlnm7  Merck
 Merck  KEYTRUDA receives FDA approval for a new indication, adding an option for certain first-line NSCLC patients https://t.co/Pe53VOZ6uB
 Merck  4  steady supply of herbal drugs/extracts. Vinblastin, quabain,etc Inbox us or whatsapp us by +2347067916243 https://t.co/xknAXPgBIN
Licensing deal to give Merck access to Scots innovation https://t.co/pzSOMBF54p
Merck More Than A Mother High Level Panel Calls for Action to Improve Access to Regulated Fertility Care and... https://t.co/zD8kgEqH6l
FDA OKs new indication for Merck's cancer med  Keytruda https://t.co/IAWrYaAygM  Merck
Lung cancer treatment. .. https://t.co/EY06XzXAY9
 _JulieNixon  EdinLicensing and here yesterday ... https://t.co/0QH4CAoYLR
 CANCER   drug  FDA approved  Merck  keytruda for treatment of  metastatic  NSCLC
For more: https://t.co/2tOBr7yzjO
 Augusta Pharmaceutical companies in ny  cafe  pharma  merck https://t.co/xZmlcfEDFo
FDA approves Merck's lung cancer drug as first-line treatment https://t.co/E4u69nuHe3 via  Reuters
Merck Drug Gets FDA Approval as a First-Line  Lung  Cancer  Treatment
 MediaSoft https://t.co/XIf7yLmDHz
TV EDUCATION FDA approves Merck's lung cancer drug as first-line treatment https://t.co/H0ohN3AVvP https://t.co/QTpWpxnw3p
Merck address apt equality by focusing on the role/position not the person. Kudos for addressing pay equality  WIL_Forum  PWNGlobal  Merck
(The Scotsman): Licensing deal to give  Merck access to Scots innovation : German healthcare giant Merck has.. https://t.co/1QAUNka0gX
 GWEF16 Gender balance makes  great economic sense - Merck
Paolo Carli / male champion of change https://t.co/yDQ5e5Wp91
Licensing deal to give Merck access to Scots innovation  EdinLicensing https://t.co/RBtqovd0Xr https://t.co/6C3i7IuZZ9
Facing Cubicin generic threat, Merck's antibiotics biz gets a nudge with new C. diff-fighter Zinplava https://t.co/bI96Z3otWo  cdiff
FDA approves Merck& 039;s lung cancer drug as first-line treatment https://t.co/be7Aw1QC9M  ShoutNews
It‚Äôs Here: Merck‚Äôs Keytruda Cleared For First-Line Lung Cancer https://t.co/M0OWeythe8
 Merck FDA approves Zinplava to reduce CDI recurrence. Read more: https://t.co/VFRw2scPbG  Merck
 Merck FDA approves Keytruda as first-line NSCLC therapy. Read more: https://t.co/MUrOWPPO8B  Merck
What To Expect From Merck& 39;s Q3 Earnings? https://t.co/bqv3p03ErL
Meet a new friend today. 

Tall handsome
A chinese
A monash phD student= Biotech rsc.
A bussiness man
27 years old
Sale specialist in Merck.
 MerckDrug Gets  FDA Approval as a First-Line  LungCancerTreatment... https://t.co/oF1hOku8Yu https://t.co/VldbjkWcff
 Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment. Read more: https://t.co/E26qGNCtEr  Merck
US  Markets What To Expect From Merck's Q3 Earnings?: Merck Merck 160 is set to report its Q3 16 earnings on Oc... https://t.co/la8X5VzQfG
New Drug: FDA Approves Merck‚Äôs Keytruda (pembrolizumab) for First-Line Treatment of Certain Patients with Metas... https://t.co/Zk7ma5FjaZ
FDA Approves Merck‚Äôs Keytruda (pembrolizumab) for First-Line Treatment of Certain Patients‚Ä¶ https://t.co/q2aoarlnm1
Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatme‚Ä¶ https://t.co/TP6HNitnmU  immunotherapy via  talkwalker
[Biospace] "so positive that  it has halted the trial" Pembrolizumab Study Stopped Early in Bladder Cancer Trial https://t.co/YIncSf6rIE
 Merck(PBR70) gets  FDA approval for  lungcancer therapy  KEYTRUDA¬Æ (pembrolizumab). https://t.co/QZv2OheqA9  Merck  Pharmaceuticals
Cancer News: FDA approves Merck‚Äôs lung cancer drug as first-line treatment https://t.co/uWkLp41Tn9
Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment  Business https://t.co/TEIWBvrmpw
More ‚Äòhalo effect‚Äô for  Keytruda? Merck asks NCCN for chemo-combo backing in lung cancer https://t.co/7NiXKxwpOt
(Reuters) - Merck & Co Inc on Monday said the U.S. Food and Drug Administration has approved its immunotherapy‚Ä¶ https://t.co/J86ar32vny
Sales Associate-San Diego - Merck KGaA - San Diego, CA via SDBN Jobs: It offers a ...  biotech  jobs https://t.co/AezXF4JIfA
FDA approves Merck's lung cancer drug as first-line treatment - Reuters UK https://t.co/XcWehWs8yh via Black Swan Intelligent Insight‚Ñ¢
Merck's Keytruda wins coveted first-line lung cancer nod.
Read more - https://t.co/Q8sit4qZsc  latest  pharma  news‚Ä¶ https://t.co/26aV1hzyu1
HealthNews: FDA approves Merck's lung cancer drug as first-line treatment https://t.co/4FcE4N9ytl
Biotech Search Engine : https://t.co/JJvQnue8tK  biotechnology  biofinder : FDA approves Merck‚Äôs ZINPLAVA to Reduce Recurrence of Clostrid‚Ä¶
Continental News: FDA approves Merck's lung cancer drug as first-line treatment https://t.co/vcUrIs9em5
FDA approves Merck‚Äôs ZINPLAVA to Reduce Recurrence of Clostridium difficile Infection https://t.co/VlnXVwMGne  biotech  biopharma  pharma
German Merck sets foot in Abidjan with representative office https://t.co/0ygKQgKVVM https://t.co/bMQF6IOaSq
"Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment"  business  feedly https://t.co/Ug0zwCjcf6
Posted at FiercePharma by Tracy Staton | Merck & Co. may have yet another lung cancer score coming for Keytruda.... https://t.co/3tjK1L9Goz
More ‚Äòhalo effect‚Äô for Keytruda? Merck asks NCCN for chemo-combo backing in lung¬†cancer https://t.co/oTZKrL4i0l
Merck, Bristol-Myers set to compete in bladder cancer https://t.co/6Be1ThS4Mv via  biopharmadive
Merck Created Hit List to "Destroy," "Neutralize" or "Discredit" Dissenting Doctors https://t.co/VX3E9164yR
FDA approves Merck's lung cancer drug as first-line treatment: (Reuters) - Merck & Co Inc on Monday said the ... https://t.co/lKSpk7OTvu
Merck, Bristol-Myers set to compete in bladder cancer: BioPharma Dive https://t.co/V3AWM4FFCe
Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment - Wall Street Journal https://t.co/zyFyTMYD8y
So happy I invested in Merck! Oh wait, no I didn't. Bummer
FDA Approves  Keytruda (pembrolizumab) for First-Line Treatment of Certain Patients with Metastatic NSCLC - https://t.co/m5OiFqz21f
FDA Approves Merck‚Äôs  Zinplava (bezlotoxumab) to Reduce Recurrence of Clostridium difficile Infection - https://t.co/p0G5XAu7kC
Merck Drug Gets FDA Approval as a First-Line Lung Cancer¬†Treatment https://t.co/7v90lhWmnn https://t.co/pc819FnN9T
U.S. FDA approves  Merck's lung cancer drug as first-line treatment. Read more: https://t.co/PFIfsrJ3wk  Merck
 Merck's Keytruda wins coveted first-line lung cancer nod, cementing rise 'from laggard to l... Read more: https://t.co/QHDqFGp4cD  Merck
Merck & Co. (Merck) Shares Bought by Alps Advisors Inc. https://t.co/mchcNtvsbX
U.S. FDA approves Merck's lung cancer drug as first-line treatment - https://t.co/N0TBhsSHrE
Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment https://t.co/mweiSTBc0y via  WSJ https://t.co/ke0xoWlt74
Merck's Keytruda wins coveted first-line lung cancer nod - FiercePharma https://t.co/uyrhzeZWhu
Merck's Keytruda wins coveted first-line lung cancer nod - FiercePharma https://t.co/1WVSigCaiC  integrativehealth
Merck & Co. (Merck) Stake Increased by VNBTrust National Association https://t.co/NelZkK07dO
MU Investments Co. Ltd. Cuts Stake in Merck & Co.  Merck https://t.co/fHKntxLaS6
FDA approves Merck's lung cancer drug as first-line treatment: Yahoo/Reuters https://t.co/edTn5JzBff
What to Expect From Merck Earnings: Yahoo/24-7 Wall St https://t.co/jjRDhz1Mvh
Merck & Co.  Merck Shares Bought by Alps Advisors Inc. https://t.co/qDfsbrpoWj
Bartlett & Co. LLC Buys 4,169 Shares of Merck & Co.  Merck https://t.co/Z0NaLpuuDo
Merck's Keytruda wins coveted first-line lung cancer nod - FiercePharma https://t.co/r18Sx8gAdq  google  health
FDA approves Merck's lung cancer drug as first-line treatment https://t.co/Me2ySfRjJj  Reuters: Health News
Merck, Bristol-Myers set to compete in bladder cancer via Cafepharma Detail Piece Daily Pharma ... https://t.co/lB5ddL5zOK
What to Expect From Merck Earnings via Cafepharma ... https://t.co/r0tO4Ym2YY
FDA approves Merck's lung cancer drug as first-line ... https://t.co/JAvHqOJuVY
GSK Files BLA for Shingles Vaccine to Compete with Merck https://t.co/O49ZFbGZno
Merck‚Äôs Keytruda wins coveted first-line cancer of the lung nod ‚Äì¬†FiercePharma https://t.co/INdDblMvzW
FDA approves Merck‚Äôs lung cancer drug as first-line treatment https://t.co/5yN0TO92Xg
U.S. FDA approves Merck's lung cancer drug as first-line treatment: Oct 24 (Reuters) - Merck & Co Inc on Monday‚Ä¶ https://t.co/8145xzTHnT
Merck & Co.  Merck Stake Increased by VNBTrust National Association https://t.co/B0vV2W9tnq
Merck's Keytruda wins coveted first-line lung cancer nod: Just a couple weeks after presenting full r... https://t.co/i074kdAc9I  pharma
Merck & Co.  Merck Shares Bought by First Midwest Bank Trust Division https://t.co/xJu6iKr6SH
FDA approves Merck's lung cancer drug as first-line treatment https://t.co/scJTorP&GmL via  ReutersIndia
Merck\'s Keytruda succeeds in key bladder cancer trial https://t.co/o8qVtiaMTj
U.S. FDA approves Merck's lung cancer drug as first-line treatment: Oct 24 (Reuters‚Ä¶ https://t.co/3JiVVE9RQ6
Merck‚Äôs Keytruda wins coveted first-line lung cancer nod ‚Äì FiercePharma
https://t.co/BZksKNWI3t
Merck's Keytruda wins coveted first-line lung cancer nod - FiercePharma  Health  News https://t.co/zQOb0f7jbx
FDA approves Merck's lung cancer drug as first-line treatment (Reuters) - Merck & Co Inc on Monday said the U.S. Food and Drug Administrati‚Ä¶
 Reuters U.S. FDA approves Merck's lung cancer drug as first-line treatment https://t.co/ILKjqXBzUY
"Merck's Keytruda wins coveted first-line lung cancer nod - FiercePharma" https://t.co/tPnu0UWgAY  HealthNews
 Merck's Keytruda wins coveted first-line lung cancer nod - FiercePharma https://t.co/L55rGj9wyc
Sorry real world stats support all  CDC and  Merck  Whistleblowers Amish Homefirst no vax no autism https://t.co/KpOhG57LOk
"Merck's Keytruda wins coveted first-line lung cancer nod - FiercePharma" https://t.co/OXFhD9pPsa  healthnews  digitalhealth
U.S. FDA approves Merck's lung cancer drug as first-line treatment
REUTERS: FDA approves Merck's lung cancer drug as first-line treatment https://t.co/uKOC4aZsLB
FDA approves Merck's lung cancer drug as first-line treatment - https://t.co/DRHiGRmTkV
https://t.co/VhKzbZMlVp. U.S. FDA approves Merck's lung cancer drug as first-line treatment: Oct 24‚Ä¶ https://t.co/Gc6egloc69
DTC Animation Study Moving Forward After FDA Rejects Merck Critique https://t.co/wAqddzno16
Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment https://t.co/TTEynhp1CK  Business  News
 Merck Watch CNN admit their corruption and promote  Hillary https://t.co/bx9KXox3OY
 entirely  health FDA approves Merck's lung cancer drug as first-line treatment https://t.co/SGq7F0m6vH
Best Seller The Merck Manual Home Health Handbook 3rd (Third) Edition byMerck Free Download https://t.co/6LUkl6J7bf
 diseases  medicine FDA approves Merck's lung cancer drug as first-line treatment: (R... https://t.co/D1uBBdgte5 https://t.co/qwIzUIjzcm
colondroneme: FDA approves Merck's lung cancer drug as first-line treatment
U.S. FDA approves Merck's lung cancer drug as first-line treatment https://t.co/EUPKGjJ5oo  reuters https://t.co/cQ6TYqrMf4
 Job  PaloAlto (USA-CA-Palo Alto) Scientist, Molecular Discovery  - Antibody: Merck & Co., Inc. Kenilworth, N... https://t.co/CeojGL9IeG
[MedNews] FDA approves Merck's lung cancer drug as first-line treatment https://t.co/BLXMQv8LIE  mednews
 Reuters FDA approves Merck's lung cancer drug as first-line treatment: (Reuters) - Merck & Co ... https://t.co/HYpd27KBEc  health  news
FDA approves Merck's lung cancer drug as first-line treatment https://t.co/KtRvfgH2Is  mediator
Reuters HealthNews: FDA approves Merck's lung cancer drug as first-line treatment: (Reuters) - Merck & Co Inc... https://t.co/BIkrJKVVaI
 mAb against  Cdiff tox B for 2017-  US_FDA approves  Zinplava to reduce recurrence https://t.co/5u6OxOm6H9  bezlotoxumab  Merck  microbiome
Merck drug gets FDA approval as a first-line lung cancer treatment http://... https://t.co/hr2syKudFq via  AskAdella https://t.co/3Omg2OIoV5
 FDA Approves  Merck‚Äôs  KEYTRUDA¬Æ (pembrolizumab) in  Metastatic  NSCLC for First-Line Treatment  Merck  lungcancer  https://t.co/tQPQQBdXtj
 HealthNews FDA approves Merck's lung cancer drug as first-line treatment https://t.co/ioqz6md6rS
U.S. FDA approves Merck's lung cancer drug as first-line treatment https://t.co/5IICSuw49M  companynews
U.S. FDA approves Merck's lung cancer drug as first-line treatment https://t.co/jtbGY1FD02  trading  market
FDA approves Merck's lung cancer drug as first-line treatment
https://t.co/seUcbZi5du
FDA approves Merck's lung cancer drug as first-line treatment https://t.co/CKVpbC60EV  health https://t.co/vsOXlKcOix
FYI: Spreading health news to the entire community from our reliable source. https://t.co/LxSmZ4MEeM
News: FDA approves Merck's lung cancer drug as first-line treatment https://t.co/7KQWslDv5t
U.S. FDA approves Merck's lung cancer drug as first-line treatment https://t.co/IHvfMTq5vs  Company  MnA
U.S. FDA approves Merck's lung cancer drug as first-line treatment https://t.co/zNtkCc2Gke  business  bloomberg
U.S. FDA approves Merck's lung cancer drug as first-line treatment https://t.co/FylEzE8Z40  company  news https://t.co/CfmBj5yLJm
U.S. FDA approves Merck's lung cancer drug as first-line treatment: Oct 24 (Reuters) - Merck & Co I... https://t.co/7Uk6ZRgPk8  iGazette
FDA OKs new indication for Merck's cancer med Keytruda - Seeking Alpha https://t.co/4bCkvXKbjJ
 Marijuana  WEED U.S. FDA approves Merck's lung cancer drug as first-line treat... https://t.co/PR5kdiEI0V https://t.co/ZbsM48QHdL  MLCG
U.S. FDA approves Merck's lung cancer drug as first-line treatment: Oct 24 (Reuters) - Merck & Co Inc on Mond... https://t.co/sUL6FSI2ZS
U.S. FDA approves Merck's lung cancer drug as first-line treatment: Oct 24 (Reuters) - Merck & ... https://t.co/xrELHKaOE3 (By  Reuters)
FDA approves Merck's lung cancer drug as first-line treatment   Health
U.S. FDA approves Merck‚Äôs lung cancer drug as first-line¬†treatment https://t.co/Moz7BoC85r
Merck & Co Inc on Monday said the U.S. Food and Drug Administration has approved its immunotherapy Keytruda for use in certain previously u‚Ä¶
BRIEF-Merck & Co says FDA also approves a labeling update for Keytruda for... https://t.co/J6RxfHEj3h
FDA approves Merck's lung  Cancer  Drug as first-line  Treatment: REUTERS: Merck & Co Inc on Monday said the ... https://t.co/LIXz62bXa3
 teamfollowback FDA approves Merck's lung cancer drug as first-line treatment https://t.co/wmfcvgVFVG  monsterfollow
Merck's Keytruda wins coveted first-line lung cancer nod, cementing rise 'from laggard to leader': Merck's Ke... https://t.co/AslbsH3pvG
Merck's Keytruda wins coveted first-line lung cancer nod, cementing rise 'from laggard to... https://t.co/o9eodev8NE  mymexicandrugstore
 Pharma Merck's Keytruda wins coveted first-line lung cancer nod, cementing rise 'from laggard to leader': Me... https://t.co/El7d19WMo9
 Health FDA approves Merck's lung cancer drug as first-line treatment https://t.co/gfbe5ohgdt
 stock U.S. FDA approves Merck's lung cancer drug as first-line treatment: Oct 24 (Reuters) - Merck & Co Inc on‚Ä¶ https://t.co/VspqpLZNXA
 Cigar U.S. FDA approves Merck's lung cancer drug as first-line treatment https://t.co/xfNyZZnsoA
U.S. FDA approves Merck's lung cancer drug as first-line treatment https://t.co/hDK1k5bscC Oct 24 (Reuters) - Merck & Co Inc on
FDA approves Merck's lung cancer drug as first-line treatment https://t.co/UMSjzaGRbr  pharmacovigilance
Merck drug gets FDA approval as a first-line lung cancer treatment https://t.co/2A97lnFOXt üîì
NEWS: FDA approves Merck's lung cancer drug as first-line treatment https://t.co/F2F1uPkYjH https://t.co/bRnC4v4fq5
Merck  Merck drug gets FDA approval as a first-line lung cancer treatment https://t.co/6SjALa9mle via  WSJ
dlvr -  FDA approves Merck's lung cancer drug as first-line treatment https://t.co/jrbdExzOdP
Merck's Keytruda wins coveted first-line lung cancer nod, cementing rise 'from laggard to leader' - https://t.co/RukEN8QPmo
FDA approves Merck's lung cancer drug as first-line treatment: REUTERS: Merck & Co Inc on Monday said the U.S... https://t.co/e1tss9WKac
FDA approves Merck's lung cancer drug as first-line treatment https://t.co/8RVpfyD63g  CancerAwareness
Cancer Update: FDA approves Merck's lung cancer drug as first-line treatment: (Reuters) - Merck & Co Inc on M... https://t.co/38WIRzJKL2
 crossborder  ecommerce  onlineretailer  GDP Merck drug gets FDA approval as a first-line lung cancer treatment https://t.co/5WdnMY7l18 üîì
WSJ: Merck drug gets FDA approval as a first-line lung cancer treatment https://t.co/1FYluGBfGU üîì
FDA approves Merck's lung cancer drug as first-line treatment: (Reuters) - Merck & Co... https://t.co/tkrgeoPiTw https://t.co/hMuc364TxS
Reuters: FDA approves Merck's lung cancer drug as first-line treatment https://t.co/3ZZOsRG96V
FDA approves Merck's lung cancer drug as first-line treatment: (Reuters) - Merck & Co Inc on Monday said the U.S.‚Ä¶‚Ä¶ https://t.co/EBKbC0YqgU
FDA approves Merck's lung cancer drug as first-line treatment https://t.co/V2IfM59ja6  world  health
WSJ : Merck drug gets FDA approval as a first-line lung cancer treatment ‚Ä¶ https://t.co/BaVox4Srm8 https://t.co/HV51upTfa6
 anonops WSJ: Merck drug gets FDA approval as a first-line lung cancer treatment https://t.co/DUSjI5gSok üîì
 HealthNews FDA approves Merck's lung cancer drug as first-line treatment: (Reuters) - Merck & Co Inc on Mond... https://t.co/9d1mnfOBqy
FDA approves Merck's lung cancer drug as first-line treatment https://t.co/lIwkGywQ2v  health  Reuters
FDA approves Merck's lung cancer drug as first-line treatment (Reuters) - Merck & Co Inc on Monday said the U.S. F‚Ä¶ https://t.co/95csYEWVh3
Health - FDA approves Merck's lung cancer drug as first-line treatment: (Reuters) - Merck & ... https://t.co/YR8PtedGR9 - Abigail Pollak
FDA approves Merck's lung cancer drug as first-line treatment https://t.co/kS2lpko4bf  health
FDA approves Merck's lung cancer drug as first-line treatment   health
FDA approves Merck's lung cancer drug as first-line treatment: (Reuters) - Merck & Co Inc on ... https://t.co/qIIrjDtnoR via  josephjett
 Reuters FDA approves Merck's lung cancer drug as first-line treatment: (Reuters) - Merck & Co Inc on Monday ... https://t.co/bkaNP24Jbw
FDA approves Merck's lung cancer drug as first-line treatment: (Reuters) - Merck & Co Inc on Monday s... https://t.co/FTfhKVRfnN  health
 Boston FDA approves Merck's lung cancer drug as first-line treatment https://t.co/IiESuwwGf0 https://t.co/8MHMUDdqes
HEALTH TV FDA approves Merck's lung cancer drug as first-line treatment https://t.co/SEhNvryhGP https://t.co/kuLJxBiYgq
FDA approves Merck's lung cancer drug as first-line treatment https://t.co/qG1M6TrmFn  Health
 DigitalPayments  epayments Merck drug gets FDA approval as a first-line lung cancer treatment https://t.co/tfZCvVYnx6 üîì
Merck drug gets FDA approval as a first-line lung cancer treatment https://t.co/SoTFQQwouh üîì  BSAFunds  MerchantCashAdvance
Merck drug gets FDA approval as a first-line lung cancer treatment https://t.co/SaumzLMNZy üîì  business
Merck drug gets FDA approval as a first-line lung cancer treatment https://t.co/qKcYiEVfas üîì
Learn on how to... https://t.co/vWTB92OxyF
Merck's Keytruda achieves 24 percent response in bladder cancer study https://t.co/ZJVJohLnAh via  Reuters
Zeroing in on  Merck rival,  GSK steps up to the  FDA with its top new  vaccine prospect https://t.co/omQE7ZtbRY‚Ä¶ by  JohnCendpts
FDA Approves Merck‚Äôs ZINPLAVA‚Ñ¢ (bezlotoxumab) to Reduce Recurrence of Clostridium difficile... | Business Wire https://t.co/V5VhKVQ96S
Merck's Keytruda wins coveted first-line lung cancer nod, cementing rise 'from laggard to leader' https://t.co/hR68xUX0U4  Merck  BMY  pharma
 news  latest Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment: s immunotherapy cancer drug Keytruda rece... ‚Ä¶
 latest  news Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment: s immunotherapy cancer drug Keytruda rece... ‚Ä¶
Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment: s immunotherapy cancer drug Keytruda rece... https://t.co/II1mXnmsq8
Screen Shot 2016-10-21 at 11.50.25 AM.png https://t.co/h6d2YYRyh9
Merck Announces Pivotal Phase 3 Study of Letermovir Met Primary Endpoint https://t.co/tWHGik4RdX
 GlaxoSmithKline Files BLA for Shingles Vaccine to Compete with Merck. Read more: https://t.co/oS4wD8InbR  GSK
Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment https://t.co/FLPmhKwees [h/t  FDALawyers]
 EMcCra2  semireg  kath2cats  AngelasGardenA  CaulfieldTim 2Cats loves Merck.
 news  Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment  business  fdlx
Great news for  lungcancer patients and their families. Proud to be a  Merck employee https://t.co/FpNcV4W9gM
Applied Technology Specialist - Food/BioMonitoring - East Region (FAS) - Merck KGaA - Missouri https://t.co/msl37pAIKH
Applied Technology Specialist - Molecular Diagnostics (FAS) - Merck KGaA - Missouri https://t.co/8FUmgemNMr
All of the sessions from the Raw Materials Workshop are available here. See speakers from  Amgen  Merck, and more. https://t.co/BVMIXW1KyE
Merck cements advantage in I/O with first-line approval ‚Äì BioPharma Dive https://t.co/lALngIdfpb
Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment https://t.co/GmPlP9gcuO  USA  US  USBiz
GSK Files BLA for Shingles Vaccine to Compete with Merck - GSK announces U.S. regulatory submission of potentia... https://t.co/1t8beZJd9s
 USMerckProducts Nice work Merck
Merck : Drug Gets FDA Approval as a First-Line Lung Cancer Treatment  https://t.co/7TE7WVKlWm
Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment - Wall Street Journal https://t.co/InMLorWU7P ‚Ä¢ https://t.co/MmJAa7KXeT
"Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment" https://t.co/ajOe9aLN92  news  feedly
News: GSK Files BLA for Shingles Vaccine to Compete with Merck https://t.co/iNTkdJYDug
Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment: Merck & Co.‚Äôs immunotherapy cancer drug Keytruda received U.S. Fo...
Breaking News: https://t.co/o3gA3l0hFe
Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment: Merck & Co.‚Äôs immunotherapy cancer drug K... https://t.co/0i2f0hVLHw
[WSJ]:" Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment https://t.co/WqEPDCU5yS "
GSK Files BLA for Shingles Vaccine to Compete with Merck - https://t.co/PsmGikloaY
Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment https://t.co/2fUbzgx1pA  PAID https://t.co/Z2SVW0HRMp
 Financial Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment https://t.co/i0unmu1NiO  News https://t.co/l69AFnDJJz
Pfizer, Merck, Other Big Pharmas Likely to Acquire Marijuana-Based Drug Companies https://t.co/OIRl3tOHo2 
 cannabiswins
 kathryn_merck I also saw tht üòÇ
Applied Technology Specialist - Food/BioMonitoring - East Region (FAS) - Merck KGaA - Missouri: Strong leader... https://t.co/gvcLx9kGe2
Merck vaccine scientist Dr. Maurice Hilleman admitted presence of SV40, AIDS and cancer viruses in vaccines: https://t.co/qO0mwFRFGj
[WSJ News] Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment https://t.co/QC8V68AaCm
New Drug: FDA Approves Merck‚Äôs Zinplava (bezlotoxumab) to Reduce Recurrence of Clostridium difficile Infection https://t.co/wAH5JiqzRF
Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment https://t.co/TCRND96dEa  WSJHealth
Lung Cancer News!!! Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment - Wall Street Journal https://t.co/rkSdyxeZoy
Clinical Trials News Merck Announces Pivotal Phase 3 Study of Letermovir Met Primary Endpoint https://t.co/gCTjfK3HF9
Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment: https://t.co/aJzc4GczAU
Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment
 Merck  Merck.XE:

Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment:

https://t.co/dWOK1FKPYq
finzine:  Merck Merck Drug Gets FDA Approval as a First- Line Lung Cancer Treatment https://t.co/MJQUA1WzBn
Clinical Trials Merck Announces Pivotal Phase 3 Study of Letermovir Met Primary Endpoint https://t.co/rwC5dfimfx
Good news in the battle against cancer that the Keytruda halo effect is broadening. Incredible PD-1 blocker! https://t.co/raCWr3vE6q
 Merck Merck Drug Gets FDA Approval as a First- Line Lung Cancer Treatment https://t.co/dRbOu67uIW
Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment - Wall Street Journal https://t.co/fCZhjRVfVj via Black Swan Intelligen‚Ä¶
 Merck: Merck: FDA approves KEYTRUDA (pembrolizumab) in metastatic NSCLC for first-line treatment https://t.co/PeXrUhxWNR
US nod for Merck‚Äôs C.difficile antitoxin - The US Food and Drug Administration has cleared Merck's Clostridium ... https://t.co/WdB1tsRYIa
Keytruda FDA OK for 1st-line NSCLC. That was quick, I've not even unpacked from ESMO https://t.co/uEXJphF2DD
World News Report https://t.co/hXn2ERbCH5
 Merck | FDA approves  Merck's KEYTRUDA¬Æ  for  Advanced Melanoma /cancer
First&Only Anti-PD-1 Compared to Ipilimumab
https://t.co/hThjsxIU3h
With Pembro approved fr pts w highPDL1 & Pembro+Chemo coming fr lowPDL1 pts, looks like  Merck has 1stline  LungCancer covered!For now  LCSM
FDA Approves Merck‚Äôs KEYTRUDA¬Æ (pembrolizumab) in Metastatic NSCLC for First-Line Treatment of Patients ... https://t.co/E5cecfaWrB
Totally lost sense of time... work work work! ;D   Leipzig, Germany https://t.co/9dwD96yjO8
 mhs_mrk lost 1-0
Merck beats by  0.09, beats on revenue https://t.co/4jW8aIlNAU  Merck
 BMY  Merck:

Merck‚Äôs Keytruda Receives First-Line Nod From FDA In Lung ‚Ä¶:

https://t.co/Oet0jT8SF5
‚ÄúWhen Jesus heard this, he told them, ‚ÄúHealthy people don‚Äôt need a doctor‚Äîsick people do. I have come to call not ‚Ä¶‚Äù https://t.co/V7qeXtsFVf
how come when you reheat shrimp it is either cold or exploding ??? There is no in between
Better Buy:  Merck & Co. Inc. vs. AbbVie Inc. Read more: https://t.co/7VYRBtJyAs  Merck
 mhomoki18 how did game go??
 a_dswizz097 how do you represent the 3 integers?
Earnings Extravaganza: V, WHR, Merck & More In Play Today  WHR  Merck  V  https://t.co/U7sNeiKQfY
"Life is short. Never leave it unsaid. Tell your family (and friends) that you love them."
Do the lung cancer drugs from  Merck+ BMY contribute to each respective total revenues without considering the pipelines of each co?
 mhs_mrk can you help I can't figure this out üò®üò®üò® https://t.co/ivbH2lIK2z
‚ÄúThe heaven and the earth shall pass away, but My words shall by no means pass away.
Mark 13:31 ISR98
https://t.co/mPQg3zF8sA
‚ÄúTruly, I say to you, this generation shall by no means pass away till all this takes place.
Mark 13:3‚Ä¶
https://t.co/Fufyck7MGI
‚ÄúSo you also, when you see these taking place, know that it is near, at the door.
Mark 13:29 ISR98
https://t.co/MN5zGMkzCd
‚ÄúAnd learn this parable from the fig tree: When its branch has already become tender, and puts forth l‚Ä¶
https://t.co/SE9ZIYdQwj
‚ÄúAnd then He shall send His messengers, and assemble His chosen ones from the four winds, from the far‚Ä¶
https://t.co/SyDyS7Sx5p
‚ÄúAnd then they shall see the Son of A·∏èam coming in the clouds with much power and esteem.
Mark 13:26 ‚Ä¶
https://t.co/G1IQZyMpTt
and the stars of heaven shall fall, and the powers in the heavens shall be shaken.
Mark 13:25 ISR98
https://t.co/jtnVUCr7Uf
‚ÄúBut in those days, after that distress, the sun shall be darkened, and the moon shall not give its li‚Ä¶
https://t.co/ixoKyjVhJr
‚ÄúAnd you, take heed. See, I have forewarned you of it all.
Mark 13:23 ISR98
https://t.co/gzZEqJAlwL
‚ÄúFor false messiahs and false prophets shall rise and show signs and wonders to lead astray, if possib‚Ä¶
https://t.co/PkaHwO2ssj
‚ÄúAnd if anyone then says to you, ‚ÄòLook, here is the Messiah!‚Äô or, ‚ÄòLook, there!‚Äô do not believe it.
Ma‚Ä¶
https://t.co/HWowC7bFvT
‚ÄúAnd if the Master had not shortened those days, no flesh would have been saved; but because of the ch‚Ä¶
https://t.co/5DKBCRCO1C
‚ÄúFor in those days there shall be distress, such as has not been from the beginning of creation which ‚Ä¶
https://t.co/9gN0sXOFSY
‚ÄúAnd pray that your flight does not take place in winter.
Mark 13:18 ISR98
https://t.co/Z6DRYBr4Ki
‚ÄúAnd woe to those who are pregnant and to those nursing children in those days!
Mark 13:17 ISR98
https://t.co/skYkrJcB2L
‚ÄúAnd he who is in the field, let him not go back to get his cloak.
Mark 13:16 ISR98
https://t.co/01Q5NgA0fL
‚ÄúBut take heed to yourselves, for they shall deliver you up to councils and to congregations. You shall‚Ä¶
https://t.co/bMJvkmuYbN
‚ÄúFor nation shall rise against nation, and reign against reign. And there shall be earthquakes in vario‚Ä¶
https://t.co/a9WqH4krjZ
‚ÄúAnd brother shall deliver up brother to death, and a father his child. And children shall rise up aga‚Ä¶
https://t.co/VWTmCI93z0
‚ÄúAnd when they lead you away and deliver you up, do not worry beforehand what you are to say. But what‚Ä¶
https://t.co/TjZQXvnDg9
‚ÄúAnd the Good News has to be proclaimed first to all the nations.
Mark 13:10 ISR98
https://t.co/er2zHiSvHE
‚ÄúAnd he who is on the house-top, let him not go down into the house, nor come in to take whatever out ‚Ä¶
https://t.co/Qu84HbyL93
‚ÄúAnd you shall be hated by all because of My Name. But he who shall have endured to the end, he shall ‚Ä¶
https://t.co/vz3jKOxGjK
‚ÄúAnd when you see the ‚Äòabomination that lays waste,‚Äô spoken of by Dani‚Äôƒïl the prophet, set up where it‚Ä¶
https://t.co/543wnPzVQi
‚ÄúAnd when you hear of fightings and reports of fightings, do not be troubled ‚Äì it has to take place, bu‚Ä¶
https://t.co/r9MBH6yUYL
for many shall come in My Name, saying, ‚ÄòI am He,‚Äô and they shall lead many astray.
Mark 13:6 ISR98
https://t.co/ogPiKX9HJP
‚ÄúSay to us, when shall these events be? And what shall be the sign when all this is going to be accompl‚Ä¶
https://t.co/r0h5oknqbK
And as He sat on the Mount of Olives opposite the Set-apart Place, Kƒïpha, and Ya‚Äõaqo·∏á, and Yo·∏•anan, a‚Ä¶
https://t.co/MGwTBkkCoq
And ◊ô◊î◊ï◊©◊¢ answering, said to him, ‚ÄúDo you see these great buildings? Not one stone shall be left upon a‚Ä¶
https://t.co/ADUObP1kA3
And as He went out of the Set-apart Place, one of His taught ones said to Him, ‚ÄúTeacher, see what stone‚Ä¶
https://t.co/tpFHCWu6Ts
Merck's Keytruda wins approval in first-line  lungcancer.  Merck  FDA https://t.co/BtGEv015nq https://t.co/mFVV5dwBqa
After FDA Approval,  Merck Posts Better-Than-Expected Earnings. Read more: https://t.co/6iX0U8F80s  Merck
Homepage Highlight: 7 Drug Stocks To Consider As Biosimilars Pick Up Pace  PFE  AMGN  NVS  Merck  MNTA  BIIB  TEVA https://t.co/sD8ByGYcMq
Better Buy: Merck & Co. Inc. vs. AbbVie Inc.: Merck (NYSE:Merck) and AbbVie (NYSE:ABBV) compete head-to... https://t.co/EBvnf6hP8n  pharma
 Merck & Co.'s Keytruda Is "Off to The Races". Read more: https://t.co/ROTL8QlYdG  Merck
 Merck talks I/O combo strategy as Keytruda nabs first-line NSCLC approval. Read more: https://t.co/UIrrSO4SFe  Merck
 Merck Consumer Health CMO on who makes healthcare decisions. Read more: https://t.co/S9DfTzs3Vl  Merck
 Merck&Co World-Wide Sales for  KEYTRUDA was 356m USD in Q3 2016 (Up 124%)  Merck https://t.co/nV4d63AuvE
 Merck&Co World-Wide Sales for  TEMODAR was 78m USD in Q3 2016 (Down 6%)  Merck https://t.co/nV4d63AuvE
 Merck&Co World-Wide Sales for  EMEND was 137m USD in Q3 2016 (Down 3%)  Merck https://t.co/nV4d63AuvE
Gardasil propelled  Merck to a strong third quarter - but don't expect that to last. Read more: https://t.co/NmjPmEuPhj  Merck
 Merck&Co World-Wide Sales for  GARDASIL/ GARDASIL9 was 860m USD in Q3 2016 (Up 38%)  Merck https://t.co/nV4d63AuvE
 Options  maxpain chart for  Merck. Free stock station app https://t.co/VCJp7MA06J  iTunes https://t.co/1rqdz5AM4V
Since launching in late 2014 sales of Merck amp Co s NYSE Merck Keytruda a cancer fighting drug are already gro... https://t.co/tRDCit5xbS
 mrk__williams  tgnclondon ulook socute when u "can't wait" Daddy  uebertangel should therefore declare thebigday to b rightnow ‚ò∫
trending stocks  BoeingC,  Apple,  KEY,  MSFT,  MU,  Merck,  PBR.A,  RF, https://t.co/TBix7ptA0A
 scooterbraun mrk, I dont have ni un centavo., plss I need tickets :( im from ECUADOR
 Merck  ABBV:

Better Buy: Merck & Co. Inc. vs. AbbVie Inc.:

https://t.co/BmgXEOgWtI
 Merck  Options OI chart. Free stock station app https://t.co/cnRpv2hkbQ  iTunes https://t.co/yS8dF5piLf
 Merck metastatic non-small cell lung cancer drug gets  FDA go, providing alternative to chemo reports  BeckermanJosh https://t.co/jIYGRzW6aH
FDA Approves  Merck & Co.'s KEYTRUDA (Pembrolizumab) In Metastatic NSCLC For First-Line Trea... Read more: https://t.co/fj7b2F4k5k  Merck
Vaccine and cancer drug sales give pharma firm  Merck a boost. Read more: https://t.co/7jUaKQv1su  Merck
 mrkhndy Hi Mrk. If you mush your boiled, skinless potatoes through a metal colander with a spoon, you will get a first rate mash.
Ingatzoned. Lol. Bye off to perps.  Gg bigti
 johnnypaige  mrkhndy  stekodat if mrk really wants skinless he'll do it. My method makes him question how much he really wants it.
 Mrk_Gallagher hello! I found your wedding invite on google. could you help us design / print ours?!  longshot
FDA grants early approval for  Merck's Keytruda for untreated lung cancer. Read more: https://t.co/UNMADk3hA2  Merck
finzine:  Merck What this Health Care analyst thinks will happen to the sector if Democrats take... https://t.co/gXMRBwpo6M
 Merck What this Health Care analyst thinks will happen to the sector if Democrats take... https://t.co/XYDhS8RIom
 Merck & Co 3rd-qtr revenues and earnings beat expectations. Read more: https://t.co/D0o6II0ltI  Merck
Thanks for the follow Olinda Wasicek! https://t.co/6wiRmxP96y I appreciate it! October 25, 2016 at 02:10PM mrk_dee
 Merck & Co 3rdqtr revenues and earnings beat expectations. Read more: https://t.co/8EdjgCvWZb  Merck
 Merck strengthens its position in oncology space with Keytruda's newest FDA approval https://t.co/MrHBzSK5jh
Apple Inc. (NASDAQ:Apple), Merck & Company, Inc. (NYSE:Merck) - A Peek Into The Markets: U.S. - https://t.co/xW9bxKePfn
 Merck Announces 'rd-Quarter Results. Read more: https://t.co/9VGnZji9qG  Merck
The best beer in the world is Stella Artois 
  me if you wanna fight
Up EPS Movers:
+11%  CR
+7%  LMT
+6%  KEY
+5%  ORAN  VLO  SWFT
+4%  RMBS  BHI  FCX
+4%  P&G  SAVE  RE
+3%  SCHN  KKR
+2%  Merck  UTX  AKS
 HATD Since launching in late 2014 sales of Merck amp Co s NYSE Merck Keytruda a cancer fighting drug are already growing quickly Howev...
Merck & Co.'s Keytruda Is "Off to The Races": Since launching in late 2014 sales of Merck amp Co s NYSE Merck K... https://t.co/fPuObyWiCA
Mark Cuban: Republican nominee questioned American democracy... | https://t.co/uJaVxIZtw5  Merck CUBoeingN  AND GARY JOHNSON
ARE POT HEAD BROTHERS
 druggedtocharli la cover de  claramarz "treat you better & mercy" de Shawn Mendes
How  metrics and  KPIs boost  business efficiency via  TurbineHQ https://t.co/BLvC7ySycJ
 Merck_666 Hi, unfort. this issue isn't at our end, but please follow the steps here: https://t.co/9so0CMWTwH Hope this helps your issue! /K
Merck & Co. (Merck) Q3 2016 Results - Earnings Call Transcript https://t.co/j6dW1Po0wf  goodmorning https://t.co/HXFDfOzIGf
Merck & Co.'s  Keytruda Is Off To The Races  mrk  nsclc  cancer  stocks  investing https://t.co/D6ZzlzvWuE
 MrK_Fishers Glad to hear it! We hope you all keep the spirit going throughout the year.
On The Fly: Top stock stories for Tuesday  Apple  UA  GM  V  P&G  Merck  UTX  DD  CAT  MMM  TWTR  GBT  CR  SONC  ... https://t.co/3u804YNi9T
Mrk no c https://t.co/DxMnUqu4Ox
Forever making an endless list of plans üìã

https://t.co/TkTusVWCfW  Mensfashion  menswear  mensstyle  maleblogger https://t.co/1kTYvCKmBoeing
Sectors Map 2016.10.25 Tuesday  Stocks  Options  Futures  WTI  CompanyEarnings  Apple  CMG  P  BoeingX  UA  CAT  JBLU‚Ä¶ https://t.co/jLtQMdj25W
Best Free-kick of CR7: https://t.co/QNgYtzKlu7 via  YouTube
Forever making an endless list of plans üìã  markmystyle  menswear  blogger  mens  mensstyle‚Ä¶ https://t.co/2eudRW7zfY
I really enjoyed the  MixLunch today!  MixItUpatLunch
Jim Cramer --  Merck, Lilly Pressured by Political Uncertainty. Read more: https://t.co/k5okGtbDUs  Merck
 Merck breezes past 3Q profit expectations, raises forecast. Read more: https://t.co/74g85uXhqL  Merck
 littlegurrier Collusion is not an illusion https://t.co/J6d1sChTfP
 Merck & Co., Inc. Surges After  Earnings,  EliLilly and Co. Slips  LLY  Merck https://t.co/DYYJ2lB32c
 Merck scores second approval in two days with Keytruda's NSCLC indication https://t.co/MrHBzSsurJ
Thanks for the follow Ryan McKenzie! https://t.co/qLL43eTtlm I appreciate it! October 25, 2016 at 01:03PM mrk_dee
w/WHOIS Real_Estate_Mrk to view profile
toptickertweets  Apple  FB  NFLX  MSFT  Merck  FinTech  trading  finance  SentiQuant 20161025-15:55
Earnings beats v misses . 
Early movers: MMM, CAT, DD, Merck, P&G, UTX, GM, UA, LLY & more https://t.co/CMv5rYSzxg
Down in the forest we'll sing a chorus, one that everybody knows. 
Hands held higher, we'll be on fire singing songs that nobody wrote. I-/
 pnani456 yea, LLY was a lay-up on the dip, due for Alzheimer's data rally , and everything going write at Merck
 OptionsHawk  LLY and  Merck good earnings reaction today
 Merck:

Merck & Co.‚Äôs Keytruda Is ‚ÄúOff to The Races‚Äù:

https://t.co/rcqcbuhS6w
Que pereza usted mrk
Keytruda drove  Merck's sales increase in Q3; now the drug is slated for more combo therapies https://t.co/h5RVUn4cPX
5  Healthcare  Stocks To Buy Despite A Clinton Victory  ANGO  WCG  SGRY  UNH  BSX Also  LLY  Merck  AMGN  TMO   MD... https://t.co/GHiDmG1Jt1
 LMSPlayers Notification: LMS Players, Rehearsal - SOM: Full Cast   Tue Oct 25, 2016 5:30pm - 7:30pm (Players, LHS/LMS - Schedule/Calendar)
 CELG 35% ROE is highest among peers, stock has more upside.  biotech  investing  dataviz  Merck  PFE  AMGN  JNJ https://t.co/8DYusswX3m
We lost one of the truly good guys this week - please donate to the Jacob Simpsons Memorial Cost https://t.co/257d6tJLbE via  gofundme
 mrkhndy hi mrk,

thanks for this.

Kind regards
 Renakku  CornyDeviless  Mr_Cynic Well I am now all a quiver with curiosity and worry
 mrkhndy hi mrk, skin is only acceptable on a jacket or chipped potato.
Real     already banked on  Merck and  Walmart early this morning. Nothing is happening since then. Good night traders. I care less  BoeingS and  HAIN
 Merck running back toward the HOD.. this stock should be at  63-64 tomorrow after upgrades.
I already hate the bow wow and Soulja boy album
 mrkhndy  danbeames you know it makes sense Mrk
3:08AM 
HappyBirthday KILIGKING
3,204 Tweets
 MrK_SoS_TF Franks and those guys?
More than a million ballots have already been turned in within  Florida  vote
World History:  Test over Age of Exploration tomorrow.  Finish study guide Mercantilism essays!   DontSacrificeIntegrity
finzine:  Merck Stocks Deepen Losses; GM Slides On Outlook; Home Improvement Industry Shaken https://t.co/60RYh03xec
Apple, GM Are Buys Into Earnings Tuesday: Investing Action Plan  Apple  GM  FCAU  LMT  Merck  EW  CMG  PNRA https://t.co/Eu1ZRXiOHv
 Merck Stocks Deepen Losses; GM Slides On Outlook; Home Improvement Industry Shaken https://t.co/6oIPYfRaDA
 mrkhndy This is great, mrk. I didn't see the plot twist coming, but I really enjoyed it when it happened.
Always new  PeteDavidson was a real one https://t.co/ShGWrxRzPj
 mrkhndy I'm confident it will be fine tomorrow, mrk. Will you serve it with anything else? Peas, perhaps?
 mrkhndy are you making masht potato to go with your pie mrk is that what is happening here
On The Ground: September IRA Activity https://t.co/ykL9KLDXxS  ED  GM  MO  Merck  O  PFE  TGT  TROW  WPC  XOM  FFC
 GM 3Q record rev.  Merck stronger than expected Q results.  TWTR layoffs and more. Link below:
https://t.co/bd1c1fCtze
 LLY,  Merck CEOs both called out CA  Prop61 on drug prices today. Industry is fighting "tooth and nail" to oppose it. https://t.co/hgautYn9dM
 TSRO very strong...up 3.3% on a dismal day. Suitors are knocking on the door...  CELG  Merck  GILD  AGN: you want a PARP inhibitor, right?
Study Stopped Early as Merck & Co. (Merck)'s Immunotherapy Drug Wows in Bladder Cancer Trial  https://t.co/k1X5I4NRA3
 Merck Tops Revenue¬†Forecast https://t.co/wbsyC1VDR7
HappyBirthday KILIGKING
 SCsupport What is wrong with the certificates it doesn't load the page?
 agn VRX  HLF  IEP  Merck  MYL  TWTR  Ko  Dps  Pep

Ssshhh. Herbalife at  60. Maybe Carl is taking a nap. Ssshhh. Don't wake him.
Register for  WESPicks webinar: Global Trends and Student Mobility - https://t.co/eEcDcbOUDz
 Merck & Co. Cements Lead Over Rivals After the FDA Grants Early Approval of Keytruda  . Read more: https://t.co/uYIbNcut4z  Merck
 Merck's Adam Schechter strongly agrees with above, acording2 today's CC.
Option trading signal alerts with over 70% accuracy. Read: https://t.co/gtjj5nMAu4  Merck  CLNE  GIS  CTSH  CTIC  NBR  SKTO  AJG  PCTY
https://t.co/G9pMgSr1JY < Review of this fantastic traders teaching service!! Try it for FREE!  LLY  DGX  Merck  NVS  AMGN
Do You Rage Quit?! https://t.co/JlSxvitigw
 Merck stands by 15-20% range &says exclusions (other than PD-L1 thesrhold) in -024 study not meaningful in practice. https://t.co/nf82nnkn2p
 Merck FDA Approves Keytruda as First-Line Treatment of Metastatic NSCLC. Read more: https://t.co/EzSE3Divhx  Merck
 Merck Wins Early U.S. Approval for Keytruda in Untreated Lung Cancer https://t.co/ZBLGBX4iHx  Merck  lungcancer  cancer  oncology  nsclc
I just registered for Renaissance‚Äôs Q&A webinar on Title I and ESSA. Have you registered?  Title1Talk https://t.co/2RTMmfQgFP
 Merck Crushes Q3 Expectations Following Lung Cancer Drug Win. Read more: https://t.co/vxcYH3fIYi  Merck
Pharmalot Pharmalittle  Merck drug wins FDA nod as firstline lung cancer treatment. Read more: https://t.co/doukNLvtra  Merck
Merck (Merck) Beats on Q3 Earnings amp; Revenues, Lifts View - https://t.co/y6Xke9DaOB https://t.co/WUUuLwxuBr https://t.co/arRIAp0eqy
Merck & Co. (Merck) Stock Price Up 1.6% After Strong Earnings https://t.co/6tW6L4SVfC
 Merck gets leg up on  BMY after FDA approval of Keytruda for NSCLC https://t.co/MrHBzSK5jh
 Merck over  62.02 and you can expect to see many disgruntled shorts.
Merck & Co.  Merck Stock Price Up 1.6% After Strong Earnings https://t.co/sNsbahvUPA
Merck & Co. (Merck) Q3 2016 Results - Earnings Call Transcript https://t.co/43PL1vaqw3
turtle net nalang everyday!
Options Traders Blitz Merck & Co., Inc. (Merck) After Earnings, Keytruda Win https://t.co/AxCQSkg6DO
finzine:  Merck Merck Announces 3rd-Quarter Results https://t.co/KqEBrXYxh8
Anyone in  h Bay Area still have a canon 5d Mrk ii?
 Merck Merck Announces 3rd-Quarter Results https://t.co/jTkXmMphaD
The Seattle Times Merck (Merck) Beats on Q3 Earnings amp; Revenues, Lifts View https://t.co/4qeLm0Ldvy Merck & Co.,‚Ä¶ https://t.co/CqkamMJOsd
This looks so interesting!  amitbhawani  phoneradarblog
OnePlus 3 + Loop VR International Giveaway! https://t.co/b9MggfOrRd
On The Fly: Top stock stories at midday   UA  GM  V  P&G  Merck  UTX  DD  CAT  MMM  TWTR  GBT  CR  SONC  S: Full Story https://t.co/FTad7ey5Q2
OnePlus 3 + Loop VR International Giveaway!  vrsourcecom  giveaway https://t.co/b9MggfwQsD
Beats Solo3 Wireless Headphones International Giveaway! https://t.co/wpRiPoUwUY
Beats Solo 3 Wireless Headphones International Giveaway  realsoundguys  giveaway https://t.co/wpRiPpc7Mw
iPhone 7 Plus International Giveaway! https://t.co/QeHnxIdUke
iPhone 7 Plus International Giveaway  tabtimes  giveaway https://t.co/QeHnxIvvbM
Best Android Phone Giveaway! https://t.co/vD1LK3qQgB
Best Android Phone International  Giveaway  androidauth - Enter Here: https://t.co/vD1LK3Ir89
Google Pixel XL International Giveaway! https://t.co/JnTNqV7pPk
Google Pixel XL International Giveaway  androidauth  giveaway https://t.co/JnTNqV7pPk
Merck & Co Inc. (Merck) Q3
Earnings: U D 2.99B.
EPS:  1.07.
Revenue: U D 10.54B.
SAlphaTrending: Merck & Co. (Merck) Q3 2016 Results - Earnings Call Transcript https://t.co/yD6IVVyDfa  Merck
Watching  TIMYRunAway replay mapapakanta ka nalang ng "so baby pull me closer, in the back seat of your rover."
 Merck reported  10.5 billion in  sales, up 4.6% vs. the year-earlier quarter.  Uptrend continues.

 Stocks‚Ä¶ https://t.co/TKssdQ277d
 Merck stock edged higher after the company recorded healthy third-quarter results.  Merck https://t.co/wy5i6vvMKJ
Merck & Co. (Merck) Q3 2016 Results - Earnings Call Transcript https://t.co/dKubXjOzzP  Merck
Merck  Drug Gets FDA Approval as a First-Line Lung  Cancer  Treatment: Merck Merck 1.48 % & Co.‚Äôs immunotherapy... https://t.co/AcFdYqBvsG
Merck Q3 call results.  Get your feed.   money  pharma  earningsseason https://t.co/6vEKecxzhy
 Merck sees two drug approvals this week: one for Zinplava and another for Keytruda indication https://t.co/6eQ08o68Kd
Sometimes it all gets a little too much..
 shawnmendes
 Merck After Earnings Option Report https://t.co/6ZDEMTWlJS https://t.co/coNfeevW8r
 WHR Earnings Extravaganza:Merck & More In Play Today https://t.co/dYxZPrPnX6  ITMS https://t.co/MxIcMdnCvD
Be on guard! Be alert! You do not know when that time will come.
Mark 13:33 NIV
https://t.co/fULlFaH3ej
Merck & Co. (Merck) Q3 2016 Results - Earnings Call Transcript https://t.co/ip2JfmISu7  StockMarketInsights
Merck & Co. (Merck) Q3 2016 Results - Earnings Call Transcript https://t.co/iZUeYYP&GEy  Markets  Finance  TCOT
 mrk_chs hope everything is ok
Early movers: MMM, CAT, DD, Merck, P&G, UTX, GM, UA, LLY & more: Names on the move ahead of the open. https://t.co/M2KlakQJG7
 alex_loew sorry guys I had to deal with an emergency
 mrk_chs where'd you go? 6th period misses you!
i love you  iamr2alonte 
HappyBirthday KILIGKING
HAPPY BIRTHDAY AGAIN  iamr2alonte 
HappyBirthday KILIGKING
Do you know that  WallStreet price for  Merck is  66.47 https://t.co/em0OFQ12L2
FY2016 Earnings Estimate for Merck & Co. Issued By SunTrust Banks  Merck https://t.co/uAS4FVexWq
Worth it to sa Thursday! <3
HappyBirthday KILIGKING
.The Future of  Integration Innovation Takes Center Stage at Cleo Customer Advisory Event https://t.co/b9YBmKK20g‚Ä¶ https://t.co/eEWS0AREJo
Lesson learned never ever eat too much. üòµüòµüòµ
 stomachache
Merck Announces 3rd-Quarter Results  Merck - https://t.co/ue9hoZF7pW https://t.co/npxyJEcfAU
TWEET.
HappyBirthday KILIGKING
Robotics Team take note.  Awesome. https://t.co/cMWLKPyX0S
happy birthday kay ronnie <3 
HappyBirthday KILIGKING https://t.co/ybadJWYcmK
Also I like how  sendkayaks has become a thing in my class https://t.co/siRhOkkJDH
Awkward silence
HappyBirthday KILIGKING
Happy birthday  MarkTVaughan (Mrk)!!!! Hope you have an awesome day and see ya soonüòäüéà
WILD WILD BoeingBYY HAHAHA
20th birthday!
HappyBirthday KILIGKING
Up! HappyBirthday KILIGKING
I love my  RingCentral phone system. One number for voice, fax, text. Request a demo.  ringcentral https://t.co/lPgcXVLQrX
The Future of  Integration Innovation Takes Center Stage at Cleo Customer Advisory Event https://t.co/OWdQteh80m‚Ä¶ https://t.co/1jtGOJDIEA
10th spot!
HappyBirthday KILIGKING
Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment: Merck Merck 1.48 % & Co.‚Äôs immunotherapy ca... https://t.co/nItYz9fmV0
Babe xx_xx
We calculated 21-day Expected Return of  Merck for you: -3.35% https://t.co/y7B8KCMIS5
 JoviLifer My sis has that same scarf! She luvs it! I wish I had gotten one for myself too üòø Awww MrK üòø
Yey! 
HappyBirthday KILIGKING https://t.co/wTE4EeJYy3
fourth na? https://t.co/ngePokc6me
Merck's Keytruda wins coveted first-line lung cancer nod, cementing rise 'from laggard to leader': https://t.co/sVEtYQTCRj  Merck  pharma
Unicorn Bay rating for  Merck is 2.51 out of 5. https://t.co/f7SGlOTADa
 Merck Beats Street 3Q Forecasts, Hikes 2016 Profit Forecast . Read more: https://t.co/0HPZgdK2V7  Merck
7 Household Chores with Unexpected  Health Benefits, from making the bed to using the vacuum:
https://t.co/xv02PSffeR
Benzinga: Epic Earnings: Many US Companies Beating Expectations As Season Continues https://t.co/mCJt79yPrY  Merck  LLY  MMM  DD  Apple  AMZN‚Ä¶
Epic Earnings: Many US Companies Beating Expectations As Season Continues https://t.co/vTn3fkmAKW  Merck  LLY  MMM  DD  Apple  AMZN  P&G  CAT
Is Merck getting out of flat? Learn more: https://t.co/dRDGXVpIUv  Merck
Why wait? FDA gives early OK to Merck‚Äôs Keytruda for frontline lung cancer - https://t.co/WO4BIDnuZ5
 Merck:

Options Traders Blitz Merck & Co., Inc. (Merck) After Earnings ‚Ä¶:

https://t.co/xYERidOWEj
Explore  fundamental numbers and pros and cons for  Merck https://t.co/RMKJb1ZAr3
Anticipating Bristol-Myers Squibb's 3Q16 Earnings on October 27 http://localhost?p=1694159  BMY  ABBV  PFE  Merck
FAM <3

HappyBirthday KILIGKING https://t.co/5iBtBMgeAO
Epic Earnings: Many US Companies Beating Expectations As Season Continues  Apple  Merck  LLY https://t.co/W1Hgma34YQ
GO! 
HappyBirthday KILIGKING https://t.co/mnGSBKg2w2
https://t.co/Phib8Zjl93 Miru latest Dubsmash with Merck Raj | Madras Corner  video  miru  latest  dubsmash  with  mrk  raj  madras
 Health Merck (Merck) Beats on Q3 Earnings amp; Revenues, Lifts View - https://t.co/sCWJ1AjReV https://t.co/SUte2JqIeK  Southeast Asia
R2
HappyBirthday KILIGKING
Wonnie
HappyBirthday KILIGKING
 Merck Earnings Extravaganza: drug  stocks and More In Play Today https://t.co/JH4udfKRYF  ITMS https://t.co/uw7hkryTHT
 realDonaldTrump So have rally goers bring their OBoeingMACARE pprs. &mrk a RED NO if they can't afford or not getting it! Let the People speak
 T new lows...  Merck new highs.
Happy Birthday!  iamr2alonte 
HappyBirthday KILIGKING
2 Stocks Analyst-Opinion Need Close Attention: Exandria, Inc. (NYSE:Merck), Sirius XM Holdings Inc. (NASDAQ:SIRI)
 AndyBiotech strong WORDS from SUN -monopoly position in 1L NSCLC for next 12 to 18 months. LUNG CA Huge market to have MONOPOLY in  Merck
 CTRV   J&J or Merck may do a TBRA like move here, from  2 to  55 or AGN , BP wants a hepB drug pipe
Party! 
HappyBirthday KILIGKING
GBP:USD +70 pips

swft+21c

mas+37c

mrk-4c

spy+30c
 Merck:

Market Misses Upside on Merck:

https://t.co/nWhDhFvxAp
 Merck talks M&A, combination therapies for Keytruda in Q3 earnings call https://t.co/h5RVUn4cPX
 SkinSales  MarcosJrdavila  redline mrk entra
 Merck is going  Higher. When upgrades start trickling in on Keytruda, the shorts here will have nowhere to hide.  Jimcramer
Merck (Merck) Tops Q3 EPS by 8c; Narrows FY16 Outlook - https://t.co/WOFp6Eoiwc https://t.co/5GhPyfEvVm
 Merck Keytruda Gets FDA Approval for First-Line Lung Cancer. Read more: https://t.co/U4xYOxZpzK  Merck
 Merck's Keytruda wins approval in first-line lung cancer. Read more: https://t.co/Pdq9WUQddd  Merck
Merck & Co. (Merck) Gains with Earnings Due https://t.co/PvTLi60HR7
 djhkh2 Legends7 loading......... As Milly would normaly say: More fire!!!!
 mrkhndy does my attraction to both sexes worry you mrk?
 Merck beats Street 3Q forecasts, hikes 2016 profit forecast. Read more: https://t.co/7HYBmSFefU  Merck
 Merck Tops Q3 Earnings, Revenue Estimates. Read more: https://t.co/o3vvGOZGk3  Merck
 Merck Beats on Q3 Earnings & Revenues, Lifts View. Read more: https://t.co/Qcb489zexb  Merck
UPDATE 2- Merck quarterly revenue beats, raises full-year forecast. Read more: https://t.co/xRlDPamHCR  Merck
 Merck beats quarterly revenue expectations. Read more: https://t.co/kFNDHlFWXm  Merck
 Merck Lifts Full-Year Guidance After Quarterly Forecast Beat. Read more: https://t.co/9bep8veA8s  Merck
 LLY like  Merck painting a nice candle on earnings - small +ve for beaten biotechs  https://t.co/z4nar3h5zE via https://t.co/11Wpw9y7t1
Hello, World!
 Merck gets early OK for Keytruda in first-line lung cancer. Read more: https://t.co/uYkMl1Bhyh  Merck
 Merck reports 19.6 percent jump in quarterly profit. Read more: https://t.co/hFbRGakLQq  Merck
 Merck Q3 Profit Rises; Lifts 2016 Outlook . Read more: https://t.co/Zc20h5nS3Z  Merck
Will Novo Nordisk's Revenue Continue to Suffer in 3Q16? https://t.co/P1ltGKfHX7  NVO  LLY  Merck  SNY
 Merck Shares Climb 3% After Third-quarter Earnings Beat. Read more: https://t.co/sKlUfUIyBu  Merck
 Merck : Revenue and Profit Rise on Cancer Drugs, Vaccines. Read more: https://t.co/6zDPqd5FYA  Merck
 Merck reports 19.6 pct jump in quarterly profit. Read more: https://t.co/tZmvSXjsyq  Merck
For this reason I tell you, whatever you  pray and ask for, believe... https://t.co/ZEswy6I2BU https://t.co/X8SrjbO4Th
 Merck Q3 Profit Rises; Lifts 2016 Outlook. Read more: https://t.co/zXf04bZucR  Merck
 Merck % of 1L NSCLC pts eligible for Keytruda in real-life much less than 25~30% as  jsoriamd discussed at  ESMO16‚Ä¶ https://t.co/LfVnmbIAY5
Merck Top news - Oct 25th, 2016  Merck http://https://t.co/N8puSajNE2
 Merck's Q3 Results, Guidance Look Strong. Read more: https://t.co/GsGI6mNKsl  Merck
 Merck raises its full-year forecast because one drug has been crushing it (). Read more: https://t.co/Bt7bglpUUu  Merck
 Merck Beats Estimates as Sales of Gardasil Vaccine Surge https://t.co/f5d09l0ux5 via
 Merck gets early OK for Keytruda in firstline lung cancer. Read more: https://t.co/XjsTPwOyAr  Merck
US OKs firstline use of  Mercks Keytruda in lung cancer. Read more: https://t.co/xT0IH35AWV  Merck
 Merck Beats Street 3Q Forecasts, Hikes 2016 Profit Forecast. Read more: https://t.co/gpRW9htLIY  Merck
 VRX  Merck  MYL  AGN  SRPT  pep  Apple  HLF  IEP  ko
Shareholders Patiently Await Mother of All Short Squeezes,  200 Apple & the mkt to crash
 Merck : beats Street 3Q forecasts. Read more: https://t.co/7Nykjq7ewZ  Merck
 Merck beats Street 3Q forecasts. Read more: https://t.co/1ln9vvEY39  Merck
 AFMD  MDGEF  Merck  TXCL Except 4 Mologen an interesting combination of cancer immunotherapy companies meetup https://t.co/MUcCS1XxGw
Wondering about risks of  Merck? The 63-day volatility is 12.7% https://t.co/F24Y08flu8
After FDA approval, Merck posts better-than-expected earnings  Merck https://t.co/6k9noekkmT via  TheStreet
 mrkhndy Playing monopoly, Mrk. We're pretending to be a different family. https://t.co/EkxaHxkdza
Hey
 Merck_herE
 KRISH619
 Shlok_L
 fixchoice
 AadhyaB

u definitely like with joy having these üòäüòä‚Ä¶ https://t.co/xsBmDkVxrj
 Merck Reports Better Than Expected 3Q Earnings. Read more: https://t.co/9ERrwwcra3  Merck
 Merck Beats Street 3Q Forecasts. Read more: https://t.co/Z6P&GtGPSDQ  Merck
Volume Alert - Merck 61.83 Merck & Company  Merck Hit a high today of 61.93 Closing the day 10:30 at 61.83 +1.08 + https://t.co/89Ha4H59yZ
 Merck Jan-18 62.5 Call buyer +4k for  4.70
Mrk estoooo!!! https://t.co/c5WpyVKRkG
 Merck Profit Rises on Cancer Drugs, Vaccines. Read more: https://t.co/WaGo0YICFk  Merck
FDA Approves  Merck's Keytruda in Metastatic NSCLC as FirstLine Treatment. Read more: https://t.co/dsKRdzju87  Merck
Earnings Extravaganza: V, WHR, Merck & More In Play¬†Today https://t.co/VJyepbUD5B https://t.co/QxHOtpcoKy
FDA Approves  Merck's Keytruda in Metastatic NSCLC as First-Line Treatment. Read more: https://t.co/6OyohITqDC  Merck
finzine:  Merck Eli Lilly Q3 Revenue, EPS Miss; CEO Praises Drug Pipeline https://t.co/hNGUNpxZrY
Early movers: MMM, CAT, DD, Merck, P&G, UTX, GM, UA, LLY & more
https://t.co/GPaqn0Xv9q
 mrkhndy Know what, mrk?

;)
 Merck Eli Lilly Q3 Revenue, EPS Miss; CEO Praises Drug Pipeline https://t.co/0C5tu6276L
Merck & Co.  Merck Posts Earnings Results, Beats Estimates By  0.08 EPS https://t.co/hOCDBvEdVF
Biotech Forum Daily Digest: Election Worries Overblown? Spotlight On Akorn https://t.co/MSoKbSvlRE  AKRX  BDSI  BMY  CEMP  GILD  INO  Merck
UPDATE 1- Merck wins early U.S. approval for Keytruda in untreated lung cancer. Read more: https://t.co/WTGwHD7zat  Merck
US OKs first-line use of  Merck's Keytruda in lung cancer. Read more: https://t.co/IeqApKktsg  Merck
Merck   Merck 
Warning in Pre-market 09:10 am  triggered 13 minutes before the security price rose   trading  markets‚Ä¶ https://t.co/gFE5G8zwj3
 Merck For 3rd-party payers,worst place 2pick fight is cutting off Tx that's working in life-thrtng indictn,where dur‚Ä¶ https://t.co/7xFB4aY1Tz
 mrkhndy mrk, I hope you are seeing this https://t.co/p2COrMecNG
 SikiuCabrera  oldmanjoseph mrk que intenso
finzine:  Merck Merck Crushes Q3 Expectations Following Lung Cancer Drug Win https://t.co/t66oyOkgnD
FDA approves  Merck's lung cancer drug as first-line treatment. Read more: https://t.co/zRPPZEyfAx  Merck
Good profit on  Walmart swing.  We nailed  Merck right at the open from  59.55 to almost  62.  What a fast    for members!
 VRX  AGN  MYL  SRPT  Merck  MYL  AMGN  TSRO
Today's Valeant Throw Back-When the Critics Wrote Off Future Price Appreciation Credits After Q1
Jim Cramer -- Merck, Lilly Pressured by Political Uncertainty  Merck https://t.co/hCBviSn4TR https://t.co/g6cp1KBrEO
After FDA Approval, Merck Posts Better-Than-Expected Earnings  Merck https://t.co/U7Mq7MMiyB https://t.co/Ke2OGmSXaY
New trademark 'STORIES TOLD HERE' filed by Merck Fine Arts, LLC https://t.co/CN3DKRlYXU
 Merck Merck Crushes Q3 Expectations Following Lung Cancer Drug Win https://t.co/rlj2Px3drm
 Achaogen INO Slips On Clinical Hold, Merck Gets FDA Nod, Be All Ears For . Read more: https://t.co/LWxRVgcgxv  AKAO
Licensing deal to give  Merck access to Scots innovation. Read more: https://t.co/QeeE5nsaJ5  Merck
 AccernAlert  avidresearch BoeingML  Merck above Street on 2017/18 EPS estimate&amp;expect Street estimates to increase as scripts and rep  stocks
 avidresearch BoeingML  Merck above Street on 2017/18 EPS estimate&expect Street estimates to increase as scripts and reported sales ramp PT 70
Is Merck getting out of flat?  Merck https://t.co/CcKSqQIRcy
FDA Approves  Merck's KEYTRUDA¬Æ (pembrolizumab) in Metastatic NSCLC for First-Line Treatment... Read more: https://t.co/FbT4uHGseJ  Merck
FDA Approves  Mercks KEYTRUDA√Ç pembrolizumab in Metastatic NSCLC for FirstLine Treatment of ... Read more: https://t.co/PvWIr0EZyR  Merck
Merck KGaA‚Äôs (Merck) ‚ÄúBuy‚Äù Rating Reaffirmed at DZ Bank AG https://t.co/5KS6QaI5mn
 VRX  AGN  MYL  SRPT  Merck  MYL  AMGN  TSRO

Valeant's Responsible and Sustainable Price Increases Shatter The Short's Thesis
Commented on StockTwits: Keytruda FDA approval was monumental for  Merck.... https://t.co/N2D0GIaZAS
BRIEF- Merck & Co says FDA also approves a labeling update for Keytruda for treatment of pat... Read more: https://t.co/wVO5iUPFt8  Merck
Since Halloween is next week... MrK wearing his spiderweb tie.  RIP Love you big guy. xxx So very handsome.‚Ä¶ https://t.co/TQvFYe6Yd4
 Merck & Co Inc. Reports 10% Increase In Q3 Profit. Read more: https://t.co/URJG10draF  Merck
Found a Transponder Snail!
For honor! Giants clash in ancient jungle!
https://t.co/dJ0wE80Q15  TreCru https://t.co/5jLnhB1QVR
 VRX  AGN  MYL  SRPT  Merck  MYL  AMGN  TSRO

Can someone please forward to me David Maris' of Wells Fargo calculation for his latest VRX PT
 Merck & Co. Shares Bought by Alps Advisors Inc. Read more: https://t.co/8whJ5CxZGV  Merck
Merck quarterly revenue beats, raises full-year forecast https://t.co/XHtoqmOM5o

REV  10.54B vs  10.24B
EPS  1.07‚Ä¶ https://t.co/OuupRAUWPl
 V Earnings Extravaganza:WHR, Merck & More In Play Today https://t.co/SE6qdV6qGs  ITMS https://t.co/byBM54wMnf
 Merck FDA Keytruda Now OK For Some Patients With Untreated Lung Cancer. Read more: https://t.co/HdeZcuxHeq  Merck
 Merck FDA: Keytruda Now OK For Some Patients With Untreated Lung Cancer. Read more: https://t.co/nDdhHlgLB6  Merck
 Merck:US Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment  MERCK & CO  https://t.co/ItPmpcSzsm  SP500
TrendTracker... don't always catch them all

 Merck https://t.co/RFeYpS8BDp
 Merck Merck Lifts Full-Year Guidance After Quarterly Forecast Beat - TheStreet https://t.co/ujiHd1gU15
October 25 Biotech Update  AGN  BIIB  LLY  Merck  omed https://t.co/U98mK4zURd
The power of  Merck.... makes sense that  Jimcramer is pushing it.
In a snap,  FDA OKs  Merck Keytruda for frontline  lungcancer https://t.co/f2HFGVca2K‚Ä¶ by  JohnCendpts
 Merck nice reversal off the weekly ema30 on e/r
Submitted Video:

Earnings Extravaganza:  V ,  WHR ,  Merck & More In Play Today

https://t.co/jFBcZO9aXR

 stocks  charts     trading
A watershed moment in cancer: chemo not first line in NSLC, Opdivo is. Buying more  Merck when excitement fades.
https://t.co/ilMMJmRwag
Early movers: MMM, CAT, DD, Merck, P&G, UTX, GM, UA, LLY & more - CNBC https://t.co/Sh5D8c7Gi1 https://t.co/quGcxKFoRY
 Merck  reported higher quarterly revenue due to sales of its vaccines &  cancer drug Keytruda; U.S. approved Monday for lung cancer patients
Merck & Co.  Merck Updates FY16 Earnings Guidance https://t.co/M5NcukfgcQ
ICYMI:  BigPharma takes big lease in South S.F. to consolidate California operations. https://t.co/dGNEDMqa2v
Vampire diaries... the soundtrack is lit https://t.co/yspNxh1WRB
Big  earnings report day today. Look for  CMG,  P,  WYNN,  PNRA,  COH,  P&G,  LMT,  Merck,  FCX, and  SAVE
 Merck partial gap close and bounce  https://t.co/08wdZmxtew via https://t.co/11Wpw9y7t1
FDA OKs Merck's bezlotoxumab to reduce recurrence of C. diff infection in certain patients https://t.co/fmH9mBdtZr  Merck
‚≠êÔ∏è  Investing ‚ñ™ Early movers: MMM, CAT, DD, Merck, P&G, UTX, GM, UA, LLY & more: Names on the move ahead of the open. https://t.co/N8McLBG9Kg
 stockmarket Early movers: MMM, CAT, DD, Merck, P&G, UTX, GM, UA, LLY & more: Names on the move ... https://t.co/Vrl2mrpacd  aapl  fb  UBQU
 avidresearch shocked  Merck could be bought under 60 at open -Merck going higher over next 12 months will nice dividend also
Always climbing those up highs üèô https://t.co/lyXPFuzCMR
 Merck well deserved strength
 CNBC  Markets Early movers: MMM, CAT, DD, Merck, P&G, UTX, GM, UA, LLY & more https://t.co/xvy0ud45sL
Merck KGaA‚Äôs  Merck ‚ÄúBuy‚Äù Rating Reaffirmed at DZ Bank AG https://t.co/ZDLEFUfbd9
Winslow Asset Management Inc. Sells 2,206 Shares of Merck & Co.  Merck https://t.co/8530IJX4J8
Merck & Co.  Merck Shares Bought by Pathstone Family Office LLC https://t.co/gNmn8w27FL
Early movers: MMM, CAT, DD, Merck, P&G, UTX, GM, UA, LLY & more https://t.co/uDUJSac5jC
Merck shares flat; co. beat estimates as sales of Gardasil vaccine surged https://t.co/LbfnTXeAHV via  business  Merck
Is loving God and others on your "To Do" list today? https://t.co/j0wDc1Dujs https://t.co/OxlwuEjYqF
Merck & Co.  Merck Posts  Earnings Results, Beats Estimates By  0.08 EPS https://t.co/mrKkrPXk1k
 srpt  VRX  AGN  TWTR  Apple  AMGN  MYL  Merck  PEP  KO  DPS  SPY  QQQ
Locker Room Talk or The Hidden Truth-It's Not A‚Ä¶ https://t.co/KwqslENmdm
Merck   Merck 
Warning in Pre-market 06:46 am  triggered 17 minutes before the security price fell   trading  markets‚Ä¶ https://t.co/2lvWlbAL0s
Bought some  Merck April 2017  62.50 and  65 calls
Merck's 3Q Keytruda sales of  356M fell short of Street views, but sales seen surging on FDA green light of use in lung cancer  Merck
Private Advisor Group LLC Increases Position in Merck & Co.  Merck https://t.co/LRlK5MmlbV
 mrk Are you shitting me? In AH drug gets FDA approved, in PM earnings beat expectations and this stock trades down? WTF?
Cramer's Mad Dash  Merck
Early movers: MMM, CAT, DD, Merck, P&G, UTX, GM, UA, LLY & more -   https://t.co/txIUIU9mAB
CNBC: Early movers: MMM, CAT, DD, Merck, P&G, UTX, GM, UA, LLY & more https://t.co/otjkqXlDhv
Breaking (8:18 AM EDT): Early movers: MMM, CAT, DD, Merck, P&G, UTX, GM, UA, LLY, BHI, WHR & more - null
 Merck great earnings release... stock is selling off....üí§üòçüòÄüòúüìâüî´üí£üî™ https://t.co/dWTdfwJsQ7
Stocks to Watch Today:  CAT,  GM,  P&G,  Merck,  TWTR https://t.co/k0eCbHqOzq  TraderGang
Get your tickets here from https://t.co/aW8K4AAK8Y https://t.co/6nPUUqMJDJ
toptickertweets  Apple  FB  Merck  P&G  NFLX  FinTech  trading  finance  SentiQuant 20161025-09:25
If we have to give a name to them:
 Merck, the come back kid;  BMY, the falling star;  AMGN, the bag holder? https://t.co/9yQIIyTxaz
Keytruda wasn't the only  Merck drug getting an okay from FDA this week https://t.co/JhpD2ddvMb
Early movers: MMM, CAT, DD, Merck, P&G, UTX, GM, UA, LLY & more https://t.co/qOoxnnOK8q  stock  stocknews
Early movers: MMM, CAT, DD, Merck, P&G, UTX, GM, UA, LLY & more https://t.co/ixj4Q3Diov  BSAFunds  MerchantCashAdvance  BlueStreakAdvances
GM, FCAU, P&G, CAT, LMT, MMM, Merck beats on earnings. Continues a steady Q3 trend.
Merck & Co.  Merck Shares Bought by Ajo LP https://t.co/GF4ZHSdMAB
 MSNCars Not a chance, the roads are a disgrace..
Pharmalot.. Pharmalittle.. Good Morning.. lots of headlines today.. https://t.co/wI5juqgAy6  pharma  Merck  SRPT  PFE  marijuana  FDA  BMY
 Merck mentioned they have some more preferred formulary status in the works for 2017 in HepC

 GILD  ABBV
 Motorcyclist 'pulled  wheelie before hitting  pensioner' https://t.co/ciwA7ARjf2
Earnings Extravaganza:  V  WHR  LLY  Merck  P&G  MMM  CAT & More In Play Today
   
https://t.co/qzQBsVPJBp
"Fade trade" is in full effect.   UA  GM  Merck  JBLU  GLW  S  V all trading lower, after initially popping on earnings release.
 EDXC.06 Red Hot Marijuana Stock-Acquisition NEWS today  P&G  Merck  MYL  VRX  VRTX  BIIB  BMY  JNJ  CELG  AKRX  REGN‚Ä¶ https://t.co/KuK9qYRm1i
Day Traders - Hot stocks Today :  BHI -  CLVS -  MMM -  Merck -  NLSN -  P&G -  SONC -  UA -  VFC
Day Traders - Hot stocks Today :  BHI -   CLVS -  MMM -  Merck -  NLSN -  P&G -  SONC -  UA -  VFC
 Investing Early movers: MMM, CAT, DD, Merck, P&G, UTX, GM, UA, LLY & more https://t.co/fzfc1elOsE  News https://t.co/c8eVAw86Tc
Here‚Äôs what to expect for  Merck next quarter. https://t.co/mkRkwm9vLD
 Earnings Extravaganza:  V,  WHR,  Merck & More In Play Today...  https://t.co/lU7wulY9NW
Merck reports better than expected 3Q  Earnings  Merck https://t.co/TcNyOHET6C  business
Recent  Merck technical alerts: Stochastic Reached Oversold... https://t.co/RZotP0LKQq
Dow earnings roundup: UTX, P&G, Merck, MMM, DD, V, CAT
10/25 Tues Stock Movers:  MMM  CAT  DD  Merck  P&G  UTX  GM  UA  WHR  TWTR  V  IBM  NFLX  SONC CHARTS & DISCUSSION... https://t.co/LXKyBlpKpl
Elder Irene Peters opens Indigenous Education Focussed CI in London.  Ni√°:wen for the opportunity to serve our FNMI‚Ä¶ https://t.co/8WlVeF97lx
10/25 Tues Stock Movers:  MMM  CAT  DD  Merck  P&G  UTX  GM  UA  WHR  TWTR  V  IBM  NFLX  SONC CHARTS & DISCUSSION ->‚Ä¶ https://t.co/jzvHk7R0LI
Business LOTP update: FoxBusiness: Merck reports better than expected 3Q  Earnings  Merck https://t.co/NiRQfhZbpR  busniess  news
 Adolf_Trump  Normsmusic  peterdaou  JoeNBC  Morning_Joe  realDonaldTrump Need Mrk Halperin Chrs Matthws Willi Geist JulianAssnge Putin pics
 Merck Keytruda Q3 2016 sales total of 356M, 50% melanoma, 25% NSCLC, 5% head and neck, 20% other, lets see how  BMY Opdivo compares Thursday
Merck reports better than expected 3Q  Earnings  Merck https://t.co/1TJG6fDVs5
A closing word from Ken Frazier on our 3Q financial results.  Merck https://t.co/JqjOTfDpdH
 Financial Dow earnings roundup: UTX, P&G, Merck, MMM, DD, V, CAT https://t.co/398ijarkBU  News https://t.co/0htQFz7ij6
Dow earnings roundup: UTX, P&G, Merck, MMM, DD, V, CAT https://t.co/e0Dutkd20s
 LaMonicaBuzz  maggielake  cnni I'm watching   UA  MMM  CAT  Apple  UTX  Merck  CB  JBLU and JNCR.
 forex  trading  learntotrade Early movers: MMM, CAT, DD, Merck, P&G, UTX, GM, UA, LLY & more https://t.co/MBYQg8U4vl
Early movers:  MMM,  CAT,  DD,  Merck,  P&G,  UTX,  GM,  UA,  LLY & more https://t.co/1DOUw503OK
Investment news: Early movers: MMM, CAT, DD, Merck, P&G, UTX, GM, UA, LLY & more https://t.co/1P2Y2446wc
Daily Updates  SwIng Trade AEM,CRZO,FSM,Merck,P&G,PSTI,TRTC https://t.co/AdHSQWJXoc
 Merck Stock Futures Edge Up; New Oriental Rises, Sonic Dives https://t.co/yoapMvwWak
11 ordinary people who are social media sensations !
https://t.co/d8IFF8zWzi
Merck & Co.  Merck Releases Earnings Results, Beats Estimates By  0.08 EPS https://t.co/5vEnIxxtSU
EARLY MOVERS:  MMM  CAT  DD  Merck  P&G  UTX  GM  UA  LLY  BHI  WHR  ZION  RMBS  NFLX  SONC  IBM  V - CNBC https://t.co/LpR3QLlbO7
 Merck: Merck beats by  0.08, beats on revs; raises FY16 EPS in-line, raises rev above consensus https://t.co/oEbGh0j6vR
Dow earnings roundup: UTX, P&G, Merck, MMM, DD, V, CAT:  https://t.co/qxOWnh54h7  usmarket  UBQU
Early movers: MMM, CAT, DD, Merck, P&G, UTX, GM, UA, LLY & more https://t.co/7ui86rTt7H  Tips2Trade  T2T https://t.co/9ekq9qVZVH
Early movers: MMM, CAT, DD, Merck, P&G, UTX, GM, UA, LLY & more https://t.co/tXRN4Jzlx6  breakingnews https://t.co/1cncF4sDYq
.
New Small Cap Pick Just Posted!
https://t.co/NnCASVANJz
.
.
 BP  XOM  KORS  PL  GOOG  IVM  SNY  CMCSA  GM  Merck‚Ä¶ https://t.co/K4JhGrL8Zu
Me when watching movies with subtitles. üòÇüòÇ https://t.co/UrDkXPjfJ4
Mixed  earnings and  Apple preview https://t.co/vWZ2itm3JQ  stocks  API  Apple  DD  Merck  GM  WHR
Dow earnings roundup: UTX, P&G, Merck, MMM, DD, V,¬†CAT https://t.co/fcLJvx70F5 https://t.co/PcUtwVzBVv
Merck  & Co. updates FY16 guidance to  3.71-3.78 EPS  & revenue guidance to  39.7-40.2 billion.  https://t.co/FFZJzV6b0e  Merck  Merck
Lots of earnings today  Merck,  LLY,  NVS and  VRTX after the close
ICYMI:  Merck get first-line lung approval for Keytruda - beating out I/O competitors https://t.co/qTK6igYJ63
Early movers: 

 MMM  CAT  DD  Merck  P&G  SONC
 UTX  GM  UA  LLY  BHI  WHR
 TWTR  V  SYT  NFLX  RMBS  NVS

https://t.co/EG0ZvDjZRU
Early movers: MMM, CAT, DD, Merck, P&G, UTX, GM, UA, LLY & more https://t.co/TXHdbRnQFL  econ  mises  keynes
God is the God of the living, not the dead.
Mark 12:27 https://t.co/NDCiW5a739
üá∫üá∏ Dow earnings roundup: UTX, P&G, Merck, MMM, DD, V, CAT https://t.co/H7V11gwIha INVESTINGcom
Merck  Merck Reports Q3 EPS  1.07 vs  0.99 est, Revenue  10.54B vs  10.18B est  stocks  trading  earnings  SPY  QQQ  DIA
DTN Canada: Merck beats Street 3Q forecasts: KENILWORTH, N.J. - Merck & Co. (Merck) on Tuesday reported third-q... https://t.co/kd6A1KeZBD
Dow earnings roundup: UTX, P&G, Merck, MMM, DD, V, CAT - https://t.co/JPznXEQTkn
 IBB Early Movers:MMM, CAT, DD, Merck, P&G, UTX, GM, UA, LLY &amp; more https://t.co/RJPCrBPbFd
Merck beats Street 3Q forecasts: KENILWORTH, N.J. - Merck & Co. (Merck) on Tuesday reported third-quarter net i... https://t.co/PsA5GJWyjA
 Parec116  mrkhndy that's mrk's job
Dow earnings roundup:  UTX,  P&G,  Merck,  MMM,  DD, V, CAT - https://t.co/Z4GUAGSK5z
YahooFinance:  Stocks to Watch Today:  CAT,  GM,  P&G,  Merck,  TWTR https://t.co/VlVA4WMjwU https://t.co/1hEaikG4wu
Early movers: MMM, CAT, DD, Merck, P&G, UTX, GM, UA, LLY & more - https://t.co/UZaAQTsUuc
Notable Monday Option Activity: RMBS, WP&G,¬†Merck https://t.co/2cqB50eKsH
YahooFinance:  Stocks to Watch Today:  CAT,  GM,  P&G,  Merck,  TWTR https://t.co/4woAqDN4Ip https://t.co/EcSE2aMPkl  BSAFunds  MerchantCash‚Ä¶
 QQQ Early Movers:MMM, CAT, DD, Merck, P&G, UTX, GM, UA, LLY &amp; more https://t.co/iuOlYZkA8R
On The Fly: Top Stock Stories For Monday, Oct. 24  COL  DVA  GM  KMB  Merck  T  TM  TWX  INO  Apple  AMTD  BEAV  TMUS  https://t.co/ZOWJkWjseu
"All I WANT is You" üëΩ
Early movers: MMM, CAT, DD, Merck, P&G, UTX, GM, UA, LLY & more: Names on the move ahead of the open. https://t.co/r1fKpfZAty  cnbc
 Merck not experiencing payer push back in PD-L1<50%, as long as PD-L1 positive in second line, but sales in second-line are limited? adds up?
Huge congratulations  iain_w_anderson really delighted for you https://t.co/MgjwwQE1Do
Early movers: MMM, CAT, DD, Merck, P&G, UTX, GM, UA, LLY & more https://t.co/3t0tdSHrkP CREDIT  peterschack ty peter  enjoy  TerrificTuesday
Caterpillar plowed under, while GM enters the fast lane - today's stocks to watch:  CAT  GM https://t.co/2W73dVya5h
 Stocks to Watch Today:  CAT,  GM,  P&G,  Merck,  TWTR https://t.co/Jb7k9tf4PH https://t.co/hIwKCIYIIa
 VRX  AGN  SRPT  Merck  MYL  TWTR  CXRX
Former WSJ Reporter Made Good Money as Charlie Grant Brags "To Die For Money" https://t.co/C099K2Ys2Z
 Merck suggesting that Keytruda/chemo combo would be promising. CTLA4 combos will be limited by tox profile
 megtirrell  Merck wake up and look at  CEMP!
megtirrell:  Merck already seeing very significant increases in PDL1 testing in lung cancer since ESMO; sees barrier to testing in 2nd line l‚Ä¶
megtirrell:  Merck CEO: News of Aug 5 didn't fundamentally change our approach to M&A
megtirrell:  Merck's Ken Frazier: fundamentally, we're looking for bolt-on opportunities as a company. We need to augment our pipeline
megtirrell: First Q on  Merck call, from Bernstein's Tim Anderson, is about biz dev and size of potential M&A
‚≠êÔ∏è  News ‚Ä¢ Early movers: MMM, CAT, DD, Merck, P&G, UTX, GM, UA, LLY & more: Names on the move ahead of the open.‚Ä¶ https://t.co/wJgWdmjAla
 Merck already seeing very significant increases in PDL1 testing in lung cancer since ESMO; sees barrier to testing in 2nd line lifting
 Merck claims Keytruda has 10% market share in 2nd-line NSCLC, mostly in >50% PD-L1 patients
adamfeuerstein:  Merck Roger Perlmutter sounded like a happy scientist on the conference call.
 Merck has ~10% mkt share among all of 2nd line NSCLC
finzine:  IBM Early movers: MMM, CAT, DD, Merck, P&G, UTX, GM, UA, LLY & more https://t.co/3Xo00mpFKI
Early movers: MMM, CAT, DD, Merck, P&G, UTX, GM, UA, LLY &amp; more  cashback https://t.co/eui0vTX7aW
Elijah & Moses had been in heaven for hundreds of years yet were still on the job! https://t.co/NOR36kmNhZ https://t.co/XBBUwgtzF6
Company News: Merck (Merck) Q3 results beat analysts‚Äô forecasts

Merck reported Q3 FY 2016 earnings of  1.07 per sha‚Ä¶ https://t.co/b2at9We2dM
 FallPanicChem15 Cleavage Furrow hahahaha joke lang
 Merck CEO: News of Aug 5 didn't fundamentally change our approach to M&A
 IBM Early movers: MMM, CAT, DD, Merck, P&G, UTX, GM, UA, LLY & more https://t.co/05AYbkdGVR
 Merck's Ken Frazier: fundamentally, we're looking for bolt-on opportunities as a company. We need to augment our pipeline
First Q on  Merck call, from Bernstein's Tim Anderson, is about biz dev and size of potential M&A
Merck  Merck is "actively engaged" in looking for partnerships & collaborations & bolt-ons, and is not limited by size
Bobby Vee (Merck) Given Average Recommendation of "Hold" by Analysts  fakeheadlinebot  learntocode  makeatwitterbot  javascript
‚ÄúLove the Lord your God with all your heart & with all your soul & with all your mind and with all your strength" https://t.co/yVNSOV29W2
Amen ‚ù§Ô∏èüôèüèª https://t.co/wfomFDPK8k https://t.co/A7WRwm98X0
other than earnings beats this am:GM, DD, P&G, UA, UTX, Merck...only concerning story today? Avocado prices surging on Shortages!!! Guacamole!!
 Merck Roger Perlmutter sounded like a happy scientist on the conference call.
 Merck says on the call that Keytruda is currently in over 360 trials, 200 of which are combos.
 Merck estimates that 25-30% of NSCLC patients express >50 PD-L1, this is key to sizing first-line potential of Keytruda                   BMY
 UCWRadio  Early movers: MMM, CAT, DD, Merck & more https://t.co/B53BcWrEbB  news  finance
Early movers: MMM, CAT, DD, Merck, P&G, UTX, GM, UA, LLY & more https://t.co/XPT9TfhHHd  cnbc
Early movers: MMM, CAT, DD, Merck, P&G, UTX, GM, UA, LLY & more https://t.co/xPK964WfKa  cnbc  topnews
 megtirrell CS on  Merck  BMY https://t.co/ySssdjcRGr
 FaLiLV_mrk oh my Sxun üòÇüòÇüòÇ
"We're committed to reducing the impact of  InfectiousDiseases, which affects millions of patients around the world." -Roger Perlmutter  Merck
https://t.co/gjSzPNm6Uw
Early movers: MMM, CAT, DD, Merck, P&G, UTX, GM, UA, LLY & more

The good stuff!!
Merck Set For Big Move After 3-Month Slumber  Merck https://t.co/xtZMEUwuAd via  investopedia
A Peek Into The Markets: U.S. Stock Futures Rise; GM, Apple Earnings In Focus https://t.co/WnE37k7MNv  SPY  USO  Apple  GM  LLY  Merck  V
 mrkhndy  danbeames if you remember Mrk I wasn't capable of owning a dog for more than two days.
"In the third quarter Merck Research Laboratories made substantial progress on multiple fronts." -Roger Perlmutter  Merck
‚Äú‚ÄúWhat do you mean, ‚ÄòIf I can‚Äô?‚Äù Jesus asked. ‚ÄúAnything is possible if a person believes.‚Äù‚Äù
Mark 9:23 NLT https://t.co/QZ0dPxRqK1
 Merck Q3 top line up +5%; net income up +20%; shares up +2%  premarket. I'm LONG  Merck long-term.
 news  latest Merck beats Street 3Q forecasts: KENILWORTH, N.J. (AP) ‚Äî Merck & Co. (Merck) on Tuesday reported third-quarter ... ‚Ä¶
"We remain confident in our  diabetes franchise and we are pleased with our continued strength globally." - AdamHSchechter  Merck
The  HomecomingOfHealth contest is still on! Do play & Grab some healthy goodies from  GaiaGoodHealth now!  Johnson_Ganesh  JohnTerence_A
How to profit  big on weed microcap stocks. Read: https://t.co/Z9gZezEHln  Merck  CLNE  GIS  CTSH  CTIC  NBR  SKTO  AJG  PCTY
‚ÄúSome people brought to [Jesus] a blind man and begged Him to touch him.‚Äù  (Mk. 6) Who am I begging Jesus to touch? https://t.co/td6ueiobKA
Lots of earnings this morning.  P&G  DD  LMT &  Merck up  premarket following their results.  MMM  LLY &  S down.
 latest  news Merck beats Street 3Q forecasts: KENILWORTH, N.J. (AP) ‚Äî Merck & Co. (Merck) on Tuesday reported third-quarter ... ‚Ä¶
megtirrell:  Merck CEO Ken Frazier says in opening earnings call remarks that appetite for business development hasn't changed, looking for o‚Ä¶
To eat food in lesser proportions rather than having a big heavy meals.  GaiaGoodHealth  ContestBoard  HomecomingOfHealth
"We drove growth across many of our core areas, including  oncology, vaccines, and hospital & specialty care." - AdamHSchechter  Merck
"Our top- & bottom-line growth in the quarter driven by solid operational performance sets us up for a strong 2016 overall" -Rob Davis  Merck
To Sip in Green tea everyday for maintaining a Good health.  GaiaGoodHealth  HomecomingOfHealth
I need to continue my habit of brisk walking for 1 Hour everyday without fail.  GaiaGoodHealth  HomecomingOfHealth
‚ÄúFor there is nothing hidden which will not be revealed, nor has anything been kept secret but that it should come‚Ä¶‚Äù https://t.co/I5BSGG2G5T
 Merck CEO Ken Frazier says in opening earnings call remarks that appetite for business development hasn't changed, looking for opportunities
I totally need a good Sleep for Atleast 7-8 hours as my Sleep cycle is all messed up.  GaiaGoodHealth  ContestBoard  HomecomingOfHealth
Merck beats Street 3Q forecasts: KENILWORTH, N.J. (AP) ‚Äî Merck & Co. (Merck) on Tuesday reported third-quarter ... https://t.co/GXb3IPPtvR
 Merck Listen to Merck & Co. earnings call and get LIVE transcript/updates here: 
https://t.co/TGm6ClJq2H  earnings  stocks  healthcare
MarketCurrents: Merck Q3 top line up 5%; net income up 20%; shares up 2% premarket https://t.co/UsyIjQOY2F  premarket  Merck
"3Q positions us well to deliver a balanced portfolio that'll generate long-term growth & value for shareholders & society" -K. Frazier  Merck
Make this Diwali a special one by taking part in  GaiaGoodHealth  HomecomingOfHealth contest to Win now!  Aritri_007  aziznava1  appie_appz
"Our appetite for BD has not changed. We continue to seek the best opportunities to augment our pipeline & portfolio." -Ken Frazier  Merck
Merck as wel
 Merck Merck Q3 top line up 5%; net income up 20%; shares up 2% premarket https://t.co/0evHn3FqkB
finzine:  Merck Merck beats Street 3Q forecasts, hikes 2016 profit forecast https://t.co/vD93wQLwmf
On Merck  Merck earnings this morning. Discussing the FDA approval of Keytruda by the FDA, which came yesterday.
 Merck Merck beats Street 3Q forecasts, hikes 2016 profit forecast https://t.co/kcdUPrZXtg
"This is what Merck is all about, and we are honored to be making a real difference in the fight against  cancer." -Ken Frazier  Merck
Merck Q3 top line up 5%; net income up 20%; shares up 2% premarket https://t.co/NNz7fFgpXR  premarket  Merck
Merck raises its full-year forecast because one drug has been crushing it (Merck) https://t.co/nj150ioqHf
 News  Business Merck raises its full-year forecast because one drug has been crushing it (Merck) https://t.co/0kplTIkzxZ
 nasdaq What To Expect From Merck's Q3 Earnings? - Merck Merck 160 is set to report its Q3 16 earnings on October... https://t.co/4Sl1L2qtgK
Investors are invited to join our sales and earnings conference call starting now. Follow the conversation at  Merck. https://t.co/YBJijkIEYi
Merck raises its full-year forecast because one drug has been crushing it (Merck) (Business Insider) https://t.co/JuTo1QzjS9
Mrk 7:4 And when they come from the market, except they wash, they eat not. And many other things there be, which‚Ä¶ TuesdayMotivation 1/2
 Merck:

New SEC Filing for Merck: Form 8-K (No. 0001104659-16-151769):

https://t.co/yeUPgtugfq https://t.co/olrhkhvM37
 mrkhndy oh god mrk don't do that
Merck raises its full-year forecast because one drug has been crushing it (Merck) https://t.co/mCL4lChdCy  ROIMentor
finzine:  Merck Merck Lifts Full-Year Guidance After Quarterly Forecast Beat https://t.co/SQhAzsYpDY
Good earnings morning to ya w/  UA  P&G  Merck  DD all posting great  s. GM w/ a huge beat..as they used to say, as GM goes so goes the country
 Merck  Merck.XE:

Merck Revenue and Profit Rise on Cancer Drugs, Vaccines:

https://t.co/OqowidhjQf
 Merck Merck Lifts Full-Year Guidance After Quarterly Forecast Beat https://t.co/YCbSfKMiH0
Wow, huge uptick in  Merck earnings. https://t.co/h1IGCvlQIc
Merck Lifts Full-Year Guidance After Quarterly Forecast Beat  Merck https://t.co/17nqf3Tlbp https://t.co/WrpcwEgPHE
 Merck 3Q16 earnings rose 20% YoY to  2.18Bil or  0.78 per share. Sales grew 5% to  10.54Bil. https://t.co/rKbCNNNRmx https://t.co/SxX7SJcb5u
 Merck:

Merck‚Äôs Q3 Results, Guidance Look Strong:

https://t.co/z6uC4WAWQL
 Merck:

Merck Lifts Full-Year Guidance After Quarterly Forecast Beat:

https://t.co/ToNJfRSOis
Good  news for our friends at  Merck.  Keytruda  NSCLC
https://t.co/SfthDoZD0I
New post: "Merck raises its full-year forecast because one drug has been crushing it (Merck)" https://t.co/7IDufTLRtO
Merck  & Co. announces earnings.  1.07 EPS. Beats estimates.  10.50b revenue. https://t.co/3vUGM7FWlj  Merck  Merck
Benzinga: Merck's Q3 Results, Guidance Look Strong https://t.co/0y4AUlKa8B  Merck
 PFE  Merck  AMGN  ABBV  GILD:

Healthcare ETFs: Gain Or Pain Ahead In Q3 Earnings?:

https://t.co/BpjvcUZ3Xe
 TWX  T  Merck  P&G:

US stock futures point to modest gains, with Apple set to take the ‚Ä¶:

https://t.co/4ok0LRFZAl
 Merck  P&G  CAT  TWTR  NFLX  T  TWX:

Wait for this signal before buying the dip in gold:

https://t.co/XqnLQ6hZyK
1 daily follower. 0 unfollowers. Crowdfire doesn't miss a trick -via https://t.co/UQBIwDqGTL
HoerterFX Notes: Merck beats Street 3Q forecasts: Merck & Co. (Merck) on Tuesday reported third-quarter net inc... https://t.co/cfrsqLsiqc
Trading Street: Merck beats Street 3Q forecasts: Merck & Co. (Merck) on Tuesday reported third-quarter net inco... https://t.co/o5f0t4b1Mj
Agreed with T&C's team! Giving my best  GaiaGoodHealth  ContestBoard  HomecomingOfHealth
 Merck Wait for this signal before buying the dip in gold https://t.co/Gf9ZVnoLkx
Merck beats Street 3Q forecasts: KENILWORTH, N.J. (AP) ‚Äî Merck & Co. (Merck) on Tuesday reported third-quarter net‚Ä¶ https://t.co/WXy1sabJDU
Missed yesterday's news?Here's what to know  pharma  GSK  FDA  IPO  SEPR  CYNA  BMY  Merck  cancer  medical‚Ä¶ https://t.co/b83sRl10KS
Merck's Q3 Results, Guidance Look Strong https://t.co/IER2s7X5hr  Merck
Doing regular cardio workouts is a must & a great habit I need to follow.  HomecomingOfHealth  GaiaGoodHealth
Play the  HomecomingOfHealth contest to Win Cool goodies from  GaiaGoodHealth
That's a great habit!  Jeeva_Ananth  GaiaGoodHealth  HomecomingOfHealth
Merck raises its full-year forecast because one drug has been crushing it (Merck) https://t.co/lCeOGKn0i8  business  news
Merck raises its full-year forecast because one drug has been crushing it (Merck)  news https://t.co/1a3OASdJcM https://t.co/hZiV6vwGro
Merck raises its full-year forecast because one drug has been crushing it (Merck): Thomson ReutersMerck & Co In... https://t.co/U4LlwE26wz
Merck raises its full-year forecast because one drug has been crushing it (Merck) https://t.co/bs9jRsPMWy  MGWV  TFB  F4F
Business Merck raises its full-year forecast because one drug has been crushing it (Merck) https://t.co/c2pNVtHAXr
Merck raises its full-year forecast because one drug has been crushing it (Merck) https://t.co/cQP1fB2Q47  businessinsider
Merck raises its full-year forecast because one drug has been crushing it (Merck): Thomson Reuters... https://t.co/aA1ZtUqzTJ  TaNeaOnline
Merck raises its full-year forecast because one drug has been crushing it (Merck): Thomson Reute... https://t.co/XDpmQyC6GI  AceNewsReport
 business Merck raises its full-year forecast because one drug has been crushing it (Merck): Thomson ReutersMer... https://t.co/DQuIt1R9Cf
Merck raises its full-year forecast because one drug has been crushing it (Merck): Thomson Reut... https://t.co/1MwsstrFVv  business  news
Merck beats Street 3Q forecasts: Merck & Co. (Merck) on Tuesday reported third-quarter net income of  2.18 billion.‚Ä¶‚Ä¶ https://t.co/qPRxVOcPbS
To indulge in outdoor sport activities like swimming & badminton rather than binge TV watching on couch.  GaiaGoodHealth  HomecomingOfHealth
 news Merck beats Street 3Q forecasts: KENILWORTH, N.J. (AP) ‚Äî Merck & Co. (Merck) on Tuesday reported third-qu... https://t.co/1FSyaWS0Om
 Merck: Merck Announces Third-Quarter 2016 Financial Results | Merck Newsroom Home https://t.co/y8xVbQaf3u
 Merck  P&G  CAT  TWTR  NFLX  T  TWX:

Wait for this signal before buying the dip on gold:

https://t.co/mmWAXPAUkD
 AccernAlert  adamfeuerstein:  Merck Keytruda Q3 sales  356M, short of  368M consensus, although more focus will be on y‚Äôday‚Äôs 1st lin  stocks
A8) It's Cutiepie.  MissMalini  MISSMALINIxoADHM  MMTriviaTuesday
 Merck Q3: It's all about  Keytruda 
https://t.co/bubgqsOTzZ 
 pharma  biotech  FDA
I want to give up on drinking soda carbonated drinks from this Diwali!  GaiaGoodHealth  HomecomingOfHealth
(Canadian Business): Merck beats  Street 3Q forecasts : KENILWORTH, N.J. (AP) _ Merck & Co. (Merck) on Tuesday.. https://t.co/VsBDryWgef
Raj Mrk üëåüëçüëçüëçüëçüëç
Another Good Performance üíü https://t.co/sWVkCqG9pX
A7) Lisa Haydon makes an appearance in the breakup song.  MissMalini  MISSMALINIxoADHM  MMTriviaTuesday
Trading the cup and handle is a great strategy to play breakouts in strong stocks.  aapl  mrk  spx  trading‚Ä¶ https://t.co/DbxZcLLK6l
Watch, Enjoy & Win big here - https://t.co/haYjH0ZBdz  ZakirKhansDiwaliParty is full on awesomeness!
I can so understand the excitement for  ZakirKhansDiwaliParty  aziznava1 https://t.co/haYjH0ZBdz
Merck  Merck Tops Q3 EPS by 8c; Narrows FY16 Outlook https://t.co/HnIyWXyPOf
Exciting goodies from  GaiaGoodHealth are to be won! Do participate in the  HomecomingOfHealth contest!  saibaz92  Sudip1210
Check out the highlights from this morning‚Äôs financial results.  Merck https://t.co/rIbAv4oXsL
Eatwell  katuraaaaay üòÄüòÄ
Exciting merchandise & Bose headphones signed by Ranbir can all be yours! Play  MISSMALINIxoADHM  MMTriviaTuesday contest now!  MissMalini
 Merck  CNBC reporting ‚¨áÔ∏è30% Remicade Revenue- look for partnering to fight biosimilars https://t.co/VNkcyjY0xD  HALO
A6) Alia Bhatt  aliaa08 has a cameo in ADHM.  MissMalini  MISSMALINIxoADHM  MMTriviaTuesday
A5) Channa Mereya is Ranbir Kapoor's favorite song from ADHM.  MissMalini  MISSMALINIxoADHM  MMTriviaTuesday
Never skip the habit of practicing yoga & meditation.  GaiaGoodHealth  HomecomingOfHealth
 Merck raises guidance
 Merck beats on EPS and Revenues.  tradetalk  trade  stocks  StockTwits
Want to include lot of fruits & veggies to my diet and completely avoid fat fried foods.  GaiaGoodHealth  HomecomingOfHealth
Good health leads to a better living!  GaiaGoodHealth  HomecomingOfHealth
And, Don't miss to win awesome Prizes too!  nony_garg  ZakirKhansDiwaliParty is so epic https://t.co/haYjH0ZBdz
Merck & Co. raises annual guidance as third-quarter profit, sales rise https://t.co/YTTEFjm31D  Merck
Whoa! iPhone7 & other exciting prizes are also to be won with  ZakirKhansDiwaliParty https://t.co/haYjH0ZBdz
Merck earnings:  1.07 a share, vs 99 cents estimate  Merck  Merckearnings https://t.co/9lsrvx1v7X https://t.co/a6SwuMSSll
Thoroughly enjoying the dhanbola game with  ZakirKhansDiwaliParty here - https://t.co/haYjH0ZBdz
 Merck & Co. Stake Increased by VNBTrust National Association. Read more: https://t.co/PbASSYwGv4  Merck
This is the habit I wanna practice & make it a routine this Diwali.   GaiaGoodHealth  ContestBoard  HomecomingOfHealth
 Merck:

Merck earnings, revenue top expectations:

https://t.co/Asavx18Z8o
A4) lehenga weighed 20 kilos & She had to climb the stairs 25-30 times a day in the palace.  MissMalini  MMTriviaTuesday  MISSMALINIxoADHM
Merck  Merck with an earnings beat in Q3. Up 3% in premarket
https://t.co/o9YmQ5BoeingFM
 Merck 3Q Keytruda sales were  356M. That's about right in line with estimates. https://t.co/bj80ANQP1M https://t.co/XYJ8OdnNBY
Merck's stock surges 2.8% premarket after Q3 results https://t.co/N80hRbsqdA
Merck beats by  0.09, beats on revenue  Merck https://t.co/CpLgUsvIMx
Never ever skip my breakfast as it's the most important meal that Kickstarts the day.  GaiaGoodHealth  HomecomingOfHealth
I'm already tuned into  ZakirKhansDiwaliParty & so enjoying it!  raj50boy  ebayindia ¬†https://t.co/haYjH0ZBdz
Tweeps,  MISSMALINIxoADHM  MMTriviaTuesday contest is now live! Don't miss to play & Win awesome Prizes from‚Ä¶ https://t.co/jCn0yoZFJC
Merck now sees 2016 adj. EPS  3.71- 3.78; FactSet consensus  3.75 https://t.co/N80hRbsqdA
Merck Q3 adj. EPS  1.07; FactSet consensus 99 cents https://t.co/N80hRbsqdA
Merck Q3 EPS 78 cents vs. 64 cents a year ago https://t.co/N80hRbsqdA
I want to go early to bed & rise up early in the morning and want to Workout without missing any day.  GaiaGoodHealth  HomecomingOfHealth
Chicken with peanut sauce!!! So awesome ‚ù§Ô∏è‚ù§Ô∏è‚ù§Ô∏è‚ù§Ô∏èüëåüëåüòÉüòÉ  foodporn  food  peanutsauce  chinesefood  ‚Ä¶ https://t.co/mZ9SvjA5c9
 Merck Keytruda Q3 sales  356M misses consensus of  386M

ZEPATIER Q3 sales  164M misses consensus of  172M
I feel like I'd know more alternative routes around Dublin than most of these guys that have been a taxi driver for‚Ä¶ https://t.co/Qq1OImnZlz
Big Church Day, In  TGNCLondon With Our Papa  UebertAngel Is Around The Corner, I JUST C A N T WAIT !! üéâ‚ù§Ô∏è https://t.co/FapPmoe3uR
MarketCurrents: Merck beats by  0.09, beats on revenue https://t.co/bDhlxBjhyc  premarket  Merck
adamfeuerstein:  Merck Keytruda Q3 sales  356M, short of  368M consensus, although more focus will be on y‚Äôday‚Äôs 1st line lung approval.
Benzinga: 12 Stocks You Should Be Watching Today https://t.co/EgqB9yALDb  Apple  CAT  ESRX  GM  P&G  V  LLY  LMT  MMM  SONC  Merck
 Merck Beat this am the options market was pricing a move of ¬±2.6% move.
https://t.co/ZMWD549FMP
 Merck Merck Announces Third-Quarter 2016 Financial Results https://t.co/h3BQQ4bTsQ
 Merck:

Merck (Merck) Tops Q3 EPS by 8c; Narrows FY16 Outlook:

https://t.co/VreSWvnzA5
Three questions of the  MISSMALINIxoADHM contest is already out! Head to  MissMalini answer & Win exciting Prizes!  MMTriviaTuesday
EARNINGS ALERT: Merck EPS beats  1.07 (adj.) vs.  0.99 (est.)  ‚Ä¢  revs. beat  10.536B vs.  10.177B (est.)

 Merck
 Merck reported earnings of  1.07, consensus was  0.98
 Merck Keytruda Q3 sales  356M, short of  368M consensus, although more focus will be on y‚Äôday‚Äôs 1st line lung approval.
A3) 'Baby Jo'.  :D  MISSMALINIxoADHM  MMTriviaTuesday  MissMalini  karanjohar
Follow  Merck for this morning's live 3Q Sales and Earnings Coverage starting at 8AM ET https://t.co/vTCsHDLt7Y
 Merck:

Merck Announces Third-Quarter 2016 Financial Results:

https://t.co/crKTQ9CyOD
 Merck Merck Announces Third-Quarter 2016 Financial Results... - https://t.co/cdT7bKtwKc
Oh yes!  ZakirKhansDiwaliParty is loaded with full of fun & so entertaining! Must Watch here - ¬†https://t.co/haYjH0ZBdz
Livesquawk:  Merck Merck & Co Q3 16 Earnings Results:
-Adj EPS:  1.07 (Estimate  0.99)
-Revenue:  10.5B (Estimate  10.2B)
Merck beats by  0.09, beats on revenue https://t.co/KAh9UYs15X  premarket  Merck
Merck raises guidance.
From late y'day: FDA: Keytruda Now OK For Some Patients With Untreated Lung Cancer https://t.co/aAfnQYEQAC by  alexlash  Merck  BMY
Make your evening an amazing one by Watching  ZakirKhansDiwaliParty live on  ebayindia Facebook page -  ¬†https://t.co/haYjH0ZBdz
Click here to see our 3Q financial results: https://t.co/iIQaDOssIx  Merck
 Merck Merck & Co Q3 16 Earnings Results:
-Adj EPS:  1.07 (Estimate  0.99)
-Revenue:  10.5B (Estimate  10.2B)
Whoa! Epic Prizes are up for grabs! Do Watch  ZakirKhansDiwaliParty here now ¬†https://t.co/haYjH0ZBdz
12 Stocks You Should Be Watching Today https://t.co/1nc2GrVFHr  Apple  CAT  ESRX  GM  P&G  V  LLY  LMT  MMM  SONC  Merck
I Badly wanna put an end to my overeating junk food habit & opt for healthy foods.  GaiaGoodHealth  HomecomingOfHealth
That awesomeness & heavenly moment when having mom's food at home is just priceless!  asianpaints  NoPlaceLikeHome
Yes, This Diwali let's pledge for a fit & healthy lifestyle with  GaiaGoodHealth  HomecomingOfHealth
Follow  MissMalini & participate in the  MISSMALINIxoADHM  MMTriviaTuesday contest to Win Cool Bose headphones signed by Ranbir Kapoor!
Woo-hoo! Totally, I'm already in love with the  MMTriviaTuesday  MISSMALINIxoADHM contest!  MissMalini
So true! It's Time to get on the Active Mode & kill the Laziness this festive season.  GaiaGoodHealth  ContestBoard  HomecomingOfHealth
I wanna get back into my habit of Cycling. Been totally missing it due to my laziness!  GaiaGoodHealth  HomecomingOfHealth
A1) An Evening in Paris.  MissMalini  AnushkaSharma  MISSMALINIxoADHM  MMTriviaTuesday
I want to look fit & Fab so that I can wear my favourite unfit clothes again!   GaiaGoodHealth  ContestBoard  HomecomingOfHealth
 iamHarunKanth  He is Raj Merck, get his dubmash in youtube....
 NoPlaceLikeHome Loved how Meha beautiful thoughts on the home & inspiration behind it. Watch - https://t.co/ZlT32lPX9G  asianpaints
US OKs First-Line Use Of  Merck ‚Äôs Keytruda In Lung Cancer  https://t.co/eddGuBbym5
Buy  Merck  gowns for  women at lowest price from  Evesplacefashions, Australia. 
https://t.co/2nBucVmYDJ https://t.co/W3B1Xwo6eH
The  Home brings all sweet & unforgettable memories with your dear ones!  NoPlaceLikeHome is a true thing!  asianpaints
Buy latest 2016 collection of  Merck  Dresses online from  Evesplacefashions, Australia. 
https://t.co/MSbXEMppkJ https://t.co/HtZdQJeSue
Tweeps! Why Home is special & inspiring Do know about it from  asianpaints  NoPlaceLikeHome video https://t.co/ZlT32lPX9G
¬© from the very supportive  mrk_ly üíó https://t.co/9eWRnxn8oZ
mrk frncs blldrs üíï
Wow!  asianpaints absolutely nailed it about  NoPlaceLikeHome with this amazing video https://t.co/ZlT32lPX9G
Btw, Estimated  Earnings Per Share for  Merck is  0.94 it's 1.55% of the current price https://t.co/W8qdenvlnd
Hey  raj50boy  seosmolinks Let's head over to https://t.co/W0F8wzoKG9 to watch  ZakirKhansDiwaliParty  ebayindia has surprises for us!
The Wait is over!  ZakirKhansDiwaliParty is gonna happen live at  ebayindia Facebook page https://t.co/W0F8wzoKG9 Bring it on!
 Evesplacefashions offers long dresses for  women, Buy  Merck long  dresses at very lowest price.‚Ä¶ https://t.co/Smbki0kwvR
"Online retailers who offer multiple delivery options grow their  ecommerce sales by 14%" https://t.co/04po3U4yu9
 BattleCatsHalloween Finalist  8: Mrk Sjr (Facebook)
LIKE to vote for this design to win the Grand Prize! https://t.co/b12uTudJtf
Woo-hoo! Just half an hour to go for  ZakirKhansDiwaliParty So geared up for the fun filled event! https://t.co/Drd6Uychlu
Hell Yeah! My Excitement is over the top for the surprise of  ZakirKhansDiwaliParty to unfold! https://t.co/228vgMFDj0
Win  OnePlusDiwali contest & have dinner with the founders of OnePlus. Go participate now https://t.co/1jCCk0MyVs  
 Merck_herE
Can't wait for the clock to strike 4PM today! Evening is all set with  ZakirKhansDiwaliParty  Zakirism https://t.co/qre9ZALzW6
I'm so curious & Damn excited for  ZakirKhansDiwaliParty https://t.co/FwS92f29yW
Can't wait to enjoy for the hilarious ride this evening!  ZakirKhansDiwaliParty  Zakirism https://t.co/UJDaK822nM
Home is a great place that teaches me a lot & makes me to Work hard to reach my goals  asianpaints  NoPlaceLikeHome
Sure this will prompt analysts to reconsider the potential of  Keytruda vs  Opdivo -  Merck  BMY https://t.co/DhNExJZ2HT
‚ÄúAnd Jesus said to him, "'If you can'! All things are possible for one who believes."‚Äù
Mark 9:23 ESV https://t.co/bi666SPNNA
Home is a place of dreams, happiness & awesomeness! Know more about  NoPlaceLikeHome here - https://t.co/ZlT32lPX9G  asianpaints
Such an incredible Video from  asianpaints is  NoPlaceLikeHome Tweeps, Don't miss to checkout https://t.co/ZlT32lPX9G
Super duper Excited!!! So eagerly looking forward for today's evening & enjoy  ZakirKhansDiwaliParty  Zakirism https://t.co/4OciqE1XK9
Thanks for the follow David Sussman! https://t.co/3cBFp7oraX I appreciate it! October 25, 2016 at 02:35AM mrk_dee
 Mrk_pearson I used my formula to bank over  236.708.43 in just 30 days. Try it  leonidakrayush2
 mrkhndy I did Mrk.
Haha true that! I'm All set for the laughter riot with  ZakirKhansDiwaliParty  Zakirism https://t.co/lsjAvL4Ewm
Fundamental analysis show Merck & Co  Merck is almost 10%  Undervalued before  Earnings https://t.co/OkbvKoqGMK https://t.co/KBB1rbawyU
FutureOrPast The Zip disc had a very Short life When the evolution of CD took over it.  SAPIndia  RunSimple‚Ä¶ https://t.co/L6gHu6iOWG
Totally Loved Meha 's  beautiful words in this lovely  NoPlaceLikeHome video!  asianpaints https://t.co/ZlT32lPX9G
Brace yourselves Tweeps, The  ZakirKhansDiwaliParty is coming to rock all of us!  Zakirism https://t.co/qFVTLth4Zn
 ZakirKhansDiwaliParty has made my  Tuesday a terrific one! Yay Thanks  Zakirism https://t.co/iHBovTCOTH
 mrkhndy I don't drink coffee at work anymore, Mrk. This is triggering. Please think about non-coffee drinkers before tweeting in future.
This news made my day! Just can't wait to enjoy  ZakirKhansDiwaliParty  Zakirism https://t.co/iynPhl1YzF
Everyone is going so mad & crazy about  ZakirKhansDiwaliParty  Zakirism https://t.co/FwS92f29yW
Scotty doesn't know, Scotty doesn't know üòÇüò≠üòÇüò≠üòÇ https://t.co/U7MZYzmiYo
Hi,  Merck_herE Participate 2 win surprise gifts in the  VinayakDiwali Contest send us ur crazy answers. For more info https://t.co/9tz4H302Az
You can be the lucky iPhone7 winner! Just follow  SAPIndia & take part in the  RunSimple FutureOrPast contest now! https://t.co/HVvFCgfWMg
ICYMI: Why wait? FDA gives early OK to Merck‚Äôs Keytruda for frontline lung cancer
 Merck  BMY
https://t.co/EgtMMz3KAb
Wait how is Messi still a nominee? No champions league and also he "retired" from international football.... I'm confused
Win  OnePlusDiwali contest & have dinner with the founders of OnePlus. Go participate now https://t.co/4SpTEHRGC1

 Merck_herE
You just Can't afford to miss out to Watch this great & thoughtful video from  asianpaints  NoPlaceLikeHome https://t.co/ZlT32lPX9G
That moment when you just finish having a shower .... So fucking cold üòÇüôà
Wow! Beautiful video from  asianpaints  NoPlaceLikeHome is so inspiring Do watch out - https://t.co/ZlT32lPX9G
 NoPlaceLikeHome  asianpaints It's the place loaded with amazing memories of all your life! Home is always an inspiration.
Hurry up and Send in your tweets to Win awesome Prizes from  SAPIndia Play  RunSimple FutureOrPast contest now!
by the line in that profile piece stating that it is a fee-paying school. Phew.
 NoPlaceLikeHome  asianpaints Home is a sweet place that can make me forget all the worries & makes me comfortable & happy!
I had to google it (High School, Rathgar). Pleb that I am I dunno where this places in on the private school spectrum, though am reassured
I found it because this piece about "the old boys network" neglected to mention DOB's alma mater https://t.co/azfdUe8sUT
 NoPlaceLikeHome Home is the inspiring place where all my loved ones who cares & Supports me  are there!  asianpaints
I've read the first 10 paragraphs of this and had to stop, but every word of it rings false https://t.co/CMfYBKJ7a1 https://t.co/KwFlXLKa86
 NoPlaceLikeHome  asianpaints At Home, I can be the real me & enjoy myself than any other place. Definitely Home inspires a lot!
And water is still wet https://t.co/nc3aJYgiT6
FutureOrPast The Polaroid cameras Were so cool back then that gives snaps instantly.  SAPIndia  RunSimple‚Ä¶ https://t.co/9lTqoYPL5a
FutureOrPast The Folding Maps are absolutely replaced by GPS devices for easy navigation.  SAPIndia  RunSimple  FutureOrPast
This is funny üòÇüò≠üòÇüò≠üòÇ https://t.co/23I41Gz6G0
November will legit be a chilled month for me... I ain't leaving the house unless it's work...
FutureOrPast The Transistor Radios that ruled it's time has an almost no existence.  SAPIndia  RunSimple‚Ä¶ https://t.co/pig2Ru8xJQ
And  Merck approval expansion in 2L NSCLC (now PD-L1 expression >1%) puts even more pressure on  BMY https://t.co/P4Io0Pooj6
Advantages apropos of business establishment coalescence goodwill india: mRK
FDA approves first-line use of Merck & Co.'s Keytruda in non-small-cell lung cancer https://t.co/ce6kgWlnm7  Merck
 Merck  KEYTRUDA receives FDA approval for a new indication, adding an option for certain first-line NSCLC patients https://t.co/Pe53VOZ6uB
Home - The four walls that never hold you back. Watch now to see why there is  NoPlaceLikeHome
https://t.co/SHYcwNb0XC
Yay!  asianpaints  NoPlaceLikeHome looks cool & Interesting!
If I were God: https://t.co/OrfWIQDoU4
 Update US Earnings Release for today:  P&G  NVS  Merck  MMM  LLY  UTX  LMT  DD  Apple  T  CB  CNI  ESRX  COF  EW  DFS
Hey  KananGill Any idea What's Zakir Khan gonna Surprise all today evening! So curious to know about it!
Woo-hoo! Can't Control my excitement to Know What Zakir Khan is planning for today's evening?! https://t.co/7rdVhaZRbZ
INO Slips On Clinical Hold, Merck Gets FDA Nod, Be All Ears For AKAO https://t.co/Sbm60qBOA9
FutureOrPast Fax machines played  a vital role in businesses those days. Not Anymore!  SAPIndia  RunSimple  FutureOrPast
I liked a  YouTube video https://t.co/Wfu1UIAt6p Chen & Baekhyun & Xiumin ‚Äì For You (ÎÑàÎ•º ÏúÑÌï¥) Color Cod/Han/Rom/Eng Lyrics
FDA OKs new indication for Merck's cancer med  Keytruda https://t.co/IAWrYaAygM  Merck
Oh yes ! I'm playing the  RunSimple FutureOrPast contest!  Dhyani1811  SAPIndia  shah_himanshu  DrMing918  nivedithg
Make your Tuesday a Winsome one with  SAPIndia  RunSimple FutureOrPast contest folks!
Time to Tweet the Technology that's no more & become obsolete to  SAPIndia with  RunSimple FutureOrPast to Win incredible prizes!
I liked a  YouTube video https://t.co/rb7ESrBdYJ Clean Bandit - Tears ft. Louisa Johnson [Official Video]
FDA approves  Merck Pembrolizumab for treatment of NSCLC with high PD-L1 expression. https://t.co/qgjFk14QQ6
iPhone7,Smartwatches & Flipkart Vouchers are to be won! Have you participated in the  SAPIndia  RunSimple FutureOrPast contest yet.
Now tracking: Pre-Market  earnings Report for October 25, 2016 : P&G, Merck, MMM, LLY, UTX, LMT, DD, CAT, GM ... https://t.co/JJ1U9MGkWZ
 toronto  business : INO Slips On Clinical Hold, Merck Gets FDA Nod, Be All Ears For AKAO  https://t.co/GS3O0kzYBb
FutureOrPast The VCR players are now obsolete & are replaced with DVD players!  SAPIndia  RunSimple  FutureOrPast https://t.co/aq6i4aoaWQ
I liked a  YouTube video https://t.co/xeRugDYD18 m.rocket live jam with takete
FutureOrPast The PDAs have completely disappeared now!  SAPIndia  RunSimple  FutureOrPast https://t.co/XqYebi5H7l
 Merck FDA approves Zinplava to reduce CDI recurrence. Read more: https://t.co/VFRw2scPbG  Merck
 Merck FDA approves Keytruda as first-line NSCLC therapy. Read more: https://t.co/MUrOWPPO8B  Merck
FutureOrPast The Old CRT monitor Computers have become a rarity nowadays.  SAPIndia  RunSimple  FutureOrPast https://t.co/62fkWnx4nE
 Merck rides high on Keytruda,high potential pipeline drugs.Median 12-m price target estimate at  68, CMP + atleast10‚Ä¶ https://t.co/RN7EmPpTQS
Thanks for the retweets this week  kaziashraf007  ImManishChauhan  ItsKaraN007 much appreciated! >> Want this üÜì? https://t.co/imi85JkvUv
FutureOrPast - The Sony Walkman is totally outdated & no longer in use.  SAPIndia  RunSimple  FutureOrPast https://t.co/FNmaNRXadV
 Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment. Read more: https://t.co/E26qGNCtEr  Merck
The Gospel. https://t.co/LvpM0VQh0G https://t.co/ObZ660pfIG
US  Markets What To Expect From Merck's Q3 Earnings?: Merck Merck 160 is set to report its Q3 16 earnings on Oc... https://t.co/la8X5VzQfG
 Sudip1210  SAPIndia  CoolRaniK  Merck_herE Yes Im playing this contest buddy!!  RunSimple  FutureOrPast
Do Share your FutureOrPast entries to  SAPIndia  RunSimple  FutureOrPast to win Cool Prizes! https://t.co/Liy1U1nBuJ
Seasonal charts of companies reporting earnings today: https://t.co/n0ckGqiGeZ  MMM  AKAM  Apple  T  BHI  BoeingX  CHRW  CNI  CAT  DD  LLY  Merck
Floppy disks are now replaced by Memory cards & Hard drives for storage purposes. FutureOrPast  SAPIndia  RunSimple  FutureOrPast
 Merck(PBR70) gets  FDA approval for  lungcancer therapy  KEYTRUDA¬Æ (pembrolizumab). https://t.co/QZv2OheqA9  Merck  Pharmaceuticals
Thanks for the recent follow  jdbftlwt  Ch3apSk8_Baws  clifforddlol Happy to connect :) have a great Tuesday. >> https://t.co/j0N95e2FKy
 Sudip1210  InFocus_IN  Dhyani1811  CoolRaniK  NehaDevjani  Sensible_Mona  sujaykoner  Anupama75  Merck_herE  VHetal join  10CoreFromInFocus
Oh yeah! Can't Control my excitement for this mega  RunSimple contest! Super set for it!  promisingace  SAPIndia FutureOrPast
And you shall love the Lord your God with all your heart, with all your soul, with all your mind, an‚Ä¶
https://t.co/FxKiYHChL4
 C4ETech Dear Team plz suggest which one is best oppo f1 plus vs one plus 3 performance and camera quality.
 geekyranjit Dear Rajiv plz suggest which one is best oppo f1 plus vs one plus 3. And both phone having simple dual sim slot  or hybrid.
 OnePlusDiwaliDash ‚Çπ 1 Sale underway! https://t.co/m3cB1rlr0H
ice cream pls? '
it girl atm.
bullying.
Top 3 Smartphones from  UmiCommunity you should take a look at https://t.co/Qqg6mrpW0G Win 2 Umi Phones on  PhoneRadarBlog Do Retweet.
I have Joined  PhoneRadarBlog's Giveaway to Win a UMI Plus Smartphone & 1 for a Friend here https://t.co/WBXlCNnYN2 Follow  PhoneRadarBlog
Pre  Market earnings  Report for october 25, 2016: pg,  Mrk -  Nasdaq the  Following  Companies are expect  Cotation https://t.co/6Gcve3k02g
Wondering about  sentiment indicator for  Merck? The Short Ratio is 3.79% https://t.co/NOy4XdVwVV
 Merck_herE  phoneradarblog wanna win the umi plus for you too buddy
Whoa! Tweeps, Super awesome Prizes are waiting for the lucky ones! Do play  SAPIndia  RunSimple FutureOrPast contes‚Ä¶ https://t.co/QBw1xDpurt
Client Update: Implications for government acquiring agencies under NSW land acquisition reform https://t.co/C0uGTzwNyR
Wanna Win the Umi Plus üì± üì± for myself & my buddy  nurav21 üëçüôåüôè   phoneradarblog
I liked a  YouTube video https://t.co/PAwNp0lngr Have u seen this???TH9 VS TH11(MAX) USING GIANT+HEALER
The  RunSimple FutureOrPast contest is about to start! Do take part & get lucky to win big from  SAPIndia https://t.co/yjXiEX0Xsq
an ii....
You Can't afford to miss out playing the  RunSimple FutureOrPast contest from  SAPIndia folks!Epic Prizes to be won! https://t.co/Zd9xg762Wr
Woo-hoo! An iPhone 7 is up for stakes! Don't miss to participate in the  SAPIndia  RunSimple FutureOrPast contest now!
Calling out all Tech lovers to be a part of  RunSimple FutureOrPast contest from  SAPIndia & Win awesome Prizes!  appie_appz  sujaykoner
Thanks for the follow Bessie Rowe! https://t.co/Gzr8PVsKQ7 I appreciate it! October 24, 2016 at 10:40PM mrk_dee
Noted & Agreed with all the rules for  FutureOrPast  RunSimple contest!  SAPIndia FutureOrPast
All set for the  RunSimple  FutureOrPast  SAPIndia contest team! FutureOrPast Can't wait to Win big with you!
‚ÄúHe who believes and is baptized will be saved; but he who does not believe will be condemned.‚Äù Mark 16:16 https://t.co/ucQwASJIs7
 InFocus_IN  Join in  10CoreFromInFocus
 hemantbatra0  
 Merck_herE  
 vrsvno  
 Manimakkar_  
 Being_Akbar  
 im_AmitS  
 MagicianBoBo
Very mainit asar
iconic socks <3
U.S. FDA approves  Merck's lung cancer drug as first-line treatment. Read more: https://t.co/PFIfsrJ3wk  Merck
 Merck's Keytruda wins coveted first-line lung cancer nod, cementing rise 'from laggard to l... Read more: https://t.co/QHDqFGp4cD  Merck
Merck & Co. (Merck) Shares Bought by Alps Advisors Inc. https://t.co/mchcNtvsbX
Me duele todo mrk):
Mrk que ascoooo
Merck & Co. (Merck) Stake Increased by VNBTrust National Association https://t.co/NelZkK07dO
MU Investments Co. Ltd. Cuts Stake in Merck & Co.  Merck https://t.co/fHKntxLaS6
Merck IS AOACUTUE IM STANBJNG
Merck & Co.  Merck Shares Bought by Alps Advisors Inc. https://t.co/qDfsbrpoWj
Bartlett & Co. LLC Buys 4,169 Shares of Merck & Co.  Merck https://t.co/Z0NaLpuuDo
 PatMcAfeeShow  RealSkipBayless OH SHIT LMAO HAHAHAHAHA damn! That was cold üòÅ
Limited by money? Try trading your skills for experiences to get more out of life. From https://t.co/78d7lXEfOz‚Ä¶ https://t.co/7ifXtAs8TT
City And Colour - "Waiting..." [Official Video] https://t.co/aopQX8oGJJ !!!
Now your heart beats on me forever „Ä∞  Tattoo  ToughSticker‚Ä¶ https://t.co/8fcf33DAeN
Merck & Co.  Merck Stake Increased by VNBTrust National Association https://t.co/B0vV2W9tnq
 mrk_thms2 I miss sharing the stage with you love üíú
Merck & Co.  Merck Shares Bought by First Midwest Bank Trust Division https://t.co/xJu6iKr6SH
La Rola !!! City and Colour - Comin' Home (Official Video) https://t.co/cokGEz5qSN
If you have a social media account but don't want to be spoiled on the most popular shows currently on tv, I've got bad news for you...
O sea no me sirve mrk, necesito food.
April Earnings To Watch | ABBV | GILD | PFE | Merck https://t.co/xO3sG35Mzp
Highest Calls & Puts ratio vs OI for notable companies reporting 10/25:  Apple  CAT  UA  GLW  WHR  Merck  P&G  LMT  GM https://t.co/nxKDrLjHnb
 Merck weak since ESMO Roche Data, now at gap support - earnings AM  https://t.co/Ht3wvh9Ly9 via https://t.co/11Wpw9y7t1
 FHS_Rozy I prefer not to hit, but what a great debate to have with students!  FHSTsinAction https://t.co/biqikKJIQL
Jesus replied, ‚ÄúYour mistake is that you don‚Äôt know the Scriptures, and you don‚Äôt know the power of God.‚Ä¶
https://t.co/1XR1wMqkOz
I added a video to a  YouTube playlist https://t.co/zNTDWfOgSW Top 14 Tips & Tricks | IELTS Reading: Part-01 | Merck IELTS
HamilHawksüò≥  laurenkotarski https://t.co/WzYH0pyvjA
Thanks for the follow Rob Filardo! https://t.co/QrACTdfo64 I appreciate it! October 24, 2016 at 08:15PM mrk_dee
5 things for  pharma  marketers to know:Mon, Oct 24  GSK  FDA  IPO  SEPR  CYNA  BMY  Merck  cancer  medical‚Ä¶ https://t.co/kN5ztACrlL
Mrk noooooo Glenn!!! T^T https://t.co/sTXKdF6p4X
 FDA Approves  Merck‚Äôs  KEYTRUDA¬Æ (pembrolizumab) in  Metastatic  NSCLC for First-Line Treatment  Merck  lungcancer  https://t.co/tQPQQBdXtj
What happened to Markiplier? "One day I woke up and got really stupid and then I started making Youtube videos" Mrk x'DDD   Markiplier
 mrk_thms2 miss you too bud
 FiercePharma Seriously  fiercepharma has a hard on the size of Florida for anything  Merck
. FoothillVB2016 Girls VB in EBoeingL Playoffs! Host Dougherty Valley on Tues. 10/25 at FHS 6:00 PM. Come out to support!  FalconPride
 gilneyabreu mrk dont be like this :(
 braydonm10 miss ya stud
Merck  Merck drug gets FDA approval as a first-line lung cancer treatment https://t.co/6SjALa9mle via  WSJ
Nd thtas why amitabh is megaster bt bunis nt up t mrk karanjohar
Great news for shareholders and more importantly, cancer patients! Glad this came early.  Merck https://t.co/MpAOvDS72m
We exercise  psychic  ability daily and do not even know it.
A great book by Mark Changizi demystifies  ESP
https://t.co/OdZk8OM2aC
 Keytruda approved for first-line non-small cell  LungCancer.  Merck https://t.co/RhT9ObxqO3
Yup ..... we are going to go at LEAST half a season with Rick being negans bitch. Yea mRk my words it will be a... https://t.co/wJGXxSa7ft
Zeroing in on  Merck rival,  GSK steps up to the  FDA with its top new  vaccine prospect https://t.co/omQE7ZtbRY‚Ä¶ by  JohnCendpts
 leftytwylite  illogicalshow  forcngpodcast Damn skippy you should.
Merck's Keytruda wins coveted first-line lung cancer nod, cementing rise 'from laggard to leader' https://t.co/hR68xUX0U4  Merck  BMY  pharma
 Merck Keytruda approved in first-line NSCLC will definitely hear more about plans in earnings call tomorrow, groundbreaking news
Money Flows: Buying on Weakness: Among stocks that were down Mon, these had the largest net INFLOWS of money  LQD  CVX  PFE  Merck  T  GE top6
 Steveonomics  tjpridonoff For me, bonds just keep me sane when the mrk goes crazy. Most important thing is to stick to the plan.
 braydonm10 TBH it sounds like my mom
 mrk_thms2 wow stud
If  Charlotte doesn't do a black flip off the cell on Sunday match garbage
Just watched TOC from senior year and forgot I used to have random girls cat call me while dancing üôÉ
White people doing white people things https://t.co/dqK6K1gPEm
‚ÄúJesus called the crowd to him along with his disciples. He said, "If anyone wants to come after me, he must say n‚Ä¶‚Äù https://t.co/ngrdknq4Qm
 SashaBanks toooooooo LIT
Biotech Stock News (CLDN) (BLUE) (QURE) (ONCE)... https://t.co/rKRV1CgP7o
 VRX  AGN  SRPT  PRGO  MYL  Merck

Did someone say Valeant Price Appreciation Credits?
Goodmorning üòä
Notable historical earnings reactions for 10/25:  Apple  UA  CAT  GM  CMG  P  LMT  P&G  DD  LLY  AMTD  PNRA  Merck  S https://t.co/lbjB4QXMAM
 findmebyotch HAHAHAHAHA mrk! Fullero!! Este domingo again. 
Say yes say yes say yes say yes https://t.co/5LoSTMSy0N
 CarlosPerez414 you catching this fade when I see you
Mrk las morenas somos bellas.
Thanks for the follow Jason Squires! https://t.co/kh1WuTKACx I appreciate it! October 24, 2016 at 06:15PM mrk_dee
Thanks for the follow TheNCBGroup! https://t.co/7Bf9EHbnkQ I appreciate it! October 24, 2016 at 06:15PM mrk_dee
We calculated 21-day Expected Return of  Merck for you: -2.76% https://t.co/y7B8KCMIS5
My life imploded on itself today
Thanks for the follow David D. Simons! https://t.co/35eZfI7cGp I appreciate it! October 24, 2016 at 06:10PM mrk_dee
6  LifeHacks Learned in Prison That Will Maximize Your  Productivity https://t.co/3Z4ealIXUE
October 25, stocks for watch:  SAEX,  CRDS,  CLUB,  Merck,  BIOC
Do you know that  Book Value for  Merck is  15.68 https://t.co/dScBsTv2Og
Jesus heals a girl and we learn a hard lesson at the same time. https://t.co/4IikMMqFhk
 Mrk_414 drake secretly a pusha t fan trying to keep him revelant lmao
 carogoddess shito mrk, la burla ese user ugh.
 VRX  AGN  PRGO  Merck  MYL

Valeant's Q3 Scripts look to be down slightly but far more profitable.
I'm mad cause I know you serious lmao https://t.co/NjzWGynxtf
 Merck  Merck.XE:

Merck Drug Gets FDA Approval as a First-Line Lung Cancer Treatment:

https://t.co/dWOK1FKPYq
 VRX  AGN  MYL  Merck  jasoninthehouse   elizabethforma  RepCummings  please contact me if David Maris of Wells Fargo tries to influence you.
Not sure what to do with  Merck? Explore our  fundamental pros and cons.  https://t.co/XR2kWaKRQ7
finzine:  Merck Merck Drug Gets FDA Approval as a First- Line Lung Cancer Treatment https://t.co/MJQUA1WzBn
ESTA PASANDO FORBIDDEN VOICES Merck MAH FILSSSSüò≠üò≠üíî
 VRX  AGN  SRPT  MYL  Merck  PRGO

Maris at Wells Fargo is Running Out of Ammunition. Look for Legal or Quality Rehash. He's at.Pivot Time!
 Merck Merck Drug Gets FDA Approval as a First- Line Lung Cancer Treatment https://t.co/dRbOu67uIW
 Merck: Merck: FDA approves KEYTRUDA (pembrolizumab) in metastatic NSCLC for first-line treatment https://t.co/PeXrUhxWNR
 Merck Stock Option Volume Spikes 2.3x its the option traders are pricing a ¬±2.6% move. https://t.co/ZMWD549FMP https://t.co/pvZmjtCvkd
Mrk esto https://t.co/TDyFmumvLc
FDA approves KEYTRUDA (pembrolizumab) in metastatic NSCLC for first-line treatment.  Merck
 Real_Estate_Mrk  globalnews well gives the common folk a break at buying a home
 Merck | FDA approves  Merck's KEYTRUDA¬Æ  for  Advanced Melanoma /cancer
First&Only Anti-PD-1 Compared to Ipilimumab
https://t.co/hThjsxIU3h
 nightriots at the  newnoisesb block party. Shot with  CanonUSAimaging 5d Mrk III with Canon 24-70mm f2.8 &‚Ä¶ https://t.co/gta7nK8FlP
gn everyone, fred & sirius r actually alive, also i love my ratia and mrk üíì
